Variation in electrode parameters and deflectable electrode to modify energy density and tissue interaction

Information

  • Patent Grant
  • 12053224
  • Patent Number
    12,053,224
  • Date Filed
    Friday, May 29, 2020
    4 years ago
  • Date Issued
    Tuesday, August 6, 2024
    4 months ago
Abstract
An end-effector is disclosed. The end-effector includes a clamp arm and an ultrasonic blade configured to acoustically couple to an ultrasonic transducer and electrically couple to a pole of an electrical generator. The clamp arm includes a clamp jaw and an electrode configured to electrically couple to an opposite pole of the electrical generator. In one configuration, the electrode is segmented. In another configuration, the ultrasonic blade includes electrically insulative material deposited on selected areas to prevent electrical shorting in the event of the ultrasonic blade contacts the electrode. In another configuration, the clamp arm, the ultrasonic blade, or both include selectively coated components.
Description
TECHNICAL FIELD

The present disclosure generally relates to end-effectors adapted and configured to operate with multiple energy modalities to enable tissue sealing and cutting employing simultaneously, independently, or sequentially applied energy modalities. More particularly, the present disclosure relates to end-effectors adapted and configured to operate with surgical instruments that employ combined ultrasonic and electrosurgical systems, such as monopolar or bipolar radio frequency (RF), to enable tissue sealing and cutting employing simultaneously, independently, or sequentially applied ultrasonic and electrosurgical energy modalities. The energy modalities may be applied based on tissue parameters or other algorithms. The end-effectors may be adapted and configured to couple to hand held or robotic surgical systems.


BACKGROUND

Ultrasonic surgical instruments employing ultrasonic energy modalities are finding increasingly widespread applications in surgical procedures by virtue of the unique performance characteristics of such instruments. Depending upon specific instrument configurations and operational parameters, ultrasonic surgical instruments can provide substantially simultaneous cutting of tissue and hemostasis by coagulation, desirably minimizing patient trauma. The cutting action is typically realized by an end-effector, ultrasonic blade, or ultrasonic blade tip, at the distal end of the instrument, which transmits ultrasonic energy to tissue brought into contact with the end-effector. An ultrasonic end-effector may comprise an ultrasonic blade, a clamp arm, and a pad, among other components.


Some surgical instruments utilize ultrasonic energy for both precise cutting and controlled coagulation. Ultrasonic energy cuts and coagulates by vibrating a blade in contact with tissue. Vibrating at high frequencies (e.g., 55,500 times per second), the ultrasonic blade denatures protein in the tissue to form a sticky coagulum. Pressure exerted on tissue with the blade surface collapses blood vessels and allows the coagulum to form a hemostatic seal. The precision of cutting and coagulation is controlled by the surgeon's technique and adjusting the power level, blade edge, tissue traction, and blade pressure.


Electrosurgical instruments for applying electrical energy modalities to tissue to treat, seal, cut, and/or destroy tissue also are finding increasingly widespread applications in surgical procedures. An electrosurgical instrument typically includes an instrument having a distally-mounted end-effector comprising one or more than one electrode. The end-effector can be positioned against the tissue such that electrical current is introduced into the tissue. Electrosurgical instruments can be configured for bipolar or monopolar operation. During bipolar operation, current is introduced though a first electrode (e.g., active electrode) into the tissue and returned from the tissue through a second electrode (e.g., return electrode). During monopolar operation, current is introduced into the tissue by an active electrode of the end-effector and returned through a return electrode such as a grounding pad, for example, separately coupled to the body of a patient. Heat generated by the current flowing through the tissue may form hemostatic seals within the tissue and/or between tissues and thus may be particularly useful for sealing blood vessels, for example. The end-effector of an electrosurgical instrument also may include a cutting member that is movable relative to the tissue and the electrodes to transect the tissue. Electrosurgical end-effectors may be adapted and configured to couple to hand held instruments as well as robotic instruments.


Electrical energy applied by an electrosurgical instrument can be transmitted to the instrument by a generator in communication with the hand piece. The electrical energy may be in the form of radio frequency (“RF”) energy. RF energy is a form of electrical energy that may be in the frequency range of 200 kilohertz (kHz) to 1 megahertz (MHz). In application, an electrosurgical instrument can transmit low frequency RF energy through tissue, which causes ionic agitation, or friction, in effect resistive heating, thereby increasing the temperature of the tissue. Because a sharp boundary is created between the affected tissue and the surrounding tissue, surgeons can operate with a high level of precision and control, without sacrificing un-targeted adjacent tissue. The low operating temperatures of RF energy is useful for removing, shrinking, or sculpting soft tissue while simultaneously sealing blood vessels. RF energy works particularly well on connective tissue, which is primarily comprised of collagen and shrinks when contacted by heat.


The RF energy may be in a frequency range described in EN 60601-2-2:2009+A11:2011, Definition 201.3.218—HIGH FREQUENCY. For example, the frequency in monopolar RF applications may be typically restricted to less than 5 MHz. However, in bipolar RF energy applications, the frequency can be almost anything. Frequencies above 200 kHz can be typically used for monopolar applications in order to avoid the unwanted stimulation of nerves and muscles that would result from the use of low frequency current. Lower frequencies may be used for bipolar applications if the risk analysis shows the possibility of neuromuscular stimulation has been mitigated to an acceptable level. Normally, frequencies above 5 MHz are not used in order to minimize the problems associated with high frequency leakage currents. Higher frequencies may, however, be used in the case of bipolar applications. It is generally recognized that 10 mA is the lower threshold of thermal effects on tissue.


Ultrasonic surgical instruments and electrosurgical instruments of the nature described herein can be configured for open surgical procedures, minimally invasive surgical procedures, or non-invasive surgical procedures. Minimally invasive surgical procedures involve the use of a camera and instruments inserted through small incisions in order to visualize and treat conditions within joints or body cavities. Minimally invasive procedures may be performed entirely within the body or, in some circumstances, can be used together with a smaller open approach. These combined approaches, known as “arthroscopic, laparoscopic or thoracoscopic-assisted surgery,” for example. The surgical instruments described herein also can be used in non-invasive procedures such as endoscopic surgical procedures, for example. The instruments may be controlled by a surgeon using a hand held instrument or a robot.


A challenge of utilizing these surgical instruments is the inability to control and customize single or multiple energy modalities depending on the type of tissue being treated. It would be desirable to provide end-effectors that overcome some of the deficiencies of current surgical instruments and improve the quality of tissue treatment, sealing, or cutting or combinations thereof. The combination energy modality end-effectors described herein overcome those deficiencies and improve the quality of tissue treatment, sealing, or cutting or combinations thereof.


SUMMARY

In one aspect, an apparatus is provided for dissecting and coagulating tissue. The apparatus comprises a surgical instrument comprising an end-effector adapted and configured to deliver a plurality of energy modalities to tissue at a distal end thereof. The energy modalities may be applied simultaneously, independently, or sequentially. A generator is electrically coupled to the surgical instrument and is configured to supply a plurality of energy modalities to the end-effector. In one aspect, the generator is configured to supply electrosurgical energy (e.g., monopolar or bipolar radio frequency (RF) energy) and ultrasonic energy to the end-effector to allow the end-effector to interact with the tissue. The energy modalities may be supplied to the end-effector by a single generator or multiple generators.


In various aspects, the present disclosure provides a surgical instrument configured to deliver at least two energy types (e.g., ultrasonic, monopolar RF, bipolar RF, microwave, or irreversible electroporation [IRE]) to tissue. The surgical instrument includes a first activation button for activating energy, a second button for selecting an energy mode for the activation button. The second button is connected to a circuit that uses at least one input parameter to define the energy mode. The input parameter can be modified remotely through connection to a generator or through a software update.


In one aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, the at least one electrode acts a deflectable support with respect to an opposing ultrasonic blade. The at least one electrode crosses over the ultrasonic blade and is configured to be deflectable with respect to the clamp arm having features to change the mechanical properties of the tissue compression under the at least one electrode. The at least one electrode includes a feature to prevent inadvertent contact between the electrode and the ultrasonic blade.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, the movable clamp jaw comprises at least one non-biased deflectable electrode to minimize contact between the ultrasonic blade and the RF electrode. The ultrasonic blade pad contains a feature for securing the electrode to the pad. As the pad height wears or is cut through, the height of the electrode with respect to the clamp jaw is progressively adjusted. Once the clamp jaw is moved away from the ultrasonic blade, the electrode remains in its new position.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, the at least one bipolar RF electrode is deflectable and has a higher distal bias than proximal bias. The bipolar RF electrode is deflectable with respect to the clamp jaw. The end-effector is configured to change the mechanical properties of the tissue compression proximal to distal end to create a more uniform or differing pattern of pressure than due to the clamping alone.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, the bipolar RF electrode is deflectable and the end-effector provides variable compression/bias along the length of the deflectable electrode. The end-effector is configured to change the mechanical properties of the tissue compression under the electrodes based on clamp jaw closure or clamping amount.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. The one aspect, the pad includes asymmetric segments to provide support for the ultrasonic blade support and the electrode is movable. The asymmetric segmented pad is configured for cooperative engagement with the movable bipolar RF electrode. The segmented ultrasonic support pad extends at least partially through the bipolar RF electrode. At least one pad element is significantly taller than a second pad element. The first pad element extends entirely through the bipolar RF electrode and the second pad element extends partially through the bipolar RF electrode. The first pad element and the second pad element are made of dissimilar materials.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, variations in the physical parameters of the electrode in combination with a deflectable electrode are employed to change the energy density delivered to the tissue and the tissue interactions. The physical aspects of the electrode vary along its length in order to change the contact area and/or the energy density of the electrode to tissue as the electrode also deflects.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, an ultrasonic transducer control algorithm is provided to reduce the power delivered by the ultrasonic or RF generator when a short circuit of contact between the ultrasonic blade and the electrode is detected to prevent damage to the ultrasonic blade. The ultrasonic blade control algorithm monitors for electrical shorting or ultrasonic blade to electrode contact. This detection is used to adjust the power/amplitude level of the ultrasonic transducer when the electrical threshold minimum is exceeded and adjusts the transducer power/amplitude threshold to a level below the minimum threshold that would cause damage to the ultrasonic blade, ultrasonic generator, bipolar RF electrode, or bipolar RF generator. The monitored electrical parameter could be tissue impedance (Z) or electrical continuity. The power adjustment could be to shut off the ultrasonic generator, bipolar RF generator, of the surgical device or it could be a proportionate response to either the electrical parameter, pressure, or time or any combination of these parameters.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, the clamp jaw features or aspects are provided in the clamp ram to minimize tissue sticking and improve tissue control. The clamp arm tissue path or clamp area includes features configured to adjust the tissue path relative to the clamp arm/ultrasonic blade to create a predefined location of contact to reduce tissue sticking and charring.


In another aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In one aspect, a partially conductive clamp arm pad is provided to enable electrode wear through and minimize electrical shorting between the ultrasonic blade and the bipolar RF electrode. The clamp arm pad includes electrically conductive and non-conductive portions allowing it to act as one of the bipolar RF electrodes while also acting as the wearable support structure for the ultrasonic blade. The electrically conductive portions of the clamp ram pad are positioned around the perimeter of the pad and not positioned directly below the ultrasonic blade contact area. The electrically conductive portion is configured to degrade or wear to prevent any contact with the ultrasonic blade from interrupting the electrical conductivity of the remaining electrically conductive pad.


In addition to the foregoing, various other method and/or system and/or program product aspects are set forth and described in the teachings such as text (e.g., claims and/or detailed description) and/or drawings of the present disclosure.


The foregoing is a summary and thus may contain simplifications, generalizations, inclusions, and/or omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is NOT intended to be in any way limiting. Other aspects, features, and advantages of the devices and/or processes and/or other subject matter described herein will become apparent in the teachings set forth herein.


In one or more various aspects, related systems include but are not limited to circuitry and/or programming for effecting herein-referenced method aspects; the circuitry and/or programming can be virtually any combination of hardware, software, and/or firmware configured to affect the herein-referenced method aspects depending upon the design choices of the system designer. In addition to the foregoing, various other method and/or system aspects are set forth and described in the teachings such as text (e.g., claims and/or detailed description) and/or drawings of the present disclosure.


Further, it is understood that any one or more of the following-described forms, expressions of forms, examples, can be combined with any one or more of the other following-described forms, expressions of forms, and examples.


The foregoing summary is illustrative only and is not intended to be in any way limiting. In addition to the illustrative aspects, embodiments, and features described above, further aspects, embodiments, and features will become apparent by reference to the drawings and the following detailed description.





FIGURES

The novel features of the described forms are set forth with particularity in the appended claims. The described forms, however, both as to organization and methods of operation, may be best understood by reference to the following description, taken in conjunction with the accompanying drawings in which:



FIG. 1 is a perspective view of a clamp arm portion of an end-effector for use with a combined ultrasonic/RF device, according to at least one aspect of the present disclosure.



FIG. 2 is an exploded view of the clamp arm shown in FIG. 1, according to at least one aspect of the present disclosure.



FIGS. 3 and 4 are perspective views of the frame, according to at least one aspect of the present disclosure.



FIG. 5 is a perspective view of the electrode, according to at least one aspect of the present disclosure.



FIG. 6 is a perspective view of the clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 7 is a perspective top view of the large gap pad, according to at least one aspect of the present disclosure.



FIG. 8 is a perspective top view of the small gap pad, according to at least one aspect of the present disclosure.



FIG. 9 is a perspective bottom view of the small gap pad shown in FIG. 8.



FIGS. 10-12 illustrate an effector comprising a shortened clamp arm for deflectable/cantilever electrode applications, according to various aspects of the present disclosure, where:



FIG. 10 is a side view of an end-effector comprising a shortened clamp arm, an ultrasonic blade, an electrode, and a clamp arm pad, according to at least one aspect of the present disclosure;



FIG. 11 is a top view of the end-effector, according to at least one aspect of the present disclosure; and



FIG. 12 illustrates a clamp arm comprising a clamp jaw, an electrode, and a clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 13 illustrates an end-effector clamp arm comprising a clamp jaw, an electrode, and a clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 14 illustrates an end-effector clamp arm comprising a clamp jaw, an electrode, and a clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 15 illustrates an end-effector clamp arm comprising a clamp jaw, an electrode, and a clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 16 illustrates bottom retainer tooth that is worn away such that the electrode can move toward the clamp jaw due to the pre-formed curve, according to at least one aspect of the present disclosure.



FIG. 17 illustrates an end-effector clamp arm comprising a clamp jaw, an electrode, and a clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 18 illustrates a retainer wall with a tapered profile worn away such that there is sufficient melting/flowing away from the retainer wall with the tapered profile region to allow the electrode to move toward the clamp jaw due to the pre-formed curve, according to at least one aspect of the present disclosure.



FIGS. 19-21 illustrate an end-effector comprising a clamp arm, an ultrasonic blade, a lattice cushion, a flexible electrode disposed above the lattice cushion, and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade, according to at least one aspect of the present disclosure, where:



FIG. 19 illustrates the clamp arm open and tissue of non-uniform thickness (Ti a, Tea, Ti a) is disposed over the flexible electrode;



FIG. 20 the clamp arm is closed to compress the tissue; and



FIG. 21 is an exploded view of the end-effector shown in FIGS. 19-20.



FIG. 22 is a section view of a conductive polymer clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 23 is a perspective view of a clamp arm pad configured to replace a conventional electrode, according to at least one aspect of the present disclosure.



FIG. 24 illustrates a clamp arm comprising the clamp arm pad described in FIG. 23, according to at least one aspect of the present disclosure.



FIG. 25 illustrates clamp arm pads configured as described in FIGS. 23-24, according to at least one aspect of the present disclosure.



FIG. 26 is a section view of a clamp arm comprising a composite clamp arm pad in contact with tissue, according to at least one aspect of the present disclosure.



FIG. 27 illustrates a clamp arm comprising a clamp jaw to support a carrier or stamping attached to the clamp jaw and a clamp arm pad, according to at least one aspect of the present disclosure.



FIG. 28 is a section view taken at section 28-28 in FIG. 27.



FIG. 29 is a section view taken at section 29-29 in FIG. 27.



FIG. 30 is a section view of an alternative implementation of a clamp arm comprising a clamp jaw, an electrically conductive pad, and an electrically non-conductive pad, according to at least one aspect of the present disclosure.



FIG. 31 is a section view of an alternative implementation of a clamp arm comprising a clamp jaw, a carrier or stamping welded to the clamp jaw, an electrically conductive pad, and an electrically non-conductive pad, according to at least one aspect of the present disclosure.



FIG. 32 illustrates insert molded electrodes, according to at least one aspect of the present disclosure.



FIG. 33 illustrates an end-effector comprising an ultrasonic blade, a clamp arm, and a clamp arm pad comprising an electrically conductive film, according to at least one aspect of the present disclosure.



FIG. 34 illustrates the clamp arm shown in FIG. 33.



FIG. 35 is a section view of the clamp arm taken along section 35-35 in FIG. 34.



FIG. 36 illustrates a clamp arm comprising a partially electrically conductive clamp arm pad, according to at least one aspect of the resent disclosure.



FIG. 37 illustrates an end-effector comprising a clamp arm, an ultrasonic blade, an electrode, and a clamp arm pad, according to at least one aspect of the present disclosure.



FIGS. 38A-38F illustrate various examples of a combination ultrasonic/RF energy end-effectors comprising selectively coated components, according to at least one aspect of the present disclosure, where:



FIG. 38A illustrates an end-effector comprising selectively coated portions on the clamp arm and the ultrasonic blade, an uncoated clamp arm pad, and bare electrode portions on the clamp arm and the ultrasonic blade;



FIG. 38B illustrates an end-effector comprising selectively coated portions on the clamp arm, an uncoated ultrasonic blade, an uncoated clamp arm pad, and a bare electrode on the clamp arm;



FIG. 38C illustrates an end-effector comprising an uncoated clamp arm, selectively coated portions on the ultrasonic blade, an uncoated clamp arm pad, and a bare electrode portion on the ultrasonic blade;



FIG. 38D illustrates an end-effector comprising selectively coated portions on the clamp arm, an uncoated ultrasonic blade, an uncoated clamp arm pad, and a bare electrode on the clamp arm including a bare electrode portion at the tip of the clamp arm;



FIG. 38E illustrates an end-effector comprising an uncoated clamp arm, selectively coated portions on the ultrasonic blade, an uncoated clamp arm pad, and a bare electrode portion on the ultrasonic blade including a bare electrode portion at the tip of the ultrasonic blade; and



FIG. 38F illustrates an end-effector comprising selectively coated portions on the clamp arm and the uncoated ultrasonic blade, an uncoated clamp arm pad, and bare electrode portions on the clamp arm and the ultrasonic blade including bare electrode portions at the tip of the clamp arm and the tip of the ultrasonic blade.



FIG. 39 illustrates an end-effector comprising an ultrasonic blade, a clamp arm, and a watch-band style segmented electrode, according to at least one aspect of the present disclosure.



FIG. 40 is a magnified view of the distal and medial segments of the segmented electrode shown in FIG. 39.



FIG. 41 illustrates a surgical device comprising a mode selection button switch on the device, according to at least one aspect of the present disclosure.



FIGS. 42A-42C illustrate three options for selecting the various operating modes of the surgical device, according to at least one aspect of the present disclosure, where:



FIG. 42A shows a first mode selection option where the button switch can be pressed forward or backward to cycle the surgical instrument through the various modes;



FIG. 42B shows a second mode selection option where the button switch is pressed up or down to cycle the surgical instrument through the various modes; and



FIG. 42C shows a third mode selection option where the button switch is pressed forward, backward, up, or down to cycle the surgical instrument through the various modes.



FIG. 43 illustrates a surgical device comprising a mode selection button switch on the back of the device, according to at least one aspect of the present disclosure.



FIG. 44A shows a first mode selection option where as the mode button switch is pressed to toggled through various modes, colored light indicates the selected mode on the user interface.



FIG. 44B shows a second mode selection option where as the mode button switch is pressed to toggle through various modes a screen indicates the selected mode (e.g., LCD, e-ink).



FIG. 44C shows a third mode selection option where as the mode button switch is pressed to toggle through various modes, labelled lights indicate the selected mode.



FIG. 44D shows a fourth mode selection option where as a labeled button switch is pressed to select a mode, when a labeled button switch is selected, it is illuminated to indicate mode selected.



FIG. 45 illustrates a surgical device comprising a trigger activation mechanism, according to at least one aspect of the present disclosure.



FIG. 46 illustrates an alternative clamp arm comprising a metal clamp jaw, an electrode, a plurality of clamp arm pads, and gap pads, according to at least one aspect of the present disclosure.



FIG. 47 is a surgical system comprising a surgical hub paired with a visualization system, a robotic system, and an intelligent instrument, in accordance with at least one aspect of the present disclosure.



FIG. 48 illustrates an example of a generator, in accordance with at least one aspect of the present disclosure.



FIG. 49 is a diagram of various modules and other components that are combinable to customize modular energy systems, in accordance with at least one aspect of the present disclosure.



FIG. 50A is a first illustrative modular energy system configuration including a header module and a display screen that renders a graphical user interface (GUI) for relaying information regarding modules connected to the header module, in accordance with at least one aspect of the present disclosure.



FIG. 50B is the modular energy system shown in FIG. 50A mounted to a cart, in accordance with at least one aspect of the present disclosure.



FIG. 51 depicts a perspective view of an exemplary surgical system having a generator and a surgical instrument operable to treat tissue with ultrasonic energy and bipolar RF energy, in accordance with at least one aspect of the present disclosure.



FIG. 52 depicts a top perspective view of an end effector of the surgical instrument of FIG. 51, having a clamp arm that provides a first electrode and an ultrasonic blade that provides a second electrode, in accordance with at least one aspect of the present disclosure.



FIG. 53 depicts a bottom perspective view of the end effector of FIG. 52, in accordance with at least one aspect of the present disclosure.



FIG. 54 depicts a partially exploded perspective view of the surgical instrument of FIG. 51, in accordance with at least one aspect of the present disclosure.



FIG. 55 depicts an enlarged exploded perspective view of a distal portion of the shaft assembly and the end effector of the surgical instrument of FIG. 51, in accordance with at least one aspect of the present disclosure.





DESCRIPTION

Applicant of the present application owns the following U.S. Provisional Patent Applications, filed on Dec. 30, 2019, the disclosure of each of which is herein incorporated by reference in its respective entirety:

    • U.S. Provisional Patent Application Ser. No. 62/955,294, entitled USER INTERFACE FOR SURGICAL INSTRUMENT WITH COMBINATION ENERGY MODALITY END-EFFECTOR;
    • U.S. Provisional Patent Application Ser. No. 62/955,299, entitled ELECTROSURGICAL INSTRUMENTS FOR COMBINATION ENERGY DELIVERY; and
    • U.S. Provisional Patent Application Ser. No. 62/955,306, entitled SURGICAL INSTRUMENTS.


Applicant of the present application owns the following U.S. Patent Applications that were filed on May 29, 2020, and which are each herein incorporated by reference in their respective entireties:

    • U.S. patent application Ser. No. 16/887,499, entitled USER INTERFACE FOR SURGICAL INSTRUMENT WITH COMBINATION ENERGY MODALITY END-EFFECTOR, now U.S. Patent Application Publication No. 2021/0196345;
    • U.S. patent application Ser. No. 16/887,493, entitled METHOD OF OPERATING A COMBINATION ULTRASONIC/BIPOLAR RF SURGICAL DEVICE WITH A COMBINATION ENERGY MODALITY END-EFFECTOR, now U.S. Patent Application Publication No. 2021/0196334;
    • U.S. patent application Ser. No. 16/887,506, entitled DEFLECTABLE SUPPORT OF RF ENERGY ELECTRODE WITH RESPECT TO OPPOSING ULTRASONIC BLADE, now U.S. Pat. No. 11,786,291;
    • U.S. patent application Ser. No. 16/887,515, entitled NON-BIASED DEFLECTABLE ELECTRODE TO MINIMIZE CONTACT BETWEEN ULTRASONIC BLADE AND ELECTRODE, now U.S. Patent Application Publication No. 2021/0196306;
    • U.S. patent application Ser. No. 16/887,519, entitled DEFLECTABLE ELECTRODE WITH HIGHER DISTAL BIAS RELATIVE TO PROXIMAL BIAS, now U.S. Patent Application Publication No. 2021/0196307;
    • U.S. patent application Ser. No. 16/887,532, entitled DEFLECTABLE ELECTRODE WITH VARIABLE COMPRESSION BIAS ALONG THE LENGTH OF THE DEFLECTABLE ELECTRODE, now U.S. Patent Application Publication No. 2021/0196335;
    • U.S. patent application Ser. No. 16/887,554, entitled ASYMMETRIC SEGMENTED ULTRASONIC SUPPORT PAD FOR COOPERATIVE ENGAGEMENT WITH A MOVABLE RF ELECTRODE, now U.S. Patent Application Publication No. 2021/0196336;
    • U.S. patent application Ser. No. 16/887,568, entitled TECHNIQUES FOR DETECTING ULTRASONIC BLADE TO ELECTRODE CONTACT AND REDUCING POWER TO ULTRASONIC BLADE, now U.S. Patent Application Publication No. 2021/0196305;
    • U.S. patent application Ser. No. 16/887,576, entitled CLAMP ARM JAW TO MINIMIZE TISSUE STICKING AND IMPROVE TISSUE CONTROL, now U.S. Pat. No. 11,779,387; and
    • U.S. patent application Ser. No. 16/887,579, entitled PARTIALLY CONDUCTIVE CLAMP ARM PAD TO ENABLE ELECTRODE WEAR THROUGH AND MINIMIZE SHORT CIRCUITING, now U.S. Patent Application Publication No. 2021/0196352.


Applicant of the present application owns the following U.S. Patent Applications that were filed on May 28, 2020, and which are each herein incorporated by reference in their respective entireties:

    • U.S. patent application Ser. No. 16/885,813, entitled METHOD FOR AN ELECTROSURGICAL PROCEDURE;
    • U.S. patent application Ser. No. 16/885,820, entitled ARTICULATABLE SURGICAL INSTRUMENT;
    • U.S. patent application Ser. No. 16/885,823, entitled SURGICAL INSTRUMENT WITH JAW ALIGNMENT FEATURES;
    • U.S. patent application Ser. No. 16/885,826, entitled SURGICAL INSTRUMENT WITH ROTATABLE AND ARTICULATABLE SURGICAL END EFFECTOR;
    • U.S. patent application Ser. No. 16/885,838, entitled ELECTROSURGICAL INSTRUMENT WITH ASYNCHRONOUS ENERGIZING ELECTRODES;
    • U.S. patent application Ser. No. 16/885,851, entitled ELECTROSURGICAL INSTRUMENT WITH ELECTRODES BIASING SUPPORT;
    • U.S. patent application Ser. No. 16/885,860, entitled ELECTROSURGICAL INSTRUMENT WITH FLEXIBLE WIRING ASSEMBLIES;
    • U.S. patent application Ser. No. 16/885,866, entitled ELECTROSURGICAL INSTRUMENT WITH VARIABLE CONTROL MECHANISMS;
    • U.S. patent application Ser. No. 16/885,870, entitled ELECTROSURGICAL SYSTEMS WITH INTEGRATED AND EXTERNAL POWER SOURCES;
    • U.S. patent application Ser. No. 16/885,873, entitled ELECTROSURGICAL INSTRUMENTS WITH ELECTRODES HAVING ENERGY FOCUSING FEATURES;
    • U.S. patent application Ser. No. 16/885,879, entitled ELECTROSURGICAL INSTRUMENTS WITH ELECTRODES HAVING VARIABLE ENERGY DENSITIES;
    • U.S. patent application Ser. No. 16/885,881, entitled ELECTROSURGICAL INSTRUMENT WITH MONOPOLAR AND BIPOLAR ENERGY CAPABILITIES;
    • U.S. patent application Ser. No. 16/885,888, entitled ELECTROSURGICAL END EFFECTORS WITH THERMALLY INSULATIVE AND THERMALLY CONDUCTIVE PORTIONS;
    • U.S. patent application Ser. No. 16/885,893, entitled ELECTROSURGICAL INSTRUMENT WITH ELECTRODES OPERABLE IN BIPOLAR AND MONOPOLAR MODES;
    • U.S. patent application Ser. No. 16/885,900, entitled ELECTROSURGICAL INSTRUMENT FOR DELIVERING BLENDED ENERGY MODALITIES TO TISSUE;
    • U.S. patent application Ser. No. 16/885,917, entitled CONTROL PROGRAM ADAPTATION BASED ON DEVICE STATUS AND USER INPUT;
    • U.S. patent application Ser. No. 16/885,923, entitled CONTROL PROGRAM FOR MODULAR COMBINATION ENERGY DEVICE; and
    • U.S. patent application Ser. No. 16/885,931, entitled SURGICAL SYSTEM COMMUNICATION PATHWAYS.


Before explaining various forms of surgical instruments in detail, it should be noted that the illustrative forms are not limited in application or use to the details of construction and arrangement of parts illustrated in the accompanying drawings and description. The illustrative forms may be implemented or incorporated in other forms, variations and modifications, and may be practiced or carried out in various ways. Further, unless otherwise indicated, the terms and expressions utilized herein have been chosen for the purpose of describing the illustrative forms for the convenience of the reader and are not for the purpose of limitation thereof.


Further, it is understood that any one or more of the following-described forms, expressions of forms, examples, can be combined with any one or more of the other following-described forms, expressions of forms, and examples.


Various forms are directed to improved ultrasonic and/or electrosurgical (RF) instruments configured for effecting tissue treating, dissecting, cutting, and/or coagulation during surgical procedures. In one form, a combined ultrasonic and electrosurgical instrument may be configured for use in open surgical procedures, but has applications in other types of surgery, such as minimally invasive laparoscopic, orthoscopic, or thoracoscopic procedures, for example, non-invasive endoscopic procedures, either in hand held or and robotic-assisted procedures. Versatility is achieved by selective application of multiple energy modalities simultaneously, independently, sequentially, or combinations thereof. For example, versatility may be achieved by selective use of ultrasonic and electrosurgical energy (e.g., monopolar or bipolar RF energy) either simultaneously, independently, sequentially, or combinations thereof.


In one aspect, the present disclosure provides an ultrasonic surgical clamp apparatus comprising an ultrasonic blade and a deflectable RF electrode such that the ultrasonic blade and deflectable RF electrode cooperate to effect sealing, cutting, and clamping of tissue by cooperation of a clamping mechanism of the apparatus comprising the RF electrode with an associated ultrasonic blade. The clamping mechanism includes a pivotal clamp arm which cooperates with the ultrasonic blade for gripping tissue therebetween. The clamp arm is preferably provided with a clamp tissue pad (also known as “clamp arm pad”) having a plurality of axially spaced gripping teeth, segments, elements, or individual units which cooperate with the ultrasonic blade of the end-effector to achieve the desired sealing and cutting effects on tissue, while facilitating grasping and gripping of tissue during surgical procedures.


In one aspect, the end-effectors described herein comprise an electrode. In other aspects, the end-effectors described herein comprise alternatives to the electrode to provide a compliant coupling of RF energy to tissue, accommodate pad wear/thinning, minimize generation of excess heat (low coefficient of friction, pressure), minimize generation of sparks, minimize interruptions due to electrical shorting, or combinations thereof. The electrode is fixed to the clamp jaw at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or as a deflectable electrode.


In other aspects, the end-effectors described herein comprise a clamp arm mechanism configured to apply high pressure between a pad and an ultrasonic blade to grasp and seal tissue, maximize probability that the clamp arm electrode contacts tissue in limiting or difficult scenarios, such as, for example, thin tissue, tissue under lateral tension, tissue tenting/vertical tension especially tenting tissue away from clamp arm.


In other aspects, the end-effectors described herein are configured to balance match of surface area/current densities between electrodes, balance and minimize thermal conduction from tissue interface, such as, for example, impacts lesion formation and symmetry, cycle time, residual thermal energy.


In other aspects, the end-effectors described herein are configured to minimize sticking, tissue adherence (minimize anchor points) and may comprise small polyimide pads.


In various aspects, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device. The combination ultrasonic/bipolar RF energy surgical device comprises an end-effector. The end-effector comprises a clamp arm and an ultrasonic blade. The clamp arm comprises a movable clamp jaw, a compliant polymeric pad, and at least one bipolar RF electrode. The at least one electrode is coupled to a positive pole of an RF generator and the ultrasonic blade is coupled to the negative pole of the RF generator. The ultrasonic blade is acoustically coupled to an ultrasonic transducer stack that is driven by an ultrasonic generator. In various aspects, the end-effector comprises electrode biasing mechanisms.


In one general aspect, the present disclosure is directed to a method for using a surgical device comprising a combination of ultrasonic and advanced bipolar RF energy with a movable RF electrode on at least one jaw of an end-effector. The movable RF electrode having a variable biasing force from a proximal end to a distal end of the movable RF electrode. The movable RF electrode being segmented into discrete portions than can be put in electrical communication or isolated from each other. The movable RF electrode being made of a conductive or partially conductive material. It will be appreciated that any of the end effectors described in this disclosure may be configured with an electrode biasing mechanism.


In one aspect, the present disclosure provides a limiting electrode biasing mechanism to prevent ultrasonic blade to electrode damage. Generally, in various aspects, the present disclosure provides an end-effector for use with a ultrasonic/RF combination device, where the end-effector comprises an electrode. In one aspect, the combination ultrasonic/bipolar RF energy surgical device comprises an electrode biasing mechanism. In one aspect, the limiting electrode biasing mechanism is configured to prevent or minimize ultrasonic blade to electrode damage. The electrode is fixed to the clamp jaw at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or as a deflectable electrode.


In various aspects, the present disclosure provides an electrode cantilever beam fixated at only one end comprising a biasing threshold mechanism. In one aspect, the deflectable cantilever electrode is configured for combination ultrasonic/bipolar RF energy surgical devices.


In one aspect, the combination ultrasonic/RF energy surgical device comprises an ultrasonic blade, a clamp arm, and at least one electrode which crosses over the ultrasonic blade. In one aspect, the electrode is configured to be deflectable with respect to the clamp arm and includes features to change the mechanical properties of the tissue under compression between the electrode and the ultrasonic blade. In another aspect, the electrode includes a feature to prevent inadvertent contact between the electrode and the ultrasonic blade to prevent or minimize ultrasonic blade to electrode damage.


In various aspects, the electrode comprises a metallic spring element attached at a proximal end of the clamp jaw of the end-effector. The metallic spring element defines openings for receives therethrough one or more clamp arm pads (also known as “tissue pads” or “clamp tissue pads”) and comprises integrated minimum gap elements. This configuration of the electrode provides a method of preventing tissue from accumulating around the biasing mechanism that can impact the performance of the electrode. This configuration also minimizes the binding between the wear pads and the biasing spring, increases the strength of the electrode to clamp arm connection, minimizes inadvertent release of the clamp arm pads by attaching the polyimide pads to the electrode, and balance matches the surface area/current densities between electrodes. The electrode is fixed to the clamp jaw at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode is deflectable and may be referred to as a cantilever beam electrode or deflectable electrode.



FIGS. 1-9 illustrate one aspect of an end-effector comprising a deflectable/cantilever electrode configured for use with a combination ultrasonic/bipolar RF energy device, according to at least one aspect of the present disclosure. FIG. 1 is a perspective view of a clamp arm 1000 portion of an end-effector for use with a combined ultrasonic/RF device, according to at least one aspect of the present disclosure. For conciseness and clarity of disclosure, the ultrasonic blade, which functions as the other clamp arm of the end-effector is not shown. The end-effector is configured such that the ultrasonic blade is one pole of the bipolar RF circuit and the clamp arm 1000 is the opposite pole. A consistent RF electrode gap is maintained between the clamp arm 1000 and the ultrasonic blade to prevent the ultrasonic blade from contacting the electrode resulting in blade breakage or a short circuit. Tissue under treatment is clamped and compressed between the clamp arm 1000 and the ultrasonic blade.


The clamp arm 1000 includes a frame 1002, an electrode 1004, at least one small electrically nonconductive gap pad 1006, at least one large electrically nonconductive gap pad 1008, at least one electrically nonconductive clamp arm pad 1010. In one aspect, the small and large gap pads 1006, 1008 are configured to set a gap between the electrode 1004 and the ultrasonic blade. The clamp arm pad 1010 is configured to grasp tissue between the clamp arm 1000 and the ultrasonic blade to assist with sealing and cutting of the tissue. In other aspects, the small and large nonconductive gap pads may be swapped. In other aspects, the nonconductive gap pads are simply sized differently regardless of the relative size difference between the nonconductive gap pads.


Pivotal movement of the clamp arm 1000 with respect to the end-effector is effected by the provision of at least one, and preferably a pair of, lever portions 1012 of the clamp arm 1000 frame 1002 at a proximal end 1014 thereof. The lever portions 1012 are positioned on respective opposite sides of an ultrasonic waveguide and end-effector, and are in operative engagement with a drive portion of a reciprocable actuating member. Reciprocable movement of the actuating member, relative to an outer tubular sheath and the ultrasonic waveguide, thereby effects pivotal movement of the clamp arm 1000 relative to the end-effector about pivot points 1016. The lever portions 1012 can be respectively positioned in a pair of openings defined by the drive portion, or otherwise suitably mechanically coupled therewith, whereby reciprocable movement of the actuating member acts through the drive portion and lever portions 1012 to pivot the clamp arm 1000.



FIG. 2 is an exploded view of the clamp arm 1000 shown in FIG. 1, according to at least one aspect of the present disclosure. In various aspects, the electrode 1004 is made of a metallic spring material attached at a proximal end 1014 of the frame 1002 of the clamp arm 1000 such that the electrode 1004 can deflect. The metallic spring electrode 1004 defines openings 1018 for receiving therethrough elements of the clamp arm pad 1010 and defines additional openings 1020, 1021 for receiving the gap pads 1006, 1008 to set a minimum gap between the electrode 1004 and the ultrasonic blade. At least one of the gap pads 1006 is disposed on a distal end 1022 of the electrode 1004. The gap pads 1006, 1008 are thus integrated with the electrode 1004. In this configuration, the electrode 1004 prevents tissue from accumulating around the biasing mechanism, e.g., cantilevered spring, that can impact the performance of the electrode 1004. This configuration also minimizes the binding between the wearable clamp arm pads 1010 and the biasing spring electrode 1004, increases the strength of the electrode 1004 to the clamp arm connection, minimizes inadvertent release of the clamp arm pads 1018 by attaching the gap pads 1006, 1008 to the electrode 1004, and balance matches the surface area/current densities between electrodes. The electrode 1004 is attached to the frame 1002 by two protrusions 1024. The electrode protrusions 1024 are attached to the proximal end 1014 of the frame 1002 as shown in FIGS. 3 and 4.



FIGS. 3 and 4 are perspective views of the frame 1002, according to at least one aspect of the present disclosure. These views illustrate the connection surfaces 1026 on the proximal end 1014 of the fame 1002 for attaching the proximal end of the electrode 1004 to the frame 1002. In one aspect, the electrode protrusions 1024 are welded to the connection surfaces 1026 of the frame 1002 such that the electrode 1004 behaves in a deflectable manner.



FIG. 5 is a perspective view of the electrode 1004, according to at least one aspect of the present disclosure. This view illustrates the bias in the electrode 1004 made of spring material as indicated by the curvature of the electrode 1004 along a longitudinal length. The openings 1018, 1020, 1021 for receiving the gap pads 1006, 1008 and the clamp arm pads 1010. In one aspect, the electrode 1004 has a thickness “d” of 0.010″ and may be selected within a range of thicknesses of 0.005″ to 0.015″, for example. With reference also to FIGS. 8 and 9, the openings 1020 are sized and configured to receive a protrusion 1036 defined on a bottom portion of the gap pads 1006.



FIG. 6 is a perspective view of the clamp arm pad 1010, according to at least one aspect of the present disclosure. The clamp arm pad 1010 comprises a plurality of clamp arm elements 1032 protruding from a backbone 1030. Throughout this disclosure, the clamp arm elements 1032 also are referred to as “teeth.” In one aspect, the clamp arm pad 1010 defines apertures 1028 in a position where the gap pads 1006 are located on the electrode 1004. With reference also to FIGS. 8 and 9, the apertures 1028 defined by the clamp arm pad 1010 are sized and configured to receive the protrusion 1036 defined on a bottom portion of the gap pads 1006. In one aspect, the clamp arm pad 1010 material is softer than the gap pad 1006, 1008 material. In one aspect, the clamp arm pad 1010 is made of a non-stick lubricious material such as polytetrafluoroethylene (PTFE) or similar synthetic fluoropolymers of tetrafluoroethylene. PTFE is a hydrophobic, non-wetting, high density and resistant to high temperatures, and versatile material and non-stick properties. In contrast, the gap pads 1006, 1008 are made of a polyimide material, and in one aspect, is made of a durable high-performance polyimide-based plastic known under the tradename VESPEL and manufactured by DuPont or other suitable polyimide, polyimide polymer alloy, or PET (Polyethylene Terephthalate), PEEK (Polyether Ether Ketone), PEKK (Poly Ether Ketone Ketone) polymer alloy, for example. Unless otherwise noted hereinbelow, the clamp arm pads and gap pads described hereinbelow are made of the materials described in this paragraph.



FIG. 7 is a perspective top view of the large gap pad 1008, according to at least one aspect of the present disclosure. The large gap pad 1008 comprises a protrusion 1034 sized and configured to fit within the opening 1021 at the proximal end 1014 of the electrode 1004. FIG. 8 is a perspective top view of the small gap pad 1006, according to at least one aspect of the present disclosure. FIG. 9 is a perspective bottom view of the small gap pad 1006 shown in FIG. 8. As shown in FIGS. 8 and 9, the small gap pads 1006 include a protrusion 1036 at the bottom portion sized and configured to be received within the openings 1020 defined by the electrode 1004 and the apertures 1028 defined by the clamp arm pad 1010. The small and large gap pads 1006, 1008 are made of a polyimide material, and in one aspect, is made of a durable high-performance polyimide-based plastic known under the tradename VESPEL and manufactured by DuPont. The durability of the polyimide material ensures that the electrode gap remains relatively constant under normal wear and tear.


In one aspect, the present disclosure also provides additional end-effector configurations for combination ultrasonic and bipolar RF energy devices. This portion of the disclosure provides end-effector configurations for use in combination ultrasonic and bipolar RF energy devices. In these configurations, the end-effector maintains a consistent gap between the RF electrode gap and the ultrasonic blade, which functions as one pole of the bipolar RF circuit, and the clamp arm, which functions as the opposite pole of the bipolar RF circuit. In conventional end-effector configurations, the electrode gap is set by a soft PTFE clamp arm pad which may be subject to wear during surgery. When the clamp arm pad wears through, the ultrasonic blade can contact the electrode resulting in blade breakage or an electrical short circuit, both of which are undesirable.


To overcome these and other limitations, various aspects of the present disclosure incorporate a deflectable RF electrode in combination with a clamp arm pad comprising a non-stick lubricious compliant (e.g., PTFE) pad fixed to the clamp arm. The RF electrode contains wear-resistant, electrically nonconductive pads which contact the blade to set the blade-to-electrode gap. The compliant clamp arm pad extends through openings defined by the electrode and reacts to the clamping force from the ultrasonic blade. As the compliant clamp arm pad wears, the electrode deflects to maintain a constant gap between the blade and the electrode. Such configuration provides a consistent gap between the electrode and the ultrasonic blade throughout the life of the device, prevents shorting and ultrasonic blade breakage, which can occur when the ultrasonic blade touches the electrode, and enables the electrode material to be positioned directly on the side that is opposite the ultrasonic blade to improve sealing performance. The electrode is fixed to the clamp jaw at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or deflectable electrode.


In one aspect, the present disclosure provides asymmetric cooperation of the clamp arm/electrode/pad to effect the ultrasonic blade-RF electrode interaction. In one aspect, the present disclosure provides a shortened clamp arm. FIGS. 10-12 illustrate an effector comprising a shortened clamp arm for deflectable/cantilever electrode applications, according to various aspects of the present disclosure. In one aspect, the end-effector is configured for asymmetric cooperation of the clamp arm, electrode, and clamp arm pad to effect the ultrasonic blade/RF electrode interaction. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In one aspect, a distal end of the clamp arm is shortened and a length of the clamp arm pad is kept the same length such that a distal end of the clamp arm pad extends beyond the distal end of the clamp arm. This would allow the electrode to hyper-extend to minimize potential for electrically shorting the distal end of the clamp arm. It also may have the benefit of extending the life of the clamp arm pad because of the additional exposed clamp arm pad material to be worn through. This configuration also can eliminate the use of the distal and middle gap setting clamp arm pads, previously referred to herein, for example, as wear resistant clamp arm pads for setting and maintaining a gap between the electrode and the ultrasonic blade.



FIG. 10 is a side view of an end-effector 1680 comprising a shortened clamp arm 1682, an ultrasonic blade 1684, an electrode 1686, and a clamp arm pad 1688, according to at least one aspect of the present disclosure. FIG. 11 is a top view of the end-effector 1680. As shown in FIGS. 10-11, the ultrasonic blade 1684 and the electrode 1686 are substantially the same length. The clamp arm 1682 is shortened to allow the electrode 1686 to overextend to prevent an electrical short circuit. In one aspect, a gap setting pad 1690 is provided at a proximal end 1692 of the end-effector 1680.



FIG. 12 illustrates a clamp arm 1700 comprising a clamp jaw 1702, an electrode 1704, and a clamp arm pad 1706, according to at least one aspect of the present disclosure. Free up space distally on clamp arm. The clamp arm 1700 is configured for use with an end-effector comprising an ultrasonic blade as disclosed in other sections herein. This configuration frees up space distally 1708 on the clamp jaw 1702. The clamp arm pad 1706 (e.g., PTFE) is fully supported underneath, but space is freed in the t-slot region and on the side walls to allow for more clamp arm pad 1706 burn through and further deflection of the electrode 1704 away from the ultrasonic blade (not shown).


In one aspect, the present disclosure provides an end-effector that employs the thermal behavior of the pad to deflect the electrode. In one aspect, the length of the clamp arm pad may be the same length as the ultrasonic blade and as the clamp arm pad expands or changes shape due to pressure or heat, the thermal expansion properties of the clamp arm pad material (e.g., PTFE) can be used to deflect the electrode out of the path of the ultrasonic blade.


In one aspect, a non-biased electrode and pad are provided. The non-biased but deflectable pad varies in position with respect to the clamp arm as the pad wears. The non-biased electrode is configured to minimize contact between the ultrasonic blade and the RF electrode. The clamp arm pad comprises a feature for securing the electrode to the clamp arm pad. In one aspect, as the height of the clamp arm pad wears or is cut through, the height of the electrode with respect to the clamp arm is progressively adjusted. In another aspect, once the clamp arm is moved away from the ultrasonic blade the electrode remains in its new position. The electrode is fixed to the clamp arm at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or as a deflectable electrode.


Configurations of end-effectors comprising a deflectable/cantilever electrode described hereinabove with respect to FIGS. 1-12 may be combined with a biased electrode as described hereinbelow with respect to FIGS. 13-18.


In one aspect, the present disclosure provides an end-effector for a combination ultrasonic/bipolar RF energy surgical device that employs pressure or clamp jaw compression to adjust the height of the electrode as the clamp arm pad wears. In one aspect, the clamp arm pad follows the clamp arm biased electrode with wearable stops. In one aspect, the clamp arm pad contains a feature for securing the electrode to the pad. As the pad height wears or is cut through, the electrode height with respect to the clamp arm is progressively adjusted. Once the clamp arm is moved away from the ultrasonic blade, the electrode stays in its new position.


Achieving sufficient clamp arm pad life on a combination ultrasonic/bipolar RF energy surgical device requires maintaining a sufficiently small yet non-zero clamp arm pad-to-electrode gap throughout the life of the instrument to provide desirable ultrasonic and bipolar RF tissue effects. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


The existing (seed) electrode is a flat electrode, which is practically horizontal or parallel to the clamp arm in the free state (no load). The electrode is fixed to the clamp arm at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or as a deflectable/cantilever electrode. When clamped on tissue, the tissue loads the electrode, causing it to deflect toward the clamp arm.


In one aspect, the electrode “follows” the pad as it wears. In this aspect, the electrode is biased toward the clamp arm in the free state (whether by being a formed/curved electrode, or by attaching/welding the electrode non-parallel to the clamp arm) using any suitable fastening technique such as welding, laser welding, brazing, soldering, pressing, among other fastening techniques. Wearable stop features (on the pad or elsewhere) keep the electrode away from the clamp arm, until said stop features are worn away during use. Once worn away, the electrode is able to approach the clamp arm. These features could be tooth or ratchet shaped, a vertical taper, or other.


In one aspect, the present disclosure provides a deflectable/cantilever electrode, wherein in a free state, the electrode is biased toward clamp arm and may attached at an angle and made of a preformed curve using any suitable fastening technique such as welding, laser welding, brazing, soldering, pressing, among other fastening techniques.


In one aspect, the present disclosure provides an end-effector with a deflectable/cantilever electrode comprising wearable stop features to prevent the electrode from reaching or contacting the clamp arm. As the stop features wear, the electrode moves toward the clamp arm until it reaches the next stop. In one aspect, the stop features wear simultaneously with the clamp arm pad to maintain the appropriate gap between the clamp arm pad and the electrode. The features may be entirely separate from the clamp arm pad. The features can be configured to withstand clamping loads, but wear away due to heat (melting/flowing) or abrasion. Possible examples include teeth on one or more clamp arm pads (PTFE, polyimide, or other) and tapered profile on one or more clamp arm pads (PTFE, polyimide, or other).



FIG. 13 illustrates an end-effector clamp arm 1710 comprising a clamp jaw 1712, an electrode 1714, and a clamp arm pad 1716, according to at least one aspect of the present disclosure. The clamp arm 1710 is configured for use with an end-effector comprising an ultrasonic blade (not shown) as described throughout this disclosure. The clamp arm 1710 also comprises a wear resistant gap pad 1717 to set a gap between the electrode 1714 and the ultrasonic blade. As shown, in the free state, the electrode 1714 is biased in a level or horizontal 1718 orientation. The electrode 1714 is fixed to the clamp jaw 1712 at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode 1714 may be referred to as a cantilever beam electrode or as a deflectable electrode.



FIG. 14 illustrates an end-effector clamp arm 1720 comprising a clamp jaw 1722, an electrode 1724, and a clamp arm pad 1726, according to at least one aspect of the present disclosure. The clamp arm 1720 is configured for use with an end-effector comprising an ultrasonic blade (not shown) as described throughout this disclosure. The clamp arm 1720 also comprises a wear resistant gap pad 1727 to set a gap between the electrode 1724 and the ultrasonic blade. As shown, in the free state, the electrode 1724 is configured pre-formed, bent, or is otherwise biased toward the clamp jaw 1722 along line 1728 away from the horizontal 1718 orientation. The electrode 1724 is fixed to the clamp arm 1720 at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode 1724 may be referred to as a cantilever beam electrode or as a deflectable electrode. To prevent the biased electrode 1724 from bending toward the clamp jaw 1722 under the biasing force, the clamp arm 1720 further comprises a retainer to prevent the biased electrode 1724 from bending toward the clamp jaw 1722 and maintaining the biased electrode 1724 in a substantially flat configuration (e.g., parallel, level, or horizontal) relative to the ultrasonic blade. Examples of retainers such as a retainer tooth 1738 and a retainer wall 1760 with a tapered profile are described below in FIGS. 15-18.



FIG. 15 illustrates an end-effector clamp arm 1730 comprising a clamp jaw 1732, an electrode 1734, and a clamp arm pad 1736, according to at least one aspect of the present disclosure. The clamp arm 1730 is configured for use with an end-effector comprising an ultrasonic blade (not shown) as described throughout this disclosure. The clamp arm 1730 also comprises a wear resistant gap pad 1737 to set a gap between the electrode 1744 and the ultrasonic blade. In the free state, the electrode 1734 is configured pre-formed curved, bent, or otherwise biased toward the clamp jaw 1732. However, a retainer tooth 1738, or similar feature, is provided on the clamp arm pad 1736 to prevent the electrode 1734 from springing in toward the clamp jaw 1732. In FIG. 16, when the bottom retainer tooth 1738 is worn away, the electrode 1734 can move toward the clamp jaw 1732 due to the pre-formed curve, according to at least one aspect of the present disclosure. The electrode 1734 is fixed to the clamp arm 1730 at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode 1734 may be referred to as a cantilever beam electrode or as a deflectable electrode.



FIG. 17 illustrates an end-effector clamp arm 1750 comprising a clamp jaw 1752, an electrode 1754, and a clamp arm pad 1756, according to at least one aspect of the present disclosure. The clamp arm 1750 is configured for use with an end-effector comprising an ultrasonic blade (not shown) as described throughout this disclosure. The clamp arm 1750 also comprises a wear resistant gap pad 1757 to set a gap between the electrode 1754 and the ultrasonic blade. In the free state, the electrode 1754 is configured pre-formed with a curve, bent, or otherwise biased toward 1758 the clamp jaw 1752. However, a retainer wall 1760 having a tapered profile, or similar feature, is provided on the clamp arm pad 1756 to prevent the electrode 1754 from springing in toward the clamp jaw 1752.


In FIG. 17, when the tapered profile retainer wall 1760 is worn away, there is sufficient melting/flowing away from the tapered profile retainer wall 1760 region to allow the electrode 1754 to move toward the clamp jaw 1752 due to the pre-formed curve, according to at least one aspect of the present disclosure. The electrode 1754 is fixed to the clamp jaw 1752 at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode 1754 may be referred to as a cantilever beam electrode or as a deflectable electrode.


In one aspect, the present disclosure provides an end-effector for a combination ultrasonic/bipolar RF energy surgical device that employs a constant pressure distribution biasing mechanism. In one aspect, the end-effector includes an elastic compressible support for mounting and insulating a deflectable electrode. In one aspect, a hollow honeycomb or chambered elastomer support attachment cushion can be employed to allow all or part of the electrode attached to it to deflect but be biased towards the ultrasonic blade. This configuration could provide the added benefit of thermally insulating the electrode from the rest of the metallic clamp jaw. This would also provide an elastomer “curtain” around the electrode to minimize tissue accumulation behind the electrode. In one aspect, a non-strut deflectable geometry for the elastomer cells will enable the deflection force to be held constant over a predefined range of deflections. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


The above configuration prevents lateral skew of the electrode under compression to prevent shorting. Further, the deflectable electrode is affixed to the elastomer and the elastomer is affixed to the metallic clamp arm. The solid height of the spring is limited from driving allowable compression while maintaining as much metallic clamp arm as possible. Thermal conduction from tissue interface is balanced and minimizes—impacts lesion formation and symmetry, cycle time, and residual thermal energy.


Configurations of end-effectors comprising a deflectable/cantilever electrode described hereinabove with respect to FIGS. 1-12 may be combined with a flexible electrode disposed above a lattice cushion and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade as described hereinbelow with respect to FIGS. 19-21.


Configurations of a biased electrode as described hereinabove with respect to FIGS. 13-18 may be combined with a flexible electrode disposed above a lattice cushion and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade as described hereinbelow with respect to FIGS. 19-21.


Configurations of end-effectors comprising a deflectable/cantilever electrode described hereinabove with respect to FIGS. 1-12 in combination with a biased electrode as described hereinabove with respect to FIGS. 13-18 may be combined with a flexible electrode disposed above a lattice cushion and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade as described hereinbelow with respect to FIGS. 19-21.



FIGS. 19-20 illustrate an end-effector 1810 comprising a clamp arm 1812, an ultrasonic blade 1814, a lattice cushion 1816, a flexible electrode 1818 disposed above the lattice cushion 1816, and a plurality of hard spacers 1820 to set a gap between the flexible electrode 1818 and the ultrasonic blade 1814, according to at least one aspect of the present disclosure. FIG. 21 is an exploded view of the end-effector 1810 shown in FIGS. 19-20. A clamp arm pad 1822 is disposed inside a slot 1825 formed within the lattice cushion 1816. The lattice cushion 1816 acts as a spring-like element. The hard spacers 1820 are used to set a gap between the flexible electrode 1818 and the ultrasonic blade 1814.


In FIG. 19 the clamp arm 1812 is open and tissue 1824 of non-uniform thickness (T1a, T2a, T3a) is disposed over the flexible electrode 1818. In FIG. 20 the clamp arm 1812 is closed to compress the tissue 1824. The lattice cushion 1816 on the clamp arm 1812 results in consistent tissue 1824 (T1b, T2b, T3b) compression across variable thickness tissue 1824 (T1a, T2a, T3a), such that:








T

1

a



T

1

b



=



T

2

a



T

2

b



=


T

3

a



T

3

b








Additional background disclosure may be found in EP3378427, WO2019/006068, which are herein incorporated by reference in their entirety.


In one aspect, the present disclosure provides an end-effector for a combination ultrasonic/bipolar RF energy surgical device with means for insuring distal tip contact with bias using a zero gap bipolar RF energy system. In various aspects, the present disclosure provides a deflectable electrode for a combination ultrasonic/bipolar RF energy surgical device with a higher distal bias than proximal bias. In one aspect, the present disclosure provides a combination energy device comprising a bipolar electrode that is deflectable with respect to the clamp arm. The combination energy device comprises features to change the mechanical properties of the tissue compression proximal to distal to create a more uniform or differing pattern of pressure than due to the clamping forces alone. In one aspect, the present disclosure provides a non-linear distal distributing mechanism and in another aspect the present disclosure provides electrical non-linear distribution of energy density. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


Configurations of end-effectors comprising a deflectable/cantilever electrode described hereinabove with respect to FIGS. 1-12 may be combined with a conductive polymer clamp arm pad as described hereinbelow with respect to FIGS. 22-36.


Configurations of a biased electrode as described hereinabove with respect to FIGS. 13-18 may be combined with a conductive polymer clamp arm pad as described hereinbelow with respect to FIGS. 22-36.


Configurations of a flexible electrode disposed above a lattice cushion and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade as described hereinabove with respect to FIGS. 19-21 may be combined with a conductive polymer clamp arm pad as described hereinbelow with respect to FIGS. 22-36.


Configurations of a biased electrode as described hereinabove with respect to FIGS. 13-18 may be combined with a flexible electrode disposed above a lattice cushion and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade as described hereinabove with respect to FIGS. 19-21 may be combined with a conductive polymer clamp arm pad as described hereinbelow with respect to FIGS. 22-36.


Configurations of a biased electrode as described hereinabove with respect to FIGS. 13-18 may be combined with a flexible electrode disposed above a lattice cushion and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade as described hereinabove with respect to FIGS. 19-21 may be combined with a conductive polymer clamp arm pad as described hereinbelow with respect to FIGS. 22-36.


Configurations of end-effectors comprising a deflectable/cantilever electrode described hereinabove with respect to FIGS. 1-12 in combination with a biased electrode as described hereinabove with respect to FIGS. 13-18 may be combined with a conductive polymer clamp arm pad as described hereinbelow with respect to FIGS. 22-36.


Configurations of end-effectors comprising a deflectable/cantilever electrode described hereinabove with respect to FIGS. 1-12 in combination with a biased electrode as described hereinabove with respect to FIGS. 13-18 may be combined with a flexible electrode disposed above a lattice cushion and a plurality of hard spacers to set a gap between the flexible electrode and the ultrasonic blade as described hereinabove with respect to FIGS. 19-21 may be combined with a conductive polymer clamp arm pad as described hereinbelow with respect to FIGS. 22-36.


In various aspects, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device comprising an ultrasonic pad with partially or fully electrically conductive portions such that the pad behaves as both the blade support/wear pad and the bipolar RF electrode. In one aspect, the present disclosure provides a partially conductive clamp arm pad to enable electrode wear and minimize short circuiting in a combination bipolar RF and ultrasonic energy device where the clamp arm pad has conductive and non-conductive portions allowing it to act as one of the RF electrodes while also acting as a wearable support structure for the ultrasonic blade. In another aspect, the present disclosure provides conductive portions around the perimeter of the clamp arm pad and not positioned directly on the side that is opposite the ultrasonic blade contact area. In another aspect, a portion of the conductive clamp arm pad is degradable or wearable preventing contact from the ultrasonic blade from interrupting the conductivity of the remaining portions of the conductive clamp arm pad.


In one aspect, the present disclosure provides an end-effector for a combination ultrasonic/bipolar RF energy surgical device comprising a conductive polymer ultrasonic clamp arm pad. In one aspect, the end-effector comprises a clamp arm pad doped with tin oxide. FIG. 22 is a section view of a conductive polymer clamp arm pad 2440, according to at least one aspect of the present disclosure. The conductive polymer clamp arm pad 2440 comprises tin oxide 2442 (SnO2) embedded in a polymer material 2444, such as Teflon (PTFE), to make the clamp arm pad 2440 electrically conductive. The doping may be achieved using a cold spray process. Once doped, the conductive polymer clamp arm pad 2440 can achieve traditional ultrasonic tissue clamp arm pad functions such as, for example, contacting the ultrasonic blade, absorbing heat from the ultrasonic blade, and assisting in tissue grasping and clamping. The tin oxide doped clamp arm pad 2440 functions as one of the two electrodes or poles of the bipolar RF circuit to deliver RF energy to tissue grasped between the ultrasonic blade and the clamp arm pad 2440. The tin oxide doped clamp arm pad 2440 is biocompatible, electrically conductive, thermally conductive, enables a large portion of the clamp arm pad 2440 to be used to improve wear resistance of the clamp arm pad 2440, and is white in color. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In one aspect, the present disclosure provides a conductive polymer ultrasonic clamp arm pad as an electrode replacement. To improve the life of the ultrasonic clamp arm pad and improve the RF tissue effects, the present disclosure provides an electrode that is improved, easier to make, and less costly to make. In one aspect, the present disclosure provides a clamp arm pad comprising hard polyimide polymer layers and electrically conductive layers to allow the clamp arm pad to achieve traditional functions as well as carry bipolar electricity to eliminate the need for a separate electrode in the clamp arm of a combined energy end-effector. In this manner, the clamp jaw can be me manufactured in a manner similar to the ultrasonic-only clamp jaw with the new clamp arm pad material swapped for the traditional ultrasonic-only clamp arm pad. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


Benefits include improved ultrasonic performance, including clamp arm pad wear, similar to current ultrasonic-only instruments because there are no electrode gaps between elements “squares” of polymer. The cost of the improved clamp jaw will be similar to current ultrasonic-only clamp jaws because of the need for a separate electrode component is eliminated and provides multiple small polymer square elements. In addition, the manufacturing steps needed to make the clamp jaw are the same as the manufacturing steps required for making current ultrasonic-only clamp jaws. Manufacturing the improved clamp jaw requires only the substitution of the clamp arm pad and does require the production of an additional electrode component to add to the clamp jaw and eliminates assembly steps.



FIG. 23 is a perspective view of a clamp arm pad 2450 configured to replace a conventional electrode, according to at least one aspect of the present disclosure. The clamp arm pad 2450 comprises electrically non-conductive layers 2452 and electrically conductive layers 2454 in a sandwich-like configuration. This configuration eliminates the need for a spring loaded electrode plate. The electrically non-conductive layers 2452 can be made of polymer, polyimide, Teflon (PTFE) and similar electrically non-conductive materials. The conductive layers 2454 may be made of thin electrically conductive polymer, metal foil, or carbon loaded material. The clamp arm pad 2450 may be manufactured such that the majority of the material contacting the ultrasonic blade are the electrically non-conductive layers 2452. In one aspect, 75% of the material contacting the ultrasonic blade is electrically non-conductive material such as PTFE. In another aspect, 85% of the material contacting the ultrasonic blade is electrically non-conductive material such as PTFE. In another aspect, 95% of the material contacting the ultrasonic blade is electrically non-conductive material such as PTFE. Additionally, as the clamp arm pad 2450 wears, the electrically conductive layers 2452 will still have available surface area to conduct RF electricity through the tissue and return electrode (e.g., ultrasonic blade).



FIG. 24 illustrates a clamp arm 2460 comprising the clamp arm pad 2450 described in FIG. 23, according to at least one aspect of the present disclosure. In the illustrated clamp arm 2460, the non-conductive layers 2452 have a large surface area compared to the conductive layers 2454, which appear as thin layers or foils.



FIG. 25 illustrates clamp arm pads configured as described in FIGS. 23-24, according to at least one aspect of the present disclosure. The first clamp arm pad 2470 is new and comprises teeth 2472 formed integrally therewith. The second clamp arm pad 2476 is new and without teeth. The third clamp arm pad 2478 worn and may be representative of either the first clamp arm pad 2470 or the second clamp arm pad 2476.


In one aspect, the present disclosure provides a composite clamp arm pad for a combination ultrasonic/bipolar RF energy surgical device. FIG. 26 is a section view of a clamp arm 2480 comprising a composite clamp arm pad 2482 in contact with tissue 2484, according to at least one aspect of the present disclosure. The end-effector 2480 comprises an upper clamp jaw 2486 and an adhesive 2488 to fixedly attach the composite clamp arm pad 2482 to the upper clamp jaw 2486. The composite clamp arm pad 2482 comprises thin electrically non-conductive layers 2490 (e.g., PTFE) and thin electrically conductive layers 2492 (e.g., thin stainless steel foils). The electrically conductive layers 2492 form the electrode portion of the composite clamp arm pad 2482. The electrically conductive layers 2492 (e.g., thin stainless steel foils) deform as the electrically non-conductive layers 2490 (e.g., PTFE) wear-away. The thickness of the electrically conductive layers 2492 enables the electrode portion of the composite clamp arm pad 2482 to deform as the electrically non-conductive layers 2490 wear-away. Advantageously, the electrically conductive layers 2492 conduct some of the heat away from the electrically non-conductive layers 2490 to keep the composite clamp arm pad 2482 cooler. As described above, the composite clamp arm pad 2482 is fixed to the upper clamp jaw 2486 by an adhesive 2488. The adhesive 2488 may be filled with carbon to make it electrically conductive and connect the electrode portions of the composite clamp arm pad 2482 to the upper clamp jaw 2486. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In one aspect, the clamp arm pad comprises cooperative conductive and insulative portions. In one aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device where the clamp arm pad has conductive and non-conductive portions allowing it to act as one of the RF electrodes while also acting as the wearable support structure for the ultrasonic blade. In another aspect, the conductive portions of the clamp arm pad are disposed around the perimeter of the pad and are not positioned directly on the side that is opposite the ultrasonic blade contact area. In another aspect, the conductive portion of the clamp arm pad is degradable or wearable to prevent contact with the ultrasonic blade from interrupting the conductivity of the remaining conductive portions of the clamp arm pad.


In one aspect, the present disclosure provides a clamp arm pad for use with combination ultrasonic/bipolar RF energy devices where portions of the clamp arm pad include electrically conductive material and other portions include electrically non-conductive material. The electrode is adapted and configured for use with a combination ultrasonic/RF energy device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In various aspects, the clamp arm pad may be manufactured using a variety of techniques. One technique comprises a two shot process of molding conductive and non-conductive materials in the same compression mold. This process effectively creates a single clamp arm pad with portions that can act as a bipolar RF electrode and others that will act as electrical insulators. Another technique comprises a super sonic cold spray embedding of metallic elements into a polymeric (e.g., Teflon, PTFE) pad or matrix. Another technique comprises 3D printing of multiple materials (e.g., Teflon, PTFE, and doped conductive polymer), printing/transfer printing conductive or functional inks onto clamp arm pad. Another technique comprises metals and conductive materials (e.g., graphite/carbon) may be applied to the clamp arm pad using chemical vapor deposition, physical vapor deposition, sputter deposition, vacuum deposition, vacuum metalizing, or thermal spray. Another technique comprises conductive/loaded clamp arm pad electrodes provide continuity through the pad with micro randomly oriented and positioned particles or macro oriented structures (e.g., fabric, woven, long constrained fibers. Another technique comprises making the surface of the clamp arm pad conductive, providing wear-through electrodes, 3D printing, thermal spraying, cold spraying, coatings/paints/epoxies, sheet/foil/wire/film wrapping or laminating, vacuum metalizing, printing/transferring, among other techniques. In another technique, polymer electrodes filled with conductive material.


In one aspect, the end-effector clamp arm comprises a fixed polymer electrode. FIG. 27 illustrates a clamp arm 2500 comprising a clamp jaw 2502 to support a carrier 2504 or stamping attached to the clamp jaw 2502 and a clamp arm pad 2506, according to at least one aspect of the present disclosure. The clamp arm pad 2506 comprises an electrically conductive pad 2508 and an electrically non-conductive pad 2510. The electrically conductive pad 2508 is made of an electrically conductive polymer and acts as one of the electrodes of the bipolar RF circuit. The clamp jaw 2502 and the carrier 2504 may be made of stainless steel and attached using any suitable fastening technique such as welding, laser welding, brazing, soldering, pressing, among other fastening techniques, for example. The electrically conductive pad 2508 may comprise a polymer such as, for example, silicone, fluorosilicone, PTFE, and similar materials. The electrically conductive pad 2508 is overmolded onto the carrier 2504 using PTFE, silicone, fluorosilicone filled with silver particles, silver over aluminum, silver over copper, copper, nickel, graphite, carbon (amorphous, chopped fiber), gold, platinum, stainless steel, iron, or zinc, or combinations thereof.



FIG. 28 is a section view taken at section 28-28 in FIG. 27 and FIG. 29 is a section view taken at section 29-29 in FIG. 27. The sections views 28-28 and 29-29 show the clamp arm 2500 comprising the clamp jaw 2502, the support carrier 2504, the electrically conductive pad 2508, and the electrically non-conductive pad 2510.



FIG. 30 is a section view of an alternative implementation of a clamp arm 2520 comprising a clamp jaw 2522, an electrically conductive pad 2524, and an electrically non-conductive pad 2526, according to at least one aspect of the present disclosure. The electrically conductive pad 2524 is made of an electrically conductive polymer and acts as one of the electrodes in the bipolar RF circuit.



FIG. 31 is a section view of an alternative implementation of a clamp arm 2530 comprising a clamp jaw 2532, a carrier 2534 or stamping welded to the clamp jaw 2532, an electrically conductive pad 2536, and an electrically non-conductive pad 2538, according to at least one aspect of the present disclosure. The electrically conductive pad 2536 is made of an electrically conductive polymer and acts as one of the electrodes in the bipolar RF circuit. The electrically conductive pad 2536 is overmolded over the carrier 2534 or stamping.


In one aspect, the end-effector clamp arm comprises a film over metal insert molded electrode assembly. In one aspect, a film may be provided over a metal (e.g., stainless steel) insert molded electrode assembly. A film over metal such as stainless steel can be insert molded to form an electrode assembly. The film on the insert molded electrode may be etched to form micro-holes, slots, honeycomb, among other patterns, to enable conduction of RF energy as well as to cut the periphery of the component. The film may be formed onto or bond onto a stainless steel electrode using IML/FIM (In-Mold Labeling/Film Insert Molding) processes described hereinbelow. The charged film electrode may be placed into a polymer injection mold tool to mold a polymer to the back of the electrode and film. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.



FIG. 32 illustrates insert molded electrodes 2540, according to at least one aspect of the present disclosure. The insert molded electrode 2540 comprises an electrically conductive element 2546, a molded polymer pad 2548, and a film 2542 coating. Features 2550 such as micro-holes, slots, honeycomb, or similar features, are formed in the film 2542 to allow the passage of RF energy. Retention features 2552 also are formed on the film 2542. The side walls 2558 of the film 2542 extend below the bottom of the polymer pad 2548 may be folded around the bottom of the polymer pad 2548 and over molded with retention posts. The retention features 2552 are molded into the holes 2554 defined by the film 2542. Although the two insert molded electrodes 2540 are shown with a gap between them, in actuality, the two insert molded electrodes 2540 are fit line-to-line 2556 via mold pressure.


The conductive element 2546 may be made of an electrically conductive metal such as stainless steel or similar conductive material. The conductive element 2546 can be about 0.010″ thick and may be selected within a range of thicknesses of 0.005″ to 0.015″ and can be formed by tamping or machining. The film 2544 can be about 0.001″ to 0.002″ thick and may be made of polyimide, polyester, or similar materials. Alternatively to mechanical retention, such as posts, the film 2544 can be directly bonded to the conductive element 2546. One example includes DuPont Pyralux HXC Kapton film with epoxy adhesive backing having a thickness of 0.002″.


Advantageously, the non-stick surface prevents tissue from sticking to the insert molded electrode 2540. The non-stick surface eliminates short circuiting of opposing electrodes by setting a gap within the range of 0.002″ to 0.004″ along the entire length of the insert molded electrode 2540. The non-stick surface minimizes lateral spread of RF energy de to coverage of side walls 2558 of the insert molded electrode 2540. Also, the insert molded electrode 2540 exhibits structural soundness and provides an easier more robust electrical connection than a multi-layer flexible circuit.


In one aspect, the end-effector comprises a conductive clamp arm and pad constructs for combination ultrasonic/bipolar RF energy surgical devices. In one aspect, the present disclosure provides a clamp arm assembly comprising a conductive or selectively conductive thin film, foil, or laminate that is applied to, around or on the clamp arm assembly to serve as a durable “pole” in a combination ultrasonic/bipolar RF energy surgical device. Further, an algorithm, software, or logic is provided to manage conditions of electrical short circuiting. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.



FIG. 33 illustrates an end-effector 2560 comprising an ultrasonic blade 2562, a clamp arm 2564, and a clamp arm pad 2566 comprising an electrically conductive film 2568, according to at least one aspect of the present disclosure.



FIG. 34 illustrates the clamp arm 2564 shown in FIG. 33. The clamp arm 2564 comprising a clamp jaw 2570 to support the clamp arm pad 2566. A thin electrically conductive film 2568 is disposed over the clamp arm pad 2566 to form an electrode of one of the poles of the bipolar RF circuit.



FIG. 35 is a section view of the clamp arm 2564 taken along section 35-35 in FIG. 34. The clamp jaw 2570 can be made of metal such as stainless steel. The clamp arm pad 2566 can be made of an electrically non-conductive complaint material such as PTFE, silicone, high temperature polymer, or similar materials. The electrically conductive film 2568 or foil can be made of an electrically conductive material such as titanium, silver, gold, aluminum, zinc, and any alloys thereof including stainless steel.



FIG. 36 illustrates a clamp arm 2580 comprising a partially electrically conductive clamp arm pad 2582, according to at least one aspect of the resent disclosure. An electrically conductive foil 2584 covers a portion of an electrically non-conductive pad 2586. The electrically non-conductive pad 2588 at the proximal end 2590 sets a gap between the clamp arm pad 2582 and the ultrasonic blade.


Elements of the electrically conductive film 2568, foil, or laminate may include, for example, a single layer of thin conductive material such as metals (titanium, silver, gold, zinc, aluminum, magnesium, iron, etc. and their alloys or stainless steels), plated metals (nickel and then gold over copper, for example) or polymers filled heavily with conductive materials such as metal powder, or filings. Preferably, it is a biocompatible metal foil such as titanium, silver, gold, zinc, or stainless steel selected from a thickness within the range of 0.001″ to 0.008″ (0.025 mm-0.20 mm).


The film 2568, foil, or laminate may include a thin polymer coating, film or layer covering the thin conductive material described above. This coating, film or layer is highly resistive, that is, it is not an effective conductor of bipolar RF energy to adjacent tissue. The coating may be perforated to allow for energy delivery from the electrode to tissue.


The conductive material may be perforated or contain holes or windows through the full thickness of the conductive material to minimize the thermal capacitance of this layer (testing has shown that long and/or thick foils result in longer transection times due to thermal energy being removed from the treatment sight. These perforations, holes or windows also may allow for retention of the foil to other parts or layers. These perforations, holes or windows may be patterned across the entire foil sheet or may be localized at the treatment site or away from the treatment site such as, for example, on the sides of the clamp arm only.


If present, the thin polymer coating, film or layer may be perforated or contain full thickness holes or windows such that the conductive film, foil or laminate is in direct communication with tissue for delivery of bipolar radiofrequency energy to the tissue. For coatings, these holes or windows may be formed by selective coating or coating removal.


Ideally, the conductive film 2568, foil, or laminate is in direct contact with the clamp arm structure that is typically fabricated from stainless steel. The resulting conductive path then allows for simplicity of construction in that the path is formed by necessary structural component, namely a support tube or actuator that connects directly to the clamp arm and then the conductive film, foil or laminate.


In one aspect, the conductive film 2568, foil, or laminate is backed by a relatively soft, high temperature, low wear polymer or elastomer pad made from materials such as PTFE, silicone, polyimide, high temperature thermoplastics, among other materials. The compliance of this relatively soft pad allows for a wide range of component tolerances to obtain a zero or near zero gap between the jaw and the ultrasonic blade along its full tissue effecting length when the jaw is fully closed, thus allowing tissue to be sealed and cut along this length. The compliance also eliminates or greatly dampens any audible vibration of the conductive layer that may occur when the ultrasonic blade is closed against the conductive layer.


The conductive film 2568, foil, or laminate may include a rigid to semi-rigid polymer on its backside/back surface (that is the surface away from the tissue and toward the clamp arm). This part is made from injection moldable polymers or polymer alloys and adhered to the film, foil or laminate by way of Film Insert Molding (FIM) or In-Mold Labeling (IML).


In testing, thin stainless steel, copper, or aluminum foils are quiet in operation (no “screeching” or emitting of obtuse squeals). The thin stainless steel, copper, or aluminum foils provide a robust surface against which the ultrasonic blade can act. Robust enough that materials such as silicone rubber that would otherwise tear and serve as a poor pad material are usable and do not easily tear or split.


The proximal portion of the jaw clamping surface may not include the conductive film, foil or laminate because this area of the jaw contacts the blade first and will be more likely result in shunting of power/shorting in this area.


In one aspect, the present disclosure provides a short circuit mitigation algorithm for activating an output including bipolar RF energy.


A short alert is not given to the user if it occurs after the energy delivered for the activation exceeds a threshold amount (thereby indicating that the tissue thinned but has likely received an adequate dose of bipolar RF energy for the sealing, coagulation of tissue), or an activation time threshold has been exceeded (again, thereby indicating that the tissue has thinned but has likely received and adequate dose), or both energy and activation time thresholds have been exceeded.


A process of making a film over stainless steel insert molded electrode assembly comprises etching the film and forming apertures (micro-holes, slots, or honeycomb) for passing RF energy; cutting periphery of the electrode component; forming a film onto/bond onto stainless steel electrode if needed; placing the charged film and electrode into a polymer injection mold tool; molding the polymer to the back of the electrode and film.


In various aspects, the present disclosure provides an end-effector for a combination ultrasonic/bipolar RF energy surgical device configured to lower tissue gap for RF welding while minimizing short circuiting the electrode to the ultrasonic blade. In one aspect, the electrodes may be separated into right and left electrodes with a distal non-conductive zone aligned with the blade projection. In one aspect, the ultrasonic blade is selectively insulated. In a combination ultrasonic/RF energy surgical instrument, there exists the risk that the positive electrode of the bipolar RF circuit will short circuit with the negative electrode of the bipolar RF circuit. Generally, the clamp arm functions as the positive (hot) electrode and the ultrasonic blade functions as the negative (cold) electrode of the bipolar RF circuit. In use, it is desirable to prevent or minimize the likelihood of the positive electrode electrically contacting the ultrasonic blade and thus creating a short circuit condition. Accordingly, it is desirable to selectively coat particular areas of the ultrasonic blade to prevent or minimize short circuiting the clamp arm to the ultrasonic blade as described hereinbelow. Further, it may be desirable to selectively coat other components of the end-effector to electrically isolate portions of the end-effector from adjacent tissue. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.



FIG. 37 illustrates an end-effector 1910 comprising a clamp arm 1912, an ultrasonic blade 1914, an electrode 1916, and a clamp arm pad 1918, according to at least one aspect of the present disclosure. The ultrasonic blade 1914 comprises an electrically insulative material 1920 on select areas of ultrasonic blade 1914 to prevent electrical shorting in the event of the ultrasonic blade 1914 contacting the upper jaw electrode 1916. In one aspect, the electrically insulative material 1920 may be applied by vapor deposition or other coating techniques. The electrically insulative material 1920 may be deposited by masking or machining off areas of the ultrasonic blade 1914 that are required to be electrically conductive. The electrically insulative material 1920 deposited on the ultrasonic blade 1914 may be a fluoropolymer material known under the tradename XYLAN, PTFE, nanocomposite coatings such as diamond-like carbon (DLC) coatings, or ceramic coatings, for example.


In one aspect, the present disclosure provides an end-effector comprising an offset electrode with a deflectable portion. In one aspect, the offset electrode may be provided in combination with a deflectable portion.


In one aspect, the present disclosure provides an end-effector that includes selectively coated components. The selective coating of end-effector components to electrically isolate portions of the end-effector from adjacent tissue. Potential advantages of selectively coating end-effector components to electrically isolate portions of the end-effector from adjacent tissue include reduce the likelihood of inadvertent RF injury to tissue, focus RF energy to desired tissue effects for shorter activation times and reduced thermal spread, and provide active electrode tips to allow for precise spot coagulation and touch up.


The electrically insulative coatings may be selectively applied in thick, thin, or in between layers depending on a desirable outcome. It may be advantageous to provide thin, electrically insulative and thermally dissipative coatings such as fluoropolymer coatings known under the tradename XYLAN, PTFE, nanocomposite coatings such as DLC coatings, or ceramic coatings, example. The coatings may be applied to masked components or selectively removed by buffing, grinding, machining, laser, or similar technique to expose the underlying electrically conductive electrode surface.



FIGS. 38A-38F illustrate various examples of combination ultrasonic/RF energy end-effectors comprising selectively coated components, according to at least one aspect of the present disclosure. In various aspects, the end-effectors include coated components, uncoated components, and bare electrode components as described hereinbelow.


In FIG. 38A, an end-effector 1930 comprises selectively coated portions 1932 on the clamp arm 1934 and the ultrasonic blade 1936, an uncoated clamp arm pad 1938, and bare electrode 1939 portions on the clamp arm 1934 and the ultrasonic blade 1936.


In FIG. 38B, an end-effector 1940 comprises selectively coated portions 1942 on the clamp arm 1934, an uncoated ultrasonic blade 1936, an uncoated clamp arm pad 1938, and a bare electrode 1944 on the clamp arm 1934.


In FIG. 38C, an end-effector 1950 comprises an uncoated clamp arm 1934, selectively coated portions 1952 on the ultrasonic blade 1936, an uncoated clamp arm pad 1938, and a bare electrode 1939 portion on the ultrasonic blade 1936.


In FIG. 38D, an end-effector 1960 comprises selectively coated portions 1962 on the clamp arm 1934, an uncoated ultrasonic blade 1936, an uncoated clamp arm pad 1938, and a bare electrode 1939 on the clamp arm 1934 including a bare electrode portion at the tip 1964 of the clamp arm 1934.


In FIG. 38E, an end-effector 1970 comprises an uncoated clamp arm 1934, selectively coated portions 1972 on the ultrasonic blade 1936, an uncoated clamp arm pad 1938, and a bare electrode 1939 portion on the ultrasonic blade 1936 including a bare electrode portion at the tip 1974 of the ultrasonic blade 1936.


In FIG. 38F, an end-effector 1980 comprises selectively coated portions 1982 on the clamp arm 1934 and the uncoated ultrasonic blade 1936, an uncoated clamp arm pad 1938, and bare electrode portions 1939 on the clamp arm 1934 and the ultrasonic blade 1936 including bare electrode portions at the tip 1984 of the clamp arm 1934 and the tip 1986 of the ultrasonic blade 1936.


In various aspects, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical instrument comprising an end-effector with a clamp arm actuation or pivot mechanism. The clamp arm actuation or pivot mechanism changes the closure gap, angle, or levelness based on the loading experienced during clamping.


In various aspects, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical instrument comprising an end-effector with an electrode configuration. In one aspect, the end-effector comprises a variable electrode with a deflectable portion. The electrode physical parameters in combination with an electrode may be varied to change the energy density and tissue interactions. An electrode is provided for use with an ultrasonic blade and RF energy electrosurgical system where the physical aspects of the electrode vary along its length in order to change the contact area and/or the energy density of the electrode to tissue as the electrode also deflects. The electrode is fixed to the clamp jaw at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or as a deflectable electrode. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In one aspect, the end-effector comprises longitudinal variations in electrode size. The electrode can vary in width from the proximal end to the distal end proportionate to the clamp arm width change. The size of the electrode can be varied to vary the energy density and contact area. In one aspect, the width of the electrically active portion of the electrode could change proximal to distal to create constant energy density limiting compression or amplifying the concentrating effect. The electrode is fixed to the clamp jaw at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or as a deflectable electrode. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In one aspect, the present disclosure provides an end-effector comprising local adjustment of the electrode to provide compliant tissue coupling. In one aspect, a segmented electrode configuration comprises independently deflectable portions. Each segment of the segmented electrode is capable of deflecting independently. In one aspect, the segmented electrode comprises independently deflectable electrodes for use in a combination ultrasonic/bipolar RF energy device. Each segment of the segmented electrode may have a separate spring rate along the length of the clamp arm jaw. This configuration may provide variable spring/compression rates. In other aspects, this configuration may enable only a portion of the electrode to be deflectable. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In one aspect, the end-effector comprises deflectable electrodes broken into multiple elements. In one aspect, the deflectable electrodes are configured as watch band-style electrode elements. The physical aspects of the deflectable electrode are configured to vary along its length in order to change the contact area and/or the energy density of the deflectable electrode to tissue as the deflectable electrode deflects.


In one aspect, the deflectable electrode may comprise a plurality of segments. In one aspect, the deflectable electrode may comprise three elements although three or more elements may be employed depending on the desired pressure profile. These segments may be joined together such that they pivot around each other like an articulation mechanism. Each electrode segment may comprise a spring type mechanism to control the resistance to compression. The spring mechanism may comprise multiple possible configurations including being integrated with stamped leaf springs, separate springs, or flexible materials acting as springs.


In one aspect, springs could be designed and tuned to apply the exact desired pressure profile. The proximal loading can be reduced to improve pad life or increase loading distally to provide better performance at the tip of the end effector. All configurations may comprise a fundamental metal electrode located above the clamp arm and a wear resistant material on the electrode and a more compliant material on the clamp arm.


In one aspect, the electrode also may be connected to the electrical return path (cold) of a bipolar circuit. Opposite the clamp arm is a titanium ultrasonic blade that acts as the electrical source path (hot) of the bipolar RF circuit. The ultrasonic blade is configured to oscillate mechanically to generate heat by creating friction between tissue and the ultrasonic blade. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.



FIG. 39 illustrates an end-effector 2380 comprising an ultrasonic blade 2382, a clamp arm 2384, and a watch-band style segmented electrode 2386, according to at least one aspect of the present disclosure. The end-effector 2380 further comprises spring elements 2388 configured to bias the segmented electrode 2386. In the illustrated aspect, the segmented electrode 2386 comprises three segments 2386a, 2386b, 2386c linked by pins 2387a, 2387b. Three springs 2388a, 2388b, 2388c are positioned between each of the electrode segments 2386a, 2386b, 2386c and the clamp jaw 2385 to apply distal, medial, and proximal bias to the electrode segments 2386a, 2386b, 2386c, respectively. In other aspects, the segmented electrode 2386 may comprise additional or fewer elements.



FIG. 40 is a magnified view of the distal and medial segments 2386a, 2386b of the segmented electrode 2386 shown in FIG. 39. The distal segment 2386a comprises a rounded distal end 2390, an opening 2392 to receive a pin 2387a, and a grooved surface 2396 at a proximal end 2398. The medial segment 2386b comprises a cylindrical insert 2400 that is received in the proximal grooved surface 2396 of the distal segment 2386a and the pin 2387a rotatably fixes the distal and medial segments 2386a, 2386b. Accordingly, the medial segment 2386b is placed into the grooved surface 2396 of the distal segment 2386a and the pin 2387a is placed through the opening 2392 to hold distal segment 2386a and the medial segment 2386b together and allowing the distal segment 2386a and the medial segment 2386b to pivot against each other by way of the grooved surface 2396 and the cylindrical insert 2400.


Additional background disclosure may be found in European Patent No. EP3420980, which is herein incorporated by reference in its entirety.


In one aspect, the present disclosure provides an end-effector comprising an electrode configured to minimize tissue sticking to the electrode. In one aspect, the electrode comprises a cooperative coating to minimize adhesion and focus energy. In one aspect, the present disclosure provides an apparatus and several techniques to prevent tissue charring due to electrical insulative properties and to improve easy clean off of accumulated material due to low frictional properties. The material could be a high melt temperature material like Teflon (PTFE) with a predefined opening or could be a DLC (diamond like coating) with high resistance and dielectric breakdown properties. The electrode is adapted and configured for use with a combination ultrasonic/bipolar RF energy surgical device and is deflectable under load, where the electrode is one pole of the bipolar RF circuit and the ultrasonic blade is the opposite pole of the bipolar RF circuit.


In various aspects, the present disclosure provides combination ultrasonic/bipolar RF energy surgical devices and systems. Various forms are directed to user interfaces for surgical instruments with ultrasonic and/or electrosurgical (RF) end-effectors configured for effecting tissue treating, dissecting, cutting, and/or coagulation during surgical procedures. In one form, a user interface is provided for a combined ultrasonic and electrosurgical instrument that may be configured for use in open surgical procedures, but has applications in other types of surgery, such as minimally invasive laparoscopic procedures, for example, non-invasive endoscopic procedures, either in hand held or and robotic-assisted procedures. Versatility is achieved by selective application of multiple energy modalities simultaneously, independently, sequentially, or combinations thereof. For example, versatility may be achieved by selective use of ultrasonic and electrosurgical energy (e.g., monopolar or bipolar RF energy) either simultaneously, independently, sequentially, or combinations thereof.


In one aspect, the present disclosure provides a user interface for an apparatus comprising an ultrasonic blade and clamp arm with a deflectable RF electrode such that the ultrasonic blade and deflectable RF electrode cooperate to effect sealing, cutting, and clamping of tissue by cooperation of a clamping mechanism of the apparatus comprising the RF electrode with an associated ultrasonic blade. The clamping mechanism includes a pivotal clamp arm which cooperates with the ultrasonic blade for gripping tissue therebetween. The clamp arm is preferably provided with a clamp tissue pad (also known as “clamp arm pad”) having a plurality of axially spaced gripping teeth, segments, elements, or individual units which cooperate with the ultrasonic blade of the end-effector to achieve the desired sealing and cutting effects on tissue, while facilitating grasping and gripping of tissue during surgical procedures.


In one aspect, the end-effectors described herein comprise an electrode. In other aspects, the end-effectors described herein comprise alternatives to the electrode to provide a compliant coupling of RF energy to tissue, accommodate pad wear/thinning, minimize generation of excess heat (low coefficient of friction, pressure), minimize generation of sparks, minimize interruptions due to electrical shorting, or combinations thereof. The electrode is fixed to the clamp jaw at the proximal end and is free to deflect at the distal end. Accordingly, throughout this disclosure the electrode may be referred to as a cantilever beam electrode or as a deflectable electrode.


In other aspects, the end-effectors described herein comprise a clamp arm mechanism configured to high pressure between a pad and an ultrasonic blade to grasp and seal tissue, maximize probability that the clamp arm electrode contacts tissue in limiting or difficult scenarios, such as, for example, thin tissue, tissue under lateral tension, tissue tenting/vertical tension especially tenting tissue away from clamp arm.


In other aspects, the end-effectors described herein are configured to balance match of surface area/current densities between electrodes, balance and minimize thermal conduction from tissue interface, such as, for example, impacts lesion formation and symmetry, cycle time, residual thermal energy. In other aspects, the end-effectors described herein are configured to minimize sticking, tissue adherence (minimize anchor points) and may comprise small polyimide pads.


In various aspects, the present disclosure provides a surgical device configured to deliver at least two energy types (e.g., ultrasonic, monopolar RF, bipolar RF, microwave, or irreversible electroporation [IRE]) to tissue. The surgical device includes a first activation button switch for activating energy, a second button switch for selecting an energy mode for the activation button switch. The second button switch is connected to a circuit that uses at least one input parameter to define the energy mode. The input parameter can be modified remotely through connection to a generator or through a software update.


In one aspect, at least one of the energy modes is a simultaneous blend of RF and ultrasonic energy, and the input parameter represents a duty cycle of the RF and ultrasonic energy.


In one aspect, the second button switch is configurable to select from a list of predefined modes and the number of modes in the list is defined by a second input parameter defined by a user.


In one aspect, the input parameter is either duty cycle, voltage, frequency, pulse width, or current.


In one aspect, the device also includes a visual indicator of the selected energy mode within the portion of device in the surgical field


In one aspect, the second button switch is a separate control from the end effector closure trigger.


In one aspect, the second button switch is configured to be activated second stage of the closure trigger. The first stage of the closure trigger in the closing direction is to actuate the end effector.


In one aspect, at least one of the energy modes is selected from ultrasonic, RF bipolar, RF monopolar, microwave, or IRE.


In one aspect, at least one of the energy modes is selected from ultrasonic, RF bipolar, RF monopolar, microwave, or IRE and is configured to be applied in a predefined duty cycle or pulsed algorithm.


In one aspect, at least one of the energy modes is selected from a sequential application of two or more of the following types of energy: ultrasonic, RF bipolar, RF monopolar, microwave, or IRE.


In one aspect, at least one of the energy modes is a simultaneous blend of two or more of the following types of energy: ultrasonic, RF bipolar, RF monopolar, microwave, and IRE.


In one aspect, at least one of the energy modes is a simultaneous blend of two or more of the following types of energy: ultrasonic, RF bipolar, RF monopolar, microwave, and IRE followed sequentially by one or more of the aforementioned energies.


In one aspect, at least one of the energy modes is one off the following types of energy: Ultrasonic, RF bipolar, RF monopolar, microwave, and IRE followed sequentially by a simultaneous blend of two or more of the aforementioned energies.


In one aspect, at least one of the energy modes is procedure or tissue specific predefined algorithm.


In one aspect, at least one of the energy modes is compiled from learned surgical behaviors or activities.


In one aspect, the input parameter is at least one of: energy type, duty cycle, voltage, frequency, pulse width, current, impedance limit, activation time, or blend of energy.


In one aspect, the second button switch is configurable to select from a list of predefined modes and the number of modes in the list is either predefined or defined by a second input parameter defined by a user.


In one aspect, the aforementioned energy modes are made available to the user through software updates to the generator.


In one aspect, the aforementioned energy modes are made available to the user through software updates to the device.


In one aspect, the preferred selections by the user are made available to multiple generators through either networking, the cloud, or manual transfer.


In one aspect, the device also includes a visual indicator of the selected energy mode within the portion of device in the surgical field.


As used herein a button switch can be a manually, mechanically, or electrically operated electromechanical device with one or more sets of electrical contacts, which are connected to external circuits. Each set of electrical contacts can be in one of two states: either “closed” meaning the contacts are touching and electricity can flow between them, or “open”, meaning the contacts are separated and the switch is electrically non-conducting. The mechanism actuating the transition between these two states (open or closed) can be either an “alternate action” (flip the switch for continuous “on” or “off”) or “momentary” (push for “on” and release for “off”) type.


In one aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device comprising on device mode selection and visual feedback. As surgical devices evolve and become more capable, the number of specialized modes in which they can be operated increases. Adding extra button switches on a device to accommodate these new additional modes would complicate the user interface and make the device more difficult to use. Accordingly, the present disclosure provides techniques for assigning different modes to a single physical button switch, which enables a wider selection of modes without adding complexity to the housing design (e.g., adding more and more button switches). In one aspect, the housing is in the form of a handle or pistol grip.


As more specialized modes become available, there is a need to provide multiple modes to a surgeon using the surgical device without creating a complex user interface. Surgeons want to be able to control the mode selection from the sterile field rather than relying on a circulating nurse at the generator. Surgeon want real time feedback so they are confident they know which mode is selected.



FIG. 41 illustrates a surgical device 100 comprising a mode selection button switch 130 on the device 100, according to at least one aspect of the present disclosure. The surgical device 100 comprises a housing 102 defining a handle 104 in the form of a pistol grip. The housing 102 comprises a trigger 106 which when squeezed is received into the internal space defined by the handle 104. The trigger 106 is used to operate a clamp arm 111 portion of an end-effector 110. A clamp jaw 112 is pivotally movable about pivot point 114. The housing 102 is coupled to the end-effector 110 through a shaft 108, which is rotatable by a knob 122.


The end-effector 110 comprises a clamp arm 111 and an ultrasonic blade 116. The clamp arm 111 comprises a clamp jaw 112, an electrode 118, and a clamp arm pad 120. In one aspect, the clamp arm pad 120 is made of a non-stick lubricious material such as PTFE or similar synthetic fluoropolymers of tetrafluoroethylene. PTFE is a hydrophobic, non-wetting, high density and resistant to high temperatures, and versatile material and non-stick properties. The clamp arm pad 120 is electrically non-conductive. In contrast, the electrode 118 is made of an electrically conductive material to deliver electrical energy such as monopolar RF, bipolar RF, microwave, or irreversible electroporation (IRE), for example. The electrode 118 may comprises gap setting pads made of a polyimide material, and in one aspect, is made of a durable high-performance polyimide-based plastic known under the tradename VESPEL and manufactured by DuPont or other suitable polyimide, polyimide polymer alloy, or PET (Polyethylene Terephthalate), PEEK (Polyether Ether Ketone), PEKK (Poly Ether Ketone Ketone) polymer alloy, for example. Unless otherwise noted hereinbelow, the clamp arm pads and gap pads described hereinbelow are made of the materials described in this paragraph.


The electrode 118 and the ultrasonic blade 116 are coupled to the generator 133. The generator 133 is configured to drive RF, microwave, or IRE energy to the electrode 118. The generator 133 also is configured to drive an ultrasonic transducer acoustically coupled to the ultrasonic blade 116. In certain implementations, the electrode 118 is one pole of an electrical circuit and the ultrasonic blade 116 is the opposite pole of the electrical circuit. The housing 102 includes a switch 124 to activate the ultrasonic blade 116. The circuit may be contained in the housing 102 or may reside in the generator 133. The surgical device 100 is coupled to the generator 133 via a cable 131. The cable 131 conducts signals for the electrosurgical functions and the ultrasonic transducer.


In various aspects, the surgical device 100 is configured to deliver at least two energy types (e.g., ultrasonic, monopolar RF, bipolar RF, microwave, or irreversible electroporation [IRE]) to tissue located in the end-effector 110 between the clamp arm 111 and the ultrasonic blade 116. The housing 102 of the surgical device 100 includes a first activation button switch 126 for activating energy and a second “mode” button switch 130 for selecting an energy mode for the activation button switch. The second button switch 130 is connected to a circuit that uses at least one input parameter to define the energy mode. The input parameter can be modified remotely through connection to a generator or through a software update. The energy mode is displayed on a user interface 128.


In one aspect, the surgical instrument 100 provides mode switching through the on device directional selector “mode” button switch 130. The user can press the mode button switch 130 to toggle through different modes and the colored light on the user interface 128 indicates the selected mode.


According to various aspects of the present disclosure, different modes of operation can be assigned to the surgical device by pressing the “mode” button switch 130, where each time the mode button switch 130 is pressed, or pushed and held, the surgical device 100 toggles through the available modes, which are displayed on the user interface 128. Once a mode is selected, the generator 133 will provide the appropriate generator tone and the surgical device 100 will have a lighted indicator on the user interface 128 to indicate which mode was selected.


In the example illustrated in FIG. 41, the “mode” selection button switch 130 is placed symmetrically on both sides of the housing 102. This enables both a right and left handed surgeon to select/toggle through modes without using a second hand. In this aspect, the “mode” selection button switch 130 can toggle in many different directions, which enables the surgeon to select from a list of options and navigate more complex selections remotely from the sterile field without having to ask a circulator to make adjustments at the generator 133. The lighted indicator on the user interface 128 of the surgical device 100, in addition to generator 133 tones, gives the surgeon feedback on which mode is selected.



FIGS. 42A-42C illustrate three options for selecting the various operating modes of the surgical device 100, according to at least one aspect of the present disclosure. In addition to the colored light user interface 128 on the housing 102 of the surgical device 100, feedback for mode selection is audible and/or visible through the generator 133 interface where the generator 133 announces the selected mode verbally and/or shows a description of the selected mode on a screen of the generator 133.



FIG. 42A shows a first mode selection option 132A where the button switch 130 can be pressed forward 136 or backward 134 to cycle the surgical instrument 100 through the various modes.



FIG. 42B shows a second mode selection option 132B where the button switch 130 is pressed up 140 or down 138 to cycle the surgical instrument 100 through the various modes.



FIG. 42C shows a third mode selection option 132C where the button switch 130 is pressed forward 136, backward 134, up 149, or down 138 to cycle the surgical instrument 100 through the various modes.



FIG. 43 illustrates a surgical device 150 comprising a mode selection button switch 180 on the back of the device 150, according to at least one aspect of the present disclosure. The surgical device 150 comprises a housing 152 defining a handle 154 in the form of a pistol grip. The housing 152 comprises a trigger 156 which when squeezed is received into the internal space defined by the handle 154. The trigger 156 is used to operate a clamp arm 161 portion of an end-effector 160. A clamp jaw 162 is pivotally movable about pivot point 164. The housing 152 is coupled to the end-effector 160 through a shaft 158, which is rotatable by a knob 172.


The end-effector 160 comprises a clamp arm 161 and an ultrasonic blade 166. The clamp arm 161 comprises a clamp jaw 162, an electrode 168, and a clamp arm pad 170. In one aspect, the clamp arm pad 170 is made of a non-stick lubricious material such as PTFE or similar synthetic fluoropolymers of tetrafluoroethylene. PTFE is a hydrophobic, non-wetting, high density and resistant to high temperatures, and versatile material and non-stick properties. The clamp arm pad 170 is electrically non-conductive. In contrast, the electrode 168 is made of an electrically conductive material to deliver electrical energy such as monopolar RF, bipolar RF, microwave, or irreversible electroporation (IRE), for example. The electrode 168 may comprises gap setting pads made of a polyimide material, and in one aspect, is made of a durable high-performance polyimide-based plastic known under the tradename VESPEL and manufactured by DuPont or other suitable polyimide, polyimide polymer alloy, or PET (Polyethylene Terephthalate), PEEK (Polyether Ether Ketone), PEKK (Poly Ether Ketone Ketone) polymer alloy, for example. Unless otherwise noted hereinbelow, the clamp arm pads and gap pads described hereinbelow are made of the materials described in this paragraph.


The electrode 168 and the ultrasonic blade 166 are coupled to the generator 133. The generator 133 is configured to drive RF, microwave, or IRE energy to the electrode 168. The generator 133 also is configured to drive an ultrasonic transducer acoustically coupled to the ultrasonic blade 166. In certain implementations, the electrode 168 is one pole of an electrical circuit and the ultrasonic blade 166 is the opposite pole of the electrical circuit. The housing 152 includes a switch 174 to activate the ultrasonic blade 166. The circuit may be contained in the housing 152 or may reside in the generator 133. The surgical device 150 is coupled to the generator 133 via a cable 181. The cable 181 conducts signals for the electrosurgical functions and the ultrasonic transducer.


In various aspects, the surgical device 100 is configured to deliver at least two energy types (e.g., ultrasonic, monopolar RF, bipolar RF, microwave, or irreversible electroporation [IRE]) to tissue located in the end-effector 110 between the clamp arm 111 and the ultrasonic blade 116. The housing 102 of the surgical device 100 includes a first activation button switch 126 for activating energy and a second “mode” button switch 130 for selecting an energy mode for the activation button switch. The second button switch 130 is connected to a circuit that uses at least one input parameter to define the energy mode. The input parameter can be modified remotely through connection to a generator or through a software update. The energy mode is displayed on a user interface 128.


In one aspect, the surgical instrument 150 provides mode switching through the on device directional selector “mode” button switch 180. The user can press the mode button switch 180 to toggle through different modes and the colored light on the user interface 178 indicates the selected mode.


According to various aspects of the present disclosure, different modes of operation can be assigned to the surgical device by pressing the “mode” button switch 180, where each time the mode button switch 180 is pressed, or pushed and held, the surgical device 150 toggles through the available modes, which are displayed on the user interface 178. Once a mode is selected, the generator 133 will provide the appropriate generator tone and the surgical device 150 will have a lighted indicator on the user interface 178 to indicate which mode was selected.


In the example illustrated in FIG. 43, the “mode” selection button switch 180 is placed on the back of the surgical device 150. The location of the “mode” selection button switch 180 is out of the reach of the surgeon's hand holding the surgical device 150 so a second hand is required to change modes. This is intended to prevent inadvertent activation. In order to change modes, a surgeon must use her second hand to intentionally press the mode button switch 180. The lighted indicator on the user interface 178 of the surgical device 150, in addition to generator tones gives the surgeon feedback on which mode is selected.



FIG. 44A shows a first mode selection option where as the mode button switch 180 is pressed to toggled through various modes, colored light indicates the selected mode on the user interface 178.



FIG. 44B shows a second mode selection option where as the mode button switch 180 is pressed to toggle through various modes a screen 182 indicates the selected mode (e.g., LCD, e-ink).



FIG. 44C shows a third mode selection option where as the mode button switch 180 is pressed to toggle through various modes, labelled lights 184 indicate the selected mode.



FIG. 44D shows a fourth mode selection option where as a labeled button switch 186 is pressed to select a mode, when a labeled button switch 180 is selected, it is illuminated to indicate mode selected


In one aspect, the present disclosure provides a combination ultrasonic/bipolar RF energy surgical device comprising energy activation with trigger closure. As more functionality is added to advanced energy surgical devices additional button switches or controls are added to the surgical devices. The additional button switches or controls make these advanced energy surgical devices complicated and difficult to use. Additionally, when using an advanced energy surgical device to control bleeding, difficult to use user interfaces or difficult to access capability will cost critical time and attention during a surgical procedure.


According to the present disclosure, monopolar RF energy or advanced bipolar RF energy is activated by closing the trigger by squeezing the trigger past a first closure click to a second activation click and holding closed until energy delivery is ceased by the power source in the generator. Energy also can be immediately reapplied by slightly releasing and re-squeezing the trigger as many times as desired.



FIG. 45 illustrates a surgical device 190 comprising a trigger 196 activation mechanism, according to at least one aspect of the present disclosure. The surgical device 190 comprises a housing 192 defining a handle 194 in the form of a pistol grip. The housing 192 comprises a trigger 196 which when squeezed is received into the internal space defined by the handle 194. The housing 192 is coupled to an end-effector through a shaft 198, which is rotatable by a knob 202. The surgical device 190 is coupled to a generator 206 via a cable 204. The cable 204 conducts signals for the electrosurgical functions and the ultrasonic transducer.


The trigger 196 is configured to operate a clamp arm portion of an end-effector and to trigger electrosurgical energy, thus eliminating the activation button switch 126, 176 shown in FIGS. 41 and 43. The trigger 196 closes to a first audible and tactile click to close the jaws for grasping tissue and further closes to a second audible and tactile click to activate electrosurgical energy such as monopolar or bipolar RF. Microwave, or IRE energy. The full sequence is completed by activating the front button switch which cuts using ultrasonic energy.


Procedure for operating the surgical device 190: squeeze the trigger 196 to a first audible and tactile click; verify targeted tissue in jaws; activate RF energy by further squeezing the trigger 196 to a second audible and tactile click until end tone is heard; cut by pressing ultrasonic front switch 200 until tissue divides.


Modified procedure for operating the surgical instrument 190 for additional capability: activate RF energy with the trigger 196 and hold while simultaneously activation the front button switch 200 to activate the ultrasonic transducer, which will result in simultaneous application of electrosurgical and ultrasonic energy modalities being delivered to the tissue at the same time.


In an alternative implementation, the front button switch 200 for activating ultrasonic energy may be toggled to different speeds via a mode selector on the surgical device 190 or on the power source generator 206.


The surgical instruments 100, 150, 190 and associated algorithms described above in connection with FIGS. 41-45 comprising the end-effectors described in FIGS. 1-40 may be implemented in the following surgical hub system in conjunction with the following generator and modular energy system, for example.



FIG. 46 illustrates an alternative clamp arm comprising a metal clamp jaw, an electrode, a plurality of clamp arm pads, and gap pads, according to at least one aspect of the present disclosure. FIG. 46 illustrates an alternative clamp arm 2900 comprising a metal clamp jaw 2904, an electrode 2906, a plurality of clamp arm pads 2920 extend through holes in the electrode 2906, a gap pad 2930, and a gap pad 2910, according to at least one aspect of the present disclosure. The electrode 2906 is attached to the metal jaw 2906 at weld locations 2908. The electrode 2906 wraps around the metal clamp jaw 2904 and electrode 2906 can deflect. The gap pad 2910 has a top PI layer 2912 and a bottom elastomer layer 2914 for pressure control that is attached directly to the metal clamp jaw 2904. The clamp arm pads 2920 are attached directly to the metal clamp jaw 2904 and are composite pads with a high pressure center zone 2922 made of PTFE for reduced heat and an outer zone 2924 made of PI for electrode 2906 deflection.


In one aspect, the combination ultrasonic/bipolar RF energy surgical device is configured to operate within a surgical hub system. FIG. 47 is a surgical system 3102 comprising a surgical hub 3106 paired with a visualization system 3108, a robotic system 3110, and an intelligent instrument 3112, in accordance with at least one aspect of the present disclosure. Referring now to FIG. 47, the hub 3106 is depicted in communication with a visualization system 3108, a robotic system 3110, and a handheld intelligent surgical instrument 3112 configured in a similar manner to the surgical instruments 100, 150, 190 as described in FIGS. 41-46. The hub 3106 includes a hub display 3135, an imaging module 3138, a generator module 3140, a communication module 3130, a processor module 3132, and a storage array 3134. In certain aspects, as illustrated in FIG. 47, the hub 3106 further includes a smoke evacuation module 3126 and/or a suction/irrigation module 3128.


During a surgical procedure, energy application to tissue, for sealing and/or cutting, is generally associated with smoke evacuation, suction of excess fluid, and/or irrigation of the tissue. Fluid, power, and/or data lines from different sources are often entangled during the surgical procedure. Valuable time can be lost addressing this issue during a surgical procedure. Detangling the lines may necessitate disconnecting the lines from their respective modules, which may require resetting the modules. The hub modular enclosure 3136 offers a unified environment for managing the power, data, and fluid lines, which reduces the frequency of entanglement between such lines.


Aspects of the present disclosure present a surgical hub for use in a surgical procedure that involves energy application to tissue at a surgical site. The surgical hub includes a hub enclosure and a combo generator module slidably receivable in a docking station of the hub enclosure. The docking station includes data and power contacts. The combo generator module includes two or more of an ultrasonic energy generator component, a bipolar RF energy generator component, and a monopolar RF energy generator component that are housed in a single unit. In one aspect, the combo generator module also includes a smoke evacuation component, at least one energy delivery cable for connecting the combo generator module to a surgical instrument, at least one smoke evacuation component configured to evacuate smoke, fluid, and/or particulates generated by the application of therapeutic energy to the tissue, and a fluid line extending from the remote surgical site to the smoke evacuation component.


In one aspect, the fluid line is a first fluid line and a second fluid line extends from the remote surgical site to a suction and irrigation module slidably received in the hub enclosure. In one aspect, the hub enclosure comprises a fluid interface.


Certain surgical procedures may require the application of more than one energy type to the tissue. One energy type may be more beneficial for cutting the tissue, while another different energy type may be more beneficial for sealing the tissue. For example, a bipolar generator can be used to seal the tissue while an ultrasonic generator can be used to cut the sealed tissue. Aspects of the present disclosure present a solution where a hub modular enclosure 136 is configured to accommodate different generators, and facilitate an interactive communication therebetween. One of the advantages of the hub modular enclosure 136 is enabling the quick removal and/or replacement of various modules.


Aspects of the present disclosure present a modular surgical enclosure for use in a surgical procedure that involves energy application to tissue. The modular surgical enclosure includes a first energy-generator module, configured to generate a first energy for application to the tissue, and a first docking station comprising a first docking port that includes first data and power contacts, wherein the first energy-generator module is slidably movable into an electrical engagement with the power and data contacts and wherein the first energy-generator module is slidably movable out of the electrical engagement with the first power and data contacts,


Further to the above, the modular surgical enclosure also includes a second energy-generator module configured to generate a second energy, different than the first energy, for application to the tissue, and a second docking station comprising a second docking port that includes second data and power contacts, wherein the second energy-generator module is slidably movable into an electrical engagement with the power and data contacts, and wherein the second energy-generator module is slidably movable out of the electrical engagement with the second power and data contacts.


In addition, the modular surgical enclosure also includes a communication bus between the first docking port and the second docking port, configured to facilitate communication between the first energy-generator module and the second energy-generator module.


In one aspect, the present disclosure provides a generator configured to drive the combination ultrasonic/bipolar RF energy surgical device. FIG. 48 illustrates an example of a generator 3900, in accordance with at least one aspect of the present disclosure. As shown in FIG. 48, the generator 3900 is one form of a generator configured to couple to a surgical instrument 100, 150, 190 as described in FIGS. 41-46, and further configured to execute adaptive ultrasonic and electrosurgical control algorithms in a surgical data network comprising a modular communication hub as shown in FIG. 47. The generator 3900 is configured to deliver multiple energy modalities to a surgical instrument. The generator 3900 provides RF and ultrasonic signals for delivering energy to a surgical instrument either independently or simultaneously. The RF and ultrasonic signals may be provided alone or in combination and may be provided simultaneously. As noted above, at least one generator output can deliver multiple energy modalities (e.g., ultrasonic, bipolar or monopolar RF, irreversible and/or reversible electroporation, and/or microwave energy, among others) through a single port, and these signals can be delivered separately or simultaneously to the end effector to treat tissue. The generator 3900 comprises a processor 3902 coupled to a waveform generator 3904. The processor 3902 and waveform generator 3904 are configured to generate a variety of signal waveforms based on information stored in a memory coupled to the processor 3902, not shown for clarity of disclosure. The digital information associated with a waveform is provided to the waveform generator 3904 which includes one or more DAC circuits to convert the digital input into an analog output. The analog output is fed to an amplifier 3906 for signal conditioning and amplification. The conditioned and amplified output of the amplifier 3906 is coupled to a power transformer 3908. The signals are coupled across the power transformer 3908 to the secondary side, which is in the patient isolation side. A first signal of a first energy modality is provided to the surgical instrument between the terminals labeled ENERGY1 and RETURN. A second signal of a second energy modality is coupled across a capacitor 3910 and is provided to the surgical instrument between the terminals labeled ENERGY2 and RETURN. It will be appreciated that more than two energy modalities may be output and thus the subscript “n” may be used to designate that up to n ENERGYn terminals may be provided, where n is a positive integer greater than 1. It also will be appreciated that up to “n” return paths RETURNn may be provided without departing from the scope of the present disclosure.


A first voltage sensing circuit 3912 is coupled across the terminals labeled ENERGY1 and the RETURN path to measure the output voltage therebetween. A second voltage sensing circuit 3924 is coupled across the terminals labeled ENERGY2 and the RETURN path to measure the output voltage therebetween. A current sensing circuit 3914 is disposed in series with the RETURN leg of the secondary side of the power transformer 3908 as shown to measure the output current for either energy modality. If different return paths are provided for each energy modality, then a separate current sensing circuit should be provided in each return leg. The outputs of the first and second voltage sensing circuits 3912, 3924 are provided to respective isolation transformers 3916, 3922 and the output of the current sensing circuit 3914 is provided to another isolation transformer 3918. The outputs of the isolation transformers 3916, 3928, 3922 in the on the primary side of the power transformer 3908 (non-patient isolated side) are provided to a one or more ADC circuit 3926. The digitized output of the ADC circuit 3926 is provided to the processor 3902 for further processing and computation. The output voltages and output current feedback information can be employed to adjust the output voltage and current provided to the surgical instrument and to compute output impedance, among other parameters. Input/output communications between the processor 3902 and patient isolated circuits is provided through an interface circuit 3920. Sensors also may be in electrical communication with the processor 3902 by way of the interface circuit 3920.


In one aspect, the impedance may be determined by the processor 3902 by dividing the output of either the first voltage sensing circuit 3912 coupled across the terminals labeled ENERGY1/RETURN or the second voltage sensing circuit 3924 coupled across the terminals labeled ENERGY2/RETURN by the output of the current sensing circuit 3914 disposed in series with the RETURN leg of the secondary side of the power transformer 3908. The outputs of the first and second voltage sensing circuits 3912, 3924 are provided to separate isolations transformers 3916, 3922 and the output of the current sensing circuit 3914 is provided to another isolation transformer 3916. The digitized voltage and current sensing measurements from the ADC circuit 3926 are provided the processor 3902 for computing impedance. As an example, the first energy modality ENERGY1 may be ultrasonic energy and the second energy modality ENERGY2 may be RF energy. Nevertheless, in addition to ultrasonic and bipolar or monopolar RF energy modalities, other energy modalities include irreversible and/or reversible electroporation and/or microwave energy, among others. Also, although the example illustrated in FIG. 48 shows a single return path RETURN may be provided for two or more energy modalities, in other aspects, multiple return paths RETURNn may be provided for each energy modality ENERGYn. Thus, as described herein, the ultrasonic transducer impedance may be measured by dividing the output of the first voltage sensing circuit 3912 by the current sensing circuit 3914 and the tissue impedance may be measured by dividing the output of the second voltage sensing circuit 3924 by the current sensing circuit 3914.


As shown in FIG. 48, the generator 3900 comprising at least one output port can include a power transformer 3908 with a single output and with multiple taps to provide power in the form of one or more energy modalities, such as ultrasonic, bipolar or monopolar RF, irreversible and/or reversible electroporation, and/or microwave energy, among others, for example, to the end effector depending on the type of treatment of tissue being performed. For example, the generator 3900 can deliver energy with higher voltage and lower current to drive an ultrasonic transducer, with lower voltage and higher current to drive RF electrodes for sealing tissue, or with a coagulation waveform for spot coagulation using either monopolar or bipolar RF electrosurgical electrodes. The output waveform from the generator 3900 can be steered, switched, or filtered to provide the frequency to the end effector of the surgical instrument. The connection of an ultrasonic transducer to the generator 3900 output would be preferably located between the output labeled ENERGY1 and RETURN as shown in FIG. 47. In one example, a connection of RF bipolar electrodes to the generator 3900 output would be preferably located between the output labeled ENERGY2 and RETURN. In the case of monopolar output, the preferred connections would be active electrode (e.g., pencil or other probe) to the ENERGY2 output and a suitable return pad connected to the RETURN output.


Additional details are disclosed in U.S. Patent Application Publication No. 2017/0086914, titled TECHNIQUES FOR OPERATING GENERATOR FOR DIGITALLY GENERATING ELECTRICAL SIGNAL WAVEFORMS AND SURGICAL INSTRUMENTS, which published on Mar. 30, 2017, which is herein incorporated by reference in its entirety.


In one aspect, the present disclosure provides a modular energy system configured to drive the combination ultrasonic/bipolar RF energy surgical device. FIG. 49 is a diagram of various modules and other components that are combinable to customize modular energy systems, in accordance with at least one aspect of the present disclosure. FIG. 50A is a first illustrative modular energy system configuration including a header module and a display screen that renders a graphical user interface (GUI) for relaying information regarding modules connected to the header module, in accordance with at least one aspect of the present disclosure. FIG. 50B is the modular energy system shown in FIG. 50A mounted to a cart, in accordance with at least one aspect of the present disclosure.


With reference now to FIGS. 48-50B, ORs everywhere in the world are a tangled web of cords, devices, and people due to the amount of equipment required to perform surgical procedures. Surgical capital equipment tends to be a major contributor to this issue because most surgical capital equipment performs a single, specialized task. Due to their specialized nature and the surgeons' needs to utilize multiple different types of devices during the course of a single surgical procedure, an OR may be forced to be stocked with two or even more pieces of surgical capital equipment, such as energy generators. Each of these pieces of surgical capital equipment must be individually plugged into a power source and may be connected to one or more other devices that are being passed between OR personnel, creating a tangle of cords that must be navigated. Another issue faced in modern ORs is that each of these specialized pieces of surgical capital equipment has its own user interface and must be independently controlled from the other pieces of equipment within the OR. This creates complexity in properly controlling multiple different devices in connection with each other and forces users to be trained on and memorize different types of user interfaces (which may further change based upon the task or surgical procedure being performed, in addition to changing between each piece of capital equipment). This cumbersome, complex process can necessitate the need for even more individuals to be present within the OR and can create danger if multiple devices are not properly controlled in tandem with each other. Therefore, consolidating surgical capital equipment technology into singular systems that are able to flexibly address surgeons' needs to reduce the footprint of surgical capital equipment within ORs would simplify the user experience, reduce the amount of clutter in ORs, and prevent difficulties and dangers associated with simultaneously controlling multiple pieces of capital equipment. Further, making such systems expandable or customizable would allow for new technology to be conveniently incorporated into existing surgical systems, obviating the need to replace entire surgical systems or for OR personnel to learn new user interfaces or equipment controls with each new technology.


A surgical hub can be configured to interchangeably receive a variety of modules, which can in turn interface with surgical devices (e.g., a surgical instrument or a smoke evacuator) or provide various other functions (e.g., communications). In one aspect, a surgical hub can be embodied as a modular energy system 4000, which is illustrated in connection with FIGS. 49-50B. The modular energy system 4000 can include a variety of different modules 4001 that are connectable together in a stacked configuration. In one aspect, the modules 4001 can be both physically and communicably coupled together when stacked or otherwise connected together into a singular assembly. Further, the modules 4001 can be interchangeably connectable together in different combinations or arrangements. In one aspect, each of the modules 4001 can include a consistent or universal array of connectors disposed along their upper and lower surfaces, thereby allowing any module 4001 to be connected to another module 4001 in any arrangement (except that, in some aspects, a particular module type, such as the header module 4002, can be configured to serve as the uppermost module within the stack, for example). In an alternative aspect, the modular energy system 4000 can include a housing that is configured to receive and retain the modules 4001, as is shown in FIG. 47. The modular energy system 4000 can also include a variety of different components or accessories that are also connectable to or otherwise associatable with the modules 4001. In another aspect, the modular energy system 4000 can be embodied as a generator module 3140, 3900 (FIGS. 47-48) of a surgical hub 3106. In yet another aspect, the modular energy system 4000 can be a distinct system from a surgical hub 3106. In such aspects, the modular energy system 4000 can be communicably couplable to a surgical hub 3106 for transmitting and/or receiving data therebetween.


The modular energy system 4000 can be assembled from a variety of different modules 4001, some examples of which are illustrated in FIG. 49. Each of the different types of modules 4001 can provide different functionality, thereby allowing the modular energy system 4000 to be assembled into different configurations to customize the functions and capabilities of the modular energy system 4000 by customizing the modules 4001 that are included in each modular energy system 4000. The modules 4001 of the modular energy system 4000 can include, for example, a header module 4002 (which can include a display screen 4006), an energy module 4004, a technology module 4040, and a visualization module 4042. In the depicted aspect, the header module 4002 is configured to serve as the top or uppermost module within the modular energy system stack and can thus lack connectors along its top surface. In another aspect, the header module 4002 can be configured to be positioned at the bottom or the lowermost module within the modular energy system stack and can thus lack connectors along its bottom surface. In yet another aspect, the header module 4002 can be configured to be positioned at an intermediate position within the modular energy system stack and can thus include connectors along both its bottom and top surfaces. The header module 4002 can be configured to control the system-wide settings of each module 4001 and component connected thereto through physical controls 4011 thereon and/or a graphical user interface (GUI) 4008 rendered on the display screen 4006. Such settings could include the activation of the modular energy system 4000, the volume of alerts, the footswitch settings, the settings icons, the appearance or configuration of the user interface, the surgeon profile logged into the modular energy system 4000, and/or the type of surgical procedure being performed. The header module 4002 can also be configured to provide communications, processing, and/or power for the modules 4001 that are connected to the header module 4002. The energy module 4004, which can also be referred to as a generator module 3140, 3900 (FIGS. 47-48), can be configured to generate one or multiple energy modalities for driving electrosurgical and/or ultrasonic surgical instruments connected thereto, such as is described above in connection with the generator 3900 illustrated in FIG. 48. The technology module 4040 can be configured to provide additional or expanded control algorithms (e.g., electrosurgical or ultrasonic control algorithms for controlling the energy output of the energy module 4004). The visualization module 4042 can be configured to interface with visualization devices (i.e., scopes) and accordingly provide increased visualization capabilities.


The modular energy system 4000 can further include a variety of accessories 4029 that are connectable to the modules 4001 for controlling the functions thereof or that are otherwise configured to work on conjunction with the modular energy system 4000. The accessories 4029 can include, for example, a single-pedal footswitch 4032, a dual-pedal footswitch 4034, and a cart 4030 for supporting the modular energy system 4000 thereon. The footswitches 4032, 4034 can be configured to control the activation or function of particular energy modalities output by the energy module 4004, for example.


By utilizing modular components, the depicted modular energy system 4000 provides a surgical platform that grows with the availability of technology and is customizable to the needs of the facility and/or surgeons. Further, the modular energy system 4000 supports combo devices (e.g., dual electrosurgical and ultrasonic energy generators) and supports software-driven algorithms for customized tissue effects. Still further, the surgical system architecture reduces the capital footprint by combining multiple technologies critical for surgery into a single system.


The various modular components utilizable in connection with the modular energy system 4000 can include monopolar energy generators, bipolar energy generators, dual electrosurgical/ultrasonic energy generators, display screens, and various other modules and/or other components, some of which are also described above in connection with FIGS. 1-46.


Referring now to FIG. 50A, the header module 4002 can, in some aspects, include a display screen 4006 that renders a GUI 4008 for relaying information regarding the modules 4001 connected to the header module 4002. In some aspects, the GUI 4008 of the display screen 4006 can provide a consolidated point of control of all of the modules 4001 making up the particular configuration of the modular energy system 4000. In alternative aspects, the header module 4002 can lack the display screen 4006 or the display screen 4006 can be detachably connected to the housing 4010 of the header module 4002. In such aspects, the header module 4002 can be communicably couplable to an external system that is configured to display the information generated by the modules 4001 of the modular energy system 4000. For example, in robotic surgical applications, the modular energy system 4000 can be communicably couplable to a robotic cart or robotic control console, which is configured to display the information generated by the modular energy system 4000 to the operator of the robotic surgical system. As another example, the modular energy system 4000 can be communicably couplable to a mobile display that can be carried or secured to a surgical staff member for viewing thereby. In yet another example, the modular energy system 4000 can be communicably couplable to a surgical hub 4100 or another computer system that can include a display 4104. In aspects utilizing a user interface that is separate from or otherwise distinct from the modular energy system 4000, the user interface can be wirelessly connectable with the modular energy system 4000 as a whole or one or more modules 4001 thereof such that the user interface can display information from the connected modules 4001 thereon.


Referring still to FIG. 50A, the energy module 4004 can include a port assembly 4012 including a number of different ports configured to deliver different energy modalities to corresponding surgical instruments that are connectable thereto. In the particular aspect illustrated in FIGS. 49-50B, the port assembly 4012 includes a bipolar port 4014, a first monopolar port 4016a, a second monopolar port 4018b, a neutral electrode port 4018 (to which a monopolar return pad is connectable), and a combination energy port 4020. However, this particular combination of ports is simply provided for illustrative purposes and alternative combinations of ports and/or energy modalities may be possible for the port assembly 4012.


As noted above, the modular energy system 4000 can be assembled into different configurations. Further, the different configurations of the modular energy system 4000 can also be utilizable for different surgical procedure types and/or different tasks. For example, FIGS. 50A-50B illustrate a first illustrative configuration of the modular energy system 4000 including a header module 4002 (including a display screen 4006) and an energy module 4004 connected together. Such a configuration can be suitable for laparoscopic and open surgical procedures, for example.



FIGS. 51-55 illustrate an example surgical system 10 with ultrasonic and electrosurgical features including any one of the end-effectors, surgical instruments, and generators described herein. FIG. 51 depicts a surgical system 10 including a generator 12 and a surgical instrument 14. The surgical instrument 14 is operatively coupled with the generator 12 via a power cable 16. The generator 12 is operable to power the surgical instrument 14 to deliver ultrasonic energy for cutting tissue, and electrosurgical bipolar RF energy (i.e., therapeutic levels of RF energy) for sealing tissue. In one aspect, the generator 12 is configured to power the surgical instrument 14 to deliver ultrasonic energy and electrosurgical bipolar RF energy simultaneously or independently.


The surgical instrument 14 of the present example comprises a handle assembly 18, a shaft assembly 20 extending distally from the handle assembly 18, and an end effector 22 arranged at a distal end of the shaft assembly 20. The handle assembly 18 comprises a body 24 including a pistol grip 26 and energy control buttons 28, 30 configured to be manipulated by a surgeon. A trigger 32 is coupled to a lower portion of the body 24 and is pivotable toward and away from the pistol grip 26 to selectively actuate the end effector 22, as described in greater detail below. In other suitable variations of the surgical instrument 14, the handle assembly 18 may comprise a scissor grip configuration, for example. An ultrasonic transducer 34 is housed internally within and supported by the body 24. In other configurations, the ultrasonic transducer 34 may be provided externally of the body 24.


As shown in FIGS. 52 and 53, the end effector 22 includes an ultrasonic blade 36 and a clamp arm 38 configured to selectively pivot toward and away from the ultrasonic blade 36, for clamping tissue therebetween. The ultrasonic blade 36 is acoustically coupled with the ultrasonic transducer 34, which is configured to drive (i.e., vibrate) the ultrasonic blade 36 at ultrasonic frequencies for cutting and/or sealing tissue positioned in contact with the ultrasonic blade 36. The clamp arm 38 is operatively coupled with the trigger 32 such that the clamp arm 38 is configured to pivot toward the ultrasonic blade 36, to a closed position, in response to pivoting of the trigger 32 toward the pistol grip 26. Further, the clamp arm 38 is configured to pivot away from the ultrasonic blade 36, to an open position (see e.g., FIGS. 51-53), in response to pivoting of the trigger 32 away from the pistol grip 26. Various suitable ways in which the clamp arm 38 may be coupled with the trigger 32 will be apparent to those of ordinary skill in the art in view of the teachings provided herein. In some versions, one or more resilient members may be incorporated to bias the clamp arm 38 and/or the trigger 32 toward the open position.


A clamp pad 40 is secured to and extends distally along a clamping side of the clamp arm 38, facing the ultrasonic blade 36. The clamp pad 40 is configured to engage and clamp tissue against a corresponding tissue treatment portion of the ultrasonic blade 36 when the clamp arm 38 is actuated to its closed position. At least a clamping-side of the clamp arm 38 provides a first electrode 42, referred to herein as clamp arm electrode 42. Additionally, at least a clamping-side of the ultrasonic blade 36 provides a second electrode 44, referred to herein as a blade electrode 44. The electrodes 42, 44 are configured to apply electrosurgical bipolar RF energy, provided by the generator 12, to tissue electrically coupled with the electrodes 42, 44. The clamp arm electrode 42 may serve as an active electrode while the blade electrode 44 serves as a return electrode, or vice-versa. The surgical instrument 14 may be configured to apply the electrosurgical bipolar RF energy through the electrodes 42, 44 while vibrating the ultrasonic blade 36 at an ultrasonic frequency, before vibrating the ultrasonic blade 36 at an ultrasonic frequency, and/or after vibrating the ultrasonic blade 36 at an ultrasonic frequency.


As shown in FIGS. 51-55, the shaft assembly 20 extends along a longitudinal axis and includes an outer tube 46, an inner tube 48 received within the outer tube 46, and an ultrasonic waveguide 50 supported within the inner tube 48. As seen best in FIGS. 52-55, the clamp arm 38 is coupled to distal ends of the inner and outer tubes 46, 48. In particular, the clamp arm 38 includes a pair of proximally extending clevis arms 52 that receive therebetween and pivotably couple to a distal end 54 of the inner tube 48 with a pivot pin 56 received through bores formed in the clevis arms 52 and the distal end 54 of the inner tube 48. The first and second clevis fingers 58 depend downwardly from the clevis arms 52 and pivotably couple to a distal end 60 of the outer tube 46. Specifically, each clevis finger 58 includes a protrusion 62 that is rotatably received within a corresponding opening 64 formed in a sidewall of the distal end 60 of the outer tube 46.


In the present example, the inner tube 48 is longitudinally fixed relative to the handle assembly 18, and the outer tube 46 is configured to translate relative to the inner tube 48 and the handle assembly 18, along the longitudinal axis of the shaft assembly 20. As the outer tube 46 translates distally, the clamp arm 38 pivots about the pivot pin 56 toward its open position. As the outer tube 46 translates proximally, the clamp arm 38 pivots in an opposite direction toward its closed position. A proximal end of the outer tube 46 is operatively coupled with the trigger 32, for example via a linkage assembly, such that actuation of the trigger 32 causes translation of the outer tube 46 relative to the inner tube 48, thereby opening or closing the clamp arm 38. In other suitable configurations not shown herein, the outer tube 46 may be longitudinally fixed and the inner tube 48 may be configured to translate for moving the clamp arm 38 between its open and closed positions.


The shaft assembly 20 and the end effector 22 are configured to rotate together about the longitudinal axis, relative to the handle assembly 18. A retaining pin 66, shown in FIG. 54, extends transversely through the proximal portions of the outer tube 46, the inner tube 48, and the waveguide 50 to thereby couple these components rotationally relative to one another. In the present example, a rotation knob 68 is provided at a proximal end portion of the shaft assembly 20 to facilitate rotation of the shaft assembly 20, and the end effector 22, relative to the handle assembly 18. The rotation knob 68 is secured rotationally to the shaft assembly 20 with the retaining pin 66, which extends through a proximal collar of the rotation knob 68. It will be appreciated that in other suitable configurations, the rotation knob 68 may be omitted or substituted with alternative rotational actuation structures.


The ultrasonic waveguide 50 is acoustically coupled at its proximal end with the ultrasonic transducer 34, for example by a threaded connection, and at its distal end with the ultrasonic blade 36, as shown in FIG. 55. The ultrasonic blade 36 is shown formed integrally with the waveguide 50 such that the blade 36 extends distally, directly from the distal end of the waveguide 50. In this manner, the waveguide 50 acoustically couples the ultrasonic transducer 34 with the ultrasonic blade 36, and functions to communicate ultrasonic mechanical vibrations from the transducer 34 to the blade 36. Accordingly, the ultrasonic transducer 34, the waveguide 50, and the ultrasonic blade 36 together define an acoustic assembly. During use, the ultrasonic blade 36 may be positioned in direct contact with tissue, with or without assistive clamping force provided by the clamp arm 38, to impart ultrasonic vibrational energy to the tissue and thereby cut and/or seal the tissue. For example, the blade 36 may cut through tissue clamped between the clamp arm 38 and a first treatment side of the blade 36, or the blade 36 may cut through tissue positioned in contact with an oppositely disposed second treatment side of the blade 36, for example during a “back-cutting” movement. In some variations, the waveguide 50 may amplify the ultrasonic vibrations delivered to the blade 36. Further, the waveguide 50 may include various features operable to control the gain of the vibrations, and/or features suitable to tune the waveguide 50 to a selected resonant frequency. Additional features of the ultrasonic blade 36 and the waveguide 50 are described in greater detail below.


The waveguide 50 is supported within the inner tube 48 by a plurality of nodal support elements 70 positioned along a length of the waveguide 50, as shown in FIGS. 54-55. Specifically, the nodal support elements 70 are positioned longitudinally along the waveguide 50 at locations corresponding to acoustic nodes defined by the resonant ultrasonic vibrations communicated through the waveguide 50. The nodal support elements 70 may provide structural support to the waveguide 50, and acoustic isolation between the waveguide 50 and the inner and outer tubes 46, 48 of the shaft assembly 20. In variations, the nodal support elements 70 may comprise o-rings. The waveguide 50 is supported at its distal-most acoustic node by a nodal support element in the form of an overmold member 72, shown in FIG. 55. The waveguide 50 is secured longitudinally and rotationally within the shaft assembly 20 by the retaining pin 66, which passes through a transverse through-bore 74 formed at a proximally arranged acoustic node of the waveguide 50, such as the proximal-most acoustic node, for example.


In the present example, a distal tip 76 of the ultrasonic blade 36 is located at a position corresponding to an anti-node associated with the resonant ultrasonic vibrations communicated through the waveguide 50. Such a configuration enables the acoustic assembly of the instrument 14 to be tuned to a preferred resonant frequency f0 when the ultrasonic blade 36 is not loaded by tissue. When the ultrasonic transducer 34 is energized by the generator 12 to transmit mechanical vibrations through the waveguide 50 to the blade 36, the distal tip 76 of the blade 36 is caused to oscillate longitudinally in the range of approximately 20 to 120 microns peak-to-peak, for example, and in some instances in the range of approximately 20 to 50 microns, at a predetermined vibratory frequency f0 of approximately 50 kHz, for example. When the ultrasonic blade 36 is positioned in contact with tissue, the ultrasonic oscillation of the blade 36 may simultaneously sever the tissue and denature the proteins in adjacent tissue cells, thereby providing a coagulative effect with minimal thermal spread.


EXAMPLES

Examples of various aspects of end-effectors and surgical instruments of the present disclosure are provided below. An aspect of the end-effector or surgical instrument may include any one or more than one, and any combination of, the examples described below:


Example 1. An end-effector, comprising: a clamp arm; and an ultrasonic blade configured to acoustically couple to an ultrasonic transducer and to electrically couple to a pole of an electrical generator; wherein the clamp arm comprises: a clamp jaw; and a segmented electrode configured to electrically couple to an opposite pole of the electrical generator.


Example 2. The end-effector of Example 1, further comprising spring elements to bias the segmented electrode.


Example 3. The end-effector of any one of Examples 1-2, wherein the segmented electrode comprises three segments linked by pins.


Example 4. The end-effector of Example 3, further comprising three springs positioned between each of the electrode segments and the clamp jaw to apply distal, medial, and proximal bias to the electrode segments, respectively.


Example 5. The end-effector of any one of Examples 3-4, wherein a distal segment comprises: a rounded distal end; an opening to receive a pin; and a grooved surface at a proximal end.


Example 6. The end-effector of Example 5, wherein the medial segment comprises a cylindrical insert that is received in the proximal grooved surface of the distal segment and the pin rotatably fixes the distal and medial segments.


Example 7. The end-effector of Example 6, wherein the medial segment is placed into the grooved surface of the distal segment and the pin is placed through the medial segment and the grooved segment to hold the medial segment and the grooved segment together and the grooved surface and the cylindrical insert allows the medial segment and the grooved segment to pivot against each other.


Example 8. An end-effector, comprising: a clamp arm; and an ultrasonic blade configured to acoustically couple to an ultrasonic transducer and to electrically couple to a pole of an electrical generator; wherein the clamp arm comprises: a clamp jaw; and an electrode configured to electrically couple to an opposite pole of the electrical generator, wherein the electrode is fixed to the clamp jaw at a proximal end and free to deflect at a distal end; wherein the ultrasonic blade comprises electrically insulative material deposited on selected areas of the ultrasonic blade to prevent electrical shorting in the event of the ultrasonic blade contacts the upper jaw electrode.


Example 9. The end-effector of Example 8, wherein the electrically insulative material is deposited by masking the ultrasonic blade.


Example 10. The end-effector of any one of Examples 8-9, wherein the electrically insulative material is machined off areas of the ultrasonic blade that needs to be electrically conductive.


Example 11. The end-effector of any one of Examples 8-10, wherein the electrically insulative material is any one of a fluoropolymer coating, a nanocomposite coating, or a ceramic coating, or combinations thereof.


Example 12. An end-effector, comprising: a clamp arm; and an ultrasonic blade configured to acoustically couple to an ultrasonic transducer and electrically couple to a pole of an electrical generator; wherein the clamp arm comprises: a clamp jaw; and a cantilever electrode configured to electrically couple to an opposite pole of the electrical generator, wherein the cantilever electrode is fixed to the clamp jaw at a proximal end and free to deflect at a distal end; wherein the clamp arm, the ultrasonic blade, or both comprise selectively coated components.


Example 13. The end-effector of Example 12, wherein the clamp jaw and the ultrasonic blade comprise selectively coated portions, and wherein the clamp arm pad and the cantilever electrode are uncoated.


Example 14. The end-effector of any one of Examples 12-13, wherein the clamp jaw comprises selectively coated portions, and wherein the ultrasonic blade, clamp arm pad, and the cantilever electrode are uncoated.


Example 15. The end-effector of any one of Examples 12-14, wherein the ultrasonic blade comprises selectively coated portions, and wherein the clamp jaw, clamp arm pad, and the cantilever electrode are uncoated.


Examples 16. The end-effector of any one of Examples 12-15, wherein the clamp jaw comprises selectively coated portions, and wherein the ultrasonic blade, the clamp arm pad, and the cantilever electrode are uncoated, and wherein the clamp jaw comprises a bare electrode portion at a tip of the clamp jaw.


Examples 17. The end-effector of any one of Examples 12-16, wherein the ultrasonic blade comprises selectively coated portions, and wherein the clamp jaw, the clamp arm pad, and the cantilever electrode are uncoated, and wherein the ultrasonic blade comprises a bare electrode portion at a tip of the ultrasonic blade.


Example 18. The end-effector of any one of Examples 12-17, wherein the clamp jaw and the ultrasonic blade comprise selectively coated portions, and wherein the clamp arm pad and the cantilever electrode are uncoated, and wherein the clamp jaw comprises a bare electrode portion at a tip of the clamp jaw, and wherein the ultrasonic blade comprises a bare electrode portion at a tip of the ultrasonic blade.


Example 19. The end-effector of any one of Examples 12-18, wherein the cantilever electrode is an offset cantilever electrode.


Example 20. A surgical instrument, comprising: a housing; an ultrasonic transducer; and the end-effector of any one of Examples 1-7; wherein the ultrasonic blade is acoustically coupled to the ultrasonic blade and electrically coupled to a pole of the electrical generator and the electrode is electrically coupled to an opposite pole of the electrical generator.


Example 21. A surgical instrument, comprising: a housing; an ultrasonic transducer; and the end-effector of any one of Examples 8-11; wherein the ultrasonic blade is acoustically coupled to the ultrasonic blade and electrically coupled to a pole of the electrical generator and the electrode is electrically coupled to an opposite pole of the electrical generator.


Example 22. A surgical instrument, comprising: a housing; an ultrasonic transducer; and the end-effector of any one of Examples 12-19; wherein the ultrasonic blade is acoustically coupled to the ultrasonic blade and electrically coupled to a pole of the electrical generator and the electrode is electrically coupled to an opposite pole of the electrical generator.


While several forms have been illustrated and described, it is not the intention of Applicant to restrict or limit the scope of the appended claims to such detail. Numerous modifications, variations, changes, substitutions, combinations, and equivalents to those forms may be implemented and will occur to those skilled in the art without departing from the scope of the present disclosure. Moreover, the structure of each element associated with the described forms can be alternatively described as a means for providing the function performed by the element. Also, where materials are disclosed for certain components, other materials may be used. It is therefore to be understood that the foregoing description and the appended claims are intended to cover all such modifications, combinations, and variations as falling within the scope of the disclosed forms. The appended claims are intended to cover all such modifications, variations, changes, substitutions, modifications, and equivalents.


The foregoing detailed description has set forth various forms of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, and/or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. Those skilled in the art will recognize that some aspects of the forms disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as one or more program products in a variety of forms, and that an illustrative form of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution.


Instructions used to program logic to perform various disclosed aspects can be stored within a memory in the system, such as dynamic random access memory (DRAM), cache, flash memory, or other storage. Furthermore, the instructions can be distributed via a network or by way of other computer readable media. Thus a machine-readable medium may include any mechanism for storing or transmitting information in a form readable by a machine (e.g., a computer), but is not limited to, floppy diskettes, optical disks, compact disc, read-only memory (CD-ROMs), and magneto-optical disks, read-only memory (ROMs), random access memory (RAM), erasable programmable read-only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), magnetic or optical cards, flash memory, or a tangible, machine-readable storage used in the transmission of information over the Internet via electrical, optical, acoustical or other forms of propagated signals (e.g., carrier waves, infrared signals, digital signals, etc.). Accordingly, the non-transitory computer-readable medium includes any type of tangible machine-readable medium suitable for storing or transmitting electronic instructions or information in a form readable by a machine (e.g., a computer).


As used in any aspect herein, the term “control circuit” may refer to, for example, hardwired circuitry, programmable circuitry (e.g., a computer processor including one or more individual instruction processing cores, processing unit, processor, microcontroller, microcontroller unit, controller, digital signal processor (DSP), programmable logic device (PLD), programmable logic array (PLA), or field programmable gate array (FPGA)), state machine circuitry, firmware that stores instructions executed by programmable circuitry, and any combination thereof. The control circuit may, collectively or individually, be embodied as circuitry that forms part of a larger system, for example, an integrated circuit (IC), an application-specific integrated circuit (ASIC), a system on-chip (SoC), desktop computers, laptop computers, tablet computers, servers, smart phones, etc. Accordingly, as used herein “control circuit” includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of random access memory), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, or optical-electrical equipment). Those having skill in the art will recognize that the subject matter described herein may be implemented in an analog or digital fashion or some combination thereof.


As used in any aspect herein, the term “logic” may refer to an app, software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices.


As used in any aspect herein, the terms “component,” “system,” “module” and the like can refer to a computer-related entity, either hardware, a combination of hardware and software, software, or software in execution.


As used in any aspect herein, an “algorithm” refers to a self-consistent sequence of steps leading to a desired result, where a “step” refers to a manipulation of physical quantities and/or logic states which may, though need not necessarily, take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated. It is common usage to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like. These and similar terms may be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities and/or states.


A network may include a packet switched network. The communication devices may be capable of communicating with each other using a selected packet switched network communications protocol. One example communications protocol may include an Ethernet communications protocol which may be capable permitting communication using a Transmission Control Protocol/Internet Protocol (TCP/IP). The Ethernet protocol may comply or be compatible with the Ethernet standard published by the Institute of Electrical and Electronics Engineers (IEEE) titled “IEEE 802.3 Standard”, published in December, 2008 and/or later versions of this standard. Alternatively or additionally, the communication devices may be capable of communicating with each other using an X.25 communications protocol. The X.25 communications protocol may comply or be compatible with a standard promulgated by the International Telecommunication Union-Telecommunication Standardization Sector (ITU-T). Alternatively or additionally, the communication devices may be capable of communicating with each other using a frame relay communications protocol. The frame relay communications protocol may comply or be compatible with a standard promulgated by Consultative Committee for International Telegraph and Telephone (CCITT) and/or the American National Standards Institute (ANSI). Alternatively or additionally, the transceivers may be capable of communicating with each other using an Asynchronous Transfer Mode (ATM) communications protocol. The ATM communications protocol may comply or be compatible with an ATM standard published by the ATM Forum titled “ATM-MPLS Network Interworking 2.0” published August 2001, and/or later versions of this standard. Of course, different and/or after-developed connection-oriented network communication protocols are equally contemplated herein.


Unless specifically stated otherwise as apparent from the foregoing disclosure, it is appreciated that, throughout the foregoing disclosure, discussions using terms such as “processing,” “computing,” “calculating,” “determining,” “displaying,” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission or display devices.


One or more components may be referred to herein as “configured to,” “configurable to,” “operable/operative to,” “adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Those skilled in the art will recognize that “configured to” can generally encompass active-state components and/or inactive-state components and/or standby-state components, unless context requires otherwise.


The terms “proximal” and “distal” are used herein with reference to a clinician manipulating the handle portion of the surgical instrument. The term “proximal” refers to the portion closest to the clinician and the term “distal” refers to the portion located away from the clinician. It will be further appreciated that, for convenience and clarity, spatial terms such as “vertical”, “horizontal”, “up”, and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and/or absolute.


Those skilled in the art will recognize that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to claims containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations.


In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that typically a disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms unless context dictates otherwise. For example, the phrase “A or B” will be typically understood to include the possibilities of “A” or “B” or “A and B.”


With respect to the appended claims, those skilled in the art will appreciate that recited operations therein may generally be performed in any order. Also, although various operational flow diagrams are presented in a sequence(s), it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently. Examples of such alternate orderings may include overlapping, interleaved, interrupted, reordered, incremental, preparatory, supplemental, simultaneous, reverse, or other variant orderings, unless context dictates otherwise. Furthermore, terms like “responsive to,” “related to,” or other past-tense adjectives are generally not intended to exclude such variants, unless context dictates otherwise.


It is worthy to note that any reference to “one aspect,” “an aspect,” “an exemplification,” “one exemplification,” and the like means that a particular feature, structure, or characteristic described in connection with the aspect is included in at least one aspect. Thus, appearances of the phrases “in one aspect,” “in an aspect,” “in an exemplification,” and “in one exemplification” in various places throughout the specification are not necessarily all referring to the same aspect. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner in one or more aspects.


Any patent application, patent, non-patent publication, or other disclosure material referred to in this specification and/or listed in any Application Data Sheet is incorporated by reference herein, to the extent that the incorporated materials is not inconsistent herewith. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.


In summary, numerous benefits have been described which result from employing the concepts described herein. The foregoing description of the one or more forms has been presented for purposes of illustration and description. It is not intended to be exhaustive or limiting to the precise form disclosed. Modifications or variations are possible in light of the above teachings. The one or more forms were chosen and described in order to illustrate principles and practical application to thereby enable one of ordinary skill in the art to utilize the various forms and with various modifications as are suited to the particular use contemplated. It is intended that the claims submitted herewith define the overall scope.

Claims
  • 1. An end-effector, comprising: a clamp arm; andan ultrasonic blade configured to acoustically couple to an ultrasonic transducer and to electrically couple to a pole of an electrical generator;wherein the clamp arm comprises: a clamp jaw; anda segmented electrode configured to electrically couple to an opposite pole of the electrical generator, wherein segments of the segmented electrode are configured to pivot relative to each other, wherein each segment of the segmented electrode comprises a spring element between the clamp arm and a portion of the segmented electrode, wherein a distal segment of the segments comprises a grooved surface, and wherein a medial segment of the segments comprises a cylindrical insert receivable in the grooved surface of the distal segment.
  • 2. The end-effector of claim 1, wherein the distal segment further comprises: a rounded distal end; andan opening to receive a pin that rotatably fixes the distal segment to the medial segment.
  • 3. The end-effector of claim 2, wherein the cylindrical insert is positionable into the grooved surface of the distal segment and the pin is positionable through the opening to hold the medial segment and the distal segment together, and wherein the grooved surface and the cylindrical insert allow the medial segment and the distal segment to pivot relative to each other.
  • 4. A medical instrument, comprising: a clamp arm; andan ultrasonic blade configured to acoustically couple to an ultrasonic transducer and to electrically couple to a pole of an electrical generator;wherein the clamp arm comprises: a clamp jaw; anda segmented electrode configured to electrically couple to an opposite pole of the electrical generator, wherein segments of the segmented electrode are configured to pivot relative each other, wherein each segment of the segmented electrode comprises a spring element between the clamp arm and a portion of the segmented electrode, wherein the segments comprise a first segment and a second segment linked by a pin, and wherein the first segment comprises a cylindrical insert that is receivable in a grooved surface of the second segment.
  • 5. The medical instrument of claim 4, wherein the second segment comprises: a rounded distal end; andan opening to receive the pin to rotatably fix the first segment to the second segment.
  • 6. The medical instrument of claim 5, wherein the cylindrical insert is positionable into the the second segment and the pin is positionable through the opening of the second segment to hold the first segment and the second segment together, and wherein the grooved surface and the cylindrical insert allow the first segment and the second segment to pivot relative to each other.
  • 7. An end-effector, comprising: an ultrasonic blade configured to acoustically couple to an ultrasonic transducer and to electrically couple to a pole of an electrical generator; anda clamp arm, comprising: a clamp jaw; anda segmented electrode configured to electrically couple to an opposite pole of the electrical generator, wherein the segmented electrode comprises three segments linked by pins, wherein a distal segment of the three segments of the segmented electrode comprises: a rounded distal end;an opening to receive one of the pins; anda grooved surface at a proximal end thereof.
  • 8. The end-effector of claim 7, wherein a medial segment of the three segments of the segmented electrode comprises a cylindrical insert that is receivable in the grooved surface of the distal segment and wherein the one of the pins rotatably fixes the distal segment and the medial segment.
  • 9. The end-effector of claim 8, wherein the cylindrical insert is positionable into the grooved surface of the distal segment and the one of the pins is positionable through the opening to hold the medial segment and the distal segment together, and wherein the grooved surface and the cylindrical insert allow the medial segment and the distal segment to pivot relative to each other.
  • 10. A medical apparatus, comprising: a clamp arm; andan ultrasonic blade configured to acoustically couple to an ultrasonic transducer and to electrically couple to a pole of an electrical generator;wherein the clamp arm comprises: a clamp jaw; anda segmented electrode configured to electrically couple to an opposite pole of the electrical generator, wherein the segmented electrode comprises three segments linked by pins, wherein a medial segment of the three segments comprises a cylindrical insert that is receivable in a proximal grooved surface of a distal segment of the three segments, and one of the pins rotatably fixes the distal segment and the medial segment.
  • 11. A medical apparatus, comprising: a clamp arm; andan ultrasonic blade configured to acoustically couple to an ultrasonic transducer and to electrically couple to a pole of an electrical generator;wherein the clamp arm comprises: a clamp jaw; anda segmented electrode configured to electrically couple to an opposite pole of the electrical generator, wherein the segmented electrode comprises three segments linked by pins, wherein a medial segment of the three segments is placed into a grooved surface of a distal segment of the three segments and at least one of the pins is placed through the medial segment and the grooved surface to hold the medial segment and the grooved surface together, wherein the grooved surface and a cylindrical insert of the medial segment allows the medial segment and the grooved surface to pivot against each other.
  • 12. An end effector, comprising: an ultrasonic blade;a clamp arm; anda segmented electrode, comprising: a first spring coupled to the clamp arm;a second spring coupled to the clamp arm;a first electrode coupled to the first spring, wherein the first electrode defines an opening;a second electrode coupled to the second spring, wherein the second electrode comprises an insert positionable in the first electrode; anda pin positionable through the opening to rotatably couple the first electrode to the second electrode.
  • 13. The end effector of claim 12, wherein the segmented electrode further comprises: a third spring coupled to the clamp arm;a third electrode coupled to the third spring; anda pin second to rotatably couple the third electrode to the second electrode.
  • 14. The end effector of claim 12, wherein the insert comprises a cylindrical insert.
  • 15. The end effector of claim 12, wherein the first electrode comprises a curved distal end.
  • 16. The end effector of claim 12, wherein the first electrode defines a grooved surface to receive the insert.
  • 17. The end effector of claim 12, wherein the first spring has a first spring constant, and wherein the second spring has a second spring constant different than the first spring constant.
  • 18. The end effector of claim 12, wherein the first spring comprises a first coil spring, and wherein the second spring comprises a second coil spring.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 62/955,292, titled COMBINATION ENERGY MODALITY END-EFFECTOR, filed Dec. 30, 2019, the disclosure of which is herein incorporated by reference in its entirety.

US Referenced Citations (3317)
Number Name Date Kind
969528 Disbrow Sep 1910 A
1570025 Young Jan 1926 A
1813902 Bovie Jul 1931 A
2188497 Calva Jan 1940 A
2366274 Luth et al. Jan 1945 A
2425245 Johnson Aug 1947 A
2442966 Wallace Jun 1948 A
2458152 Eakins Jan 1949 A
2510693 Green Jun 1950 A
2597564 Bugg May 1952 A
2704333 Calosi et al. Mar 1955 A
2736960 Armstrong Mar 1956 A
2748967 Roach Jun 1956 A
2845072 Shafer Jul 1958 A
2849788 Creek Sep 1958 A
2867039 Zach Jan 1959 A
2874470 Richards Feb 1959 A
2990616 Balamuth et al. Jul 1961 A
RE25033 Balamuth et al. Aug 1961 E
3015961 Roney Jan 1962 A
3033407 Alfons May 1962 A
3053124 Balamuth et al. Sep 1962 A
3082805 Royce Mar 1963 A
3166971 Stoecker Jan 1965 A
3322403 Murphy May 1967 A
3432691 Shoh Mar 1969 A
3433226 Boyd Mar 1969 A
3489930 Shoh Jan 1970 A
3513848 Winston et al. May 1970 A
3514856 Camp et al. Jun 1970 A
3525912 Wallin Aug 1970 A
3526219 Balamuth Sep 1970 A
3554198 Tatoian et al. Jan 1971 A
3580841 Cadotte et al. May 1971 A
3606682 Camp et al. Sep 1971 A
3614484 Shoh Oct 1971 A
3616375 Inoue Oct 1971 A
3629726 Popescu Dec 1971 A
3636943 Balamuth Jan 1972 A
3668486 Silver Jun 1972 A
3702948 Balamuth Nov 1972 A
3703651 Blowers Nov 1972 A
3776238 Peyman et al. Dec 1973 A
3777760 Essner Dec 1973 A
3805787 Banko Apr 1974 A
3809977 Balamuth et al. May 1974 A
3830098 Antonevich Aug 1974 A
3854737 Gilliam, Sr. Dec 1974 A
3862630 Balamuth Jan 1975 A
3875945 Friedman Apr 1975 A
3885438 Harris, Sr. et al. May 1975 A
3900823 Sokal et al. Aug 1975 A
3918442 Nikolaev et al. Nov 1975 A
3924335 Balamuth et al. Dec 1975 A
3946738 Newton et al. Mar 1976 A
3955859 Stella et al. May 1976 A
3956826 Perdreaux, Jr. May 1976 A
3989952 Hohmann Nov 1976 A
4005714 Hiltebrandt Feb 1977 A
4012647 Balamuth et al. Mar 1977 A
4034762 Cosens et al. Jul 1977 A
4058126 Leveen Nov 1977 A
4074719 Semm Feb 1978 A
4156187 Murry et al. May 1979 A
4167944 Banko Sep 1979 A
4188927 Harris Feb 1980 A
4200106 Douvas et al. Apr 1980 A
4203430 Takahashi May 1980 A
4203444 Bonnell et al. May 1980 A
4220154 Semm Sep 1980 A
4237441 van Konynenburg et al. Dec 1980 A
4244371 Farin Jan 1981 A
4281785 Brooks Aug 1981 A
4300083 Heiges Nov 1981 A
4302728 Nakamura Nov 1981 A
4304987 van Konynenburg Dec 1981 A
4306570 Matthews Dec 1981 A
4314559 Allen Feb 1982 A
4353371 Cosman Oct 1982 A
4409981 Lundberg Oct 1983 A
4445063 Smith Apr 1984 A
4461304 Kuperstein Jul 1984 A
4463759 Garito et al. Aug 1984 A
4491132 Aikins Jan 1985 A
4492231 Auth Jan 1985 A
4494759 Kieffer Jan 1985 A
4504264 Kelman Mar 1985 A
4512344 Barber Apr 1985 A
4526571 Wuchinich Jul 1985 A
4535773 Yoon Aug 1985 A
4541638 Ogawa et al. Sep 1985 A
4545374 Jacobson Oct 1985 A
4545926 Fouts, Jr. et al. Oct 1985 A
4549147 Kondo Oct 1985 A
4550870 Krumme et al. Nov 1985 A
4553544 Nomoto et al. Nov 1985 A
4562838 Walker Jan 1986 A
4574615 Bower et al. Mar 1986 A
4582236 Hirose Apr 1986 A
4593691 Lindstrom et al. Jun 1986 A
4608981 Rothfuss et al. Sep 1986 A
4617927 Manes Oct 1986 A
4633119 Thompson Dec 1986 A
4633874 Chow et al. Jan 1987 A
4634420 Spinosa et al. Jan 1987 A
4640279 Beard Feb 1987 A
4641053 Takeda Feb 1987 A
4646738 Trott Mar 1987 A
4646756 Watmough et al. Mar 1987 A
4649919 Thimsen et al. Mar 1987 A
4662068 Polonsky May 1987 A
4674502 Imonti Jun 1987 A
4694835 Strand Sep 1987 A
4708127 Abdelghani Nov 1987 A
4712722 Hood et al. Dec 1987 A
4735603 Goodson et al. Apr 1988 A
4739759 Rexroth et al. Apr 1988 A
4761871 O'Connor et al. Aug 1988 A
4808154 Freeman Feb 1989 A
4819635 Shapiro Apr 1989 A
4827911 Broadwin et al. May 1989 A
4830462 Karny et al. May 1989 A
4832683 Idemoto et al. May 1989 A
4836186 Scholz Jun 1989 A
4838853 Parisi Jun 1989 A
4844064 Thimsen et al. Jul 1989 A
4849133 Yoshida et al. Jul 1989 A
4850354 McGurk-Burleson et al. Jul 1989 A
4852578 Companion et al. Aug 1989 A
4860745 Farin et al. Aug 1989 A
4862890 Stasz et al. Sep 1989 A
4865159 Jamison Sep 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4878493 Pasternak et al. Nov 1989 A
4880015 Nierman Nov 1989 A
4881550 Kothe Nov 1989 A
4896009 Pawlowski Jan 1990 A
4903696 Stasz et al. Feb 1990 A
4910389 Sherman et al. Mar 1990 A
4915643 Samejima et al. Apr 1990 A
4920978 Colvin May 1990 A
4922902 Wuchinich et al. May 1990 A
4926860 Stice et al. May 1990 A
4936842 D'Amelio et al. Jun 1990 A
4954960 Lo et al. Sep 1990 A
4965532 Sakurai Oct 1990 A
4979952 Kubota et al. Dec 1990 A
4981756 Rhandhawa Jan 1991 A
5001649 Lo et al. Mar 1991 A
5003693 Atkinson et al. Apr 1991 A
5009661 Michelson Apr 1991 A
5013956 Kurozumi et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5020514 Heckele Jun 1991 A
5026370 Lottick Jun 1991 A
5026387 Thomas Jun 1991 A
5035695 Weber, Jr. et al. Jul 1991 A
5042461 Inoue et al. Aug 1991 A
5042707 Taheri Aug 1991 A
5052145 Wang Oct 1991 A
5061269 Muller Oct 1991 A
5075839 Fisher et al. Dec 1991 A
5084052 Jacobs Jan 1992 A
5099840 Goble et al. Mar 1992 A
5104025 Main et al. Apr 1992 A
5105117 Yamaguchi Apr 1992 A
5106538 Barma et al. Apr 1992 A
5108383 White Apr 1992 A
5109819 Custer et al. May 1992 A
5112300 Ureche May 1992 A
5113139 Furukawa May 1992 A
5123903 Quaid et al. Jun 1992 A
5126618 Takahashi et al. Jun 1992 A
D327872 McMills et al. Jul 1992 S
5152762 McElhenney Oct 1992 A
5156633 Smith Oct 1992 A
5160334 Billings et al. Nov 1992 A
5162044 Gahn et al. Nov 1992 A
5163421 Bernstein et al. Nov 1992 A
5163537 Radev Nov 1992 A
5163945 Ortiz et al. Nov 1992 A
5167619 Wuchinich Dec 1992 A
5167725 Clark et al. Dec 1992 A
5172344 Ehrlich Dec 1992 A
5174276 Crockard Dec 1992 A
D332660 Rawson et al. Jan 1993 S
5176677 Wuchinich Jan 1993 A
5176695 Dulebohn Jan 1993 A
5184605 Grzeszykowski Feb 1993 A
5188102 Idemoto et al. Feb 1993 A
D334173 Liu et al. Mar 1993 S
5190517 Zieve et al. Mar 1993 A
5190518 Takasu Mar 1993 A
5190541 Abele et al. Mar 1993 A
5196007 Ellman et al. Mar 1993 A
5203380 Chikama Apr 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5205817 Idemoto et al. Apr 1993 A
5209719 Baruch et al. May 1993 A
5213569 Davis May 1993 A
5214339 Naito May 1993 A
5217460 Knoepfler Jun 1993 A
5218529 Meyer et al. Jun 1993 A
5221282 Wuchinich Jun 1993 A
5222937 Kagawa Jun 1993 A
5226909 Evans et al. Jul 1993 A
5226910 Kajiyama et al. Jul 1993 A
5231989 Middleman et al. Aug 1993 A
5234428 Kaufman Aug 1993 A
5241236 Sasaki et al. Aug 1993 A
5241968 Slater Sep 1993 A
5242339 Thornton Sep 1993 A
5242460 Klein et al. Sep 1993 A
5246003 DeLonzor Sep 1993 A
5254129 Alexander Oct 1993 A
5257988 L'Esperance, Jr. Nov 1993 A
5258004 Bales et al. Nov 1993 A
5258006 Rydell et al. Nov 1993 A
5261922 Hood Nov 1993 A
5263957 Davison Nov 1993 A
5264925 Shipp et al. Nov 1993 A
5269297 Weng et al. Dec 1993 A
5275166 Vaitekunas et al. Jan 1994 A
5275607 Lo et al. Jan 1994 A
5275609 Pingleton et al. Jan 1994 A
5282800 Foshee et al. Feb 1994 A
5282817 Hoogeboom et al. Feb 1994 A
5285795 Ryan et al. Feb 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5290286 Parins Mar 1994 A
5293863 Zhu et al. Mar 1994 A
5300068 Rosar et al. Apr 1994 A
5304115 Pflueger et al. Apr 1994 A
D347474 Olson May 1994 S
5307976 Olson et al. May 1994 A
5309927 Welch May 1994 A
5312023 Green et al. May 1994 A
5312425 Evans et al. May 1994 A
5318525 West et al. Jun 1994 A
5318563 Malis et al. Jun 1994 A
5318564 Eggers Jun 1994 A
5318570 Hood et al. Jun 1994 A
5318589 Lichtman Jun 1994 A
5322055 Davison et al. Jun 1994 A
5324299 Davison et al. Jun 1994 A
5326013 Green et al. Jul 1994 A
5326342 Pflueger et al. Jul 1994 A
5330471 Eggers Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5334183 Wuchinich Aug 1994 A
5339723 Huitema Aug 1994 A
5342356 Ellman et al. Aug 1994 A
5342359 Rydell Aug 1994 A
5344420 Hilal et al. Sep 1994 A
5345937 Middleman et al. Sep 1994 A
5346502 Estabrook et al. Sep 1994 A
5353474 Good et al. Oct 1994 A
5357164 Imabayashi et al. Oct 1994 A
5357423 Weaver et al. Oct 1994 A
5359994 Krauter et al. Nov 1994 A
5361583 Huitema Nov 1994 A
5366466 Christian et al. Nov 1994 A
5368557 Nita et al. Nov 1994 A
5370645 Klicek et al. Dec 1994 A
5371429 Manna Dec 1994 A
5374813 Shipp Dec 1994 A
D354564 Medema Jan 1995 S
5381067 Greenstein et al. Jan 1995 A
5383874 Jackson et al. Jan 1995 A
5383917 Desai et al. Jan 1995 A
5387207 Dyer et al. Feb 1995 A
5387215 Fisher Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5394187 Shipp Feb 1995 A
5395033 Byrne et al. Mar 1995 A
5395312 Desai Mar 1995 A
5395363 Billings et al. Mar 1995 A
5395364 Anderhub et al. Mar 1995 A
5396266 Brimhall Mar 1995 A
5396900 Slater et al. Mar 1995 A
5400267 Denen et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403334 Evans et al. Apr 1995 A
5406503 Williams, Jr. et al. Apr 1995 A
5408268 Shipp Apr 1995 A
D358887 Feinberg May 1995 S
5411481 Allen et al. May 1995 A
5417709 Slater May 1995 A
5419761 Narayanan et al. May 1995 A
5421829 Olichney et al. Jun 1995 A
5423844 Miller Jun 1995 A
5428504 Bhatla Jun 1995 A
5429131 Scheinman et al. Jul 1995 A
5438997 Sieben et al. Aug 1995 A
5441499 Fritzsch Aug 1995 A
5443463 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5445639 Kuslich et al. Aug 1995 A
5447509 Mills et al. Sep 1995 A
5449370 Vaitekunas Sep 1995 A
5451053 Garrido Sep 1995 A
5451161 Sharp Sep 1995 A
5451220 Ciervo Sep 1995 A
5451227 Michaelson Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5462604 Shibano et al. Oct 1995 A
5465895 Knodel et al. Nov 1995 A
5471988 Fujio et al. Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5478003 Green et al. Dec 1995 A
5480409 Riza Jan 1996 A
5483501 Park et al. Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5486162 Brumbach Jan 1996 A
5486189 Mudry et al. Jan 1996 A
5490860 Middle et al. Feb 1996 A
5496317 Goble et al. Mar 1996 A
5499992 Meade et al. Mar 1996 A
5500216 Julian et al. Mar 1996 A
5501654 Failla et al. Mar 1996 A
5504650 Katsui et al. Apr 1996 A
5505693 Mackool Apr 1996 A
5507297 Slater et al. Apr 1996 A
5507738 Ciervo Apr 1996 A
5509922 Aranyi et al. Apr 1996 A
5511556 DeSantis Apr 1996 A
5520704 Castro et al. May 1996 A
5522832 Kugo et al. Jun 1996 A
5522839 Pilling Jun 1996 A
5527331 Kresch et al. Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5536267 Edwards et al. Jul 1996 A
5540681 Strul et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540693 Fisher Jul 1996 A
5542916 Hirsch et al. Aug 1996 A
5548286 Craven Aug 1996 A
5549637 Crainich Aug 1996 A
5553675 Pitzen et al. Sep 1996 A
5558671 Yates Sep 1996 A
5562609 Brumbach Oct 1996 A
5562610 Brumbach Oct 1996 A
5562659 Morris Oct 1996 A
5562703 Desai Oct 1996 A
5563179 Stone et al. Oct 1996 A
5569164 Lurz Oct 1996 A
5571121 Heifetz Nov 1996 A
5573424 Poppe Nov 1996 A
5573533 Strul Nov 1996 A
5573534 Stone Nov 1996 A
5577654 Bishop Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5591187 Dekel Jan 1997 A
5593414 Shipp et al. Jan 1997 A
5599350 Schulze et al. Feb 1997 A
5600526 Russell et al. Feb 1997 A
5601601 Tal et al. Feb 1997 A
5603773 Campbell Feb 1997 A
5607436 Pratt et al. Mar 1997 A
5607450 Zvenyatsky et al. Mar 1997 A
5609573 Sandock Mar 1997 A
5611813 Lichtman Mar 1997 A
5618304 Hart et al. Apr 1997 A
5618307 Donlon et al. Apr 1997 A
5618492 Auten et al. Apr 1997 A
5620447 Smith et al. Apr 1997 A
5624452 Yates Apr 1997 A
5626587 Bishop et al. May 1997 A
5626595 Sklar et al. May 1997 A
5626608 Cuny et al. May 1997 A
5628760 Knoepfler May 1997 A
5630420 Vaitekunas May 1997 A
5632432 Schulze et al. May 1997 A
5632717 Yoon May 1997 A
5638827 Palmer et al. Jun 1997 A
5640741 Yano Jun 1997 A
D381077 Hunt Jul 1997 S
5647871 Levine et al. Jul 1997 A
5649937 Bito et al. Jul 1997 A
5649955 Hashimoto et al. Jul 1997 A
5651780 Jackson et al. Jul 1997 A
5653713 Michelson Aug 1997 A
5655100 Ebrahim et al. Aug 1997 A
5658281 Heard Aug 1997 A
5662662 Bishop et al. Sep 1997 A
5662667 Knodel Sep 1997 A
5665085 Nardella Sep 1997 A
5665100 Yoon Sep 1997 A
5669922 Hood Sep 1997 A
5674219 Monson et al. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5674235 Parisi Oct 1997 A
5678568 Uchikubo et al. Oct 1997 A
5688270 Yates et al. Nov 1997 A
5690269 Bolanos et al. Nov 1997 A
5693042 Boiarski et al. Dec 1997 A
5693051 Schulze et al. Dec 1997 A
5694936 Fujimoto et al. Dec 1997 A
5695510 Hood Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5704534 Huitema et al. Jan 1998 A
5704791 Gillio Jan 1998 A
5707369 Vaitekunas et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5711472 Bryan Jan 1998 A
5713896 Nardella Feb 1998 A
5715817 Stevens-Wright et al. Feb 1998 A
5716366 Yates Feb 1998 A
5717306 Shipp Feb 1998 A
5720742 Zacharias Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5722980 Schulz et al. Mar 1998 A
5723970 Bell Mar 1998 A
5728130 Ishikawa et al. Mar 1998 A
5730752 Alden et al. Mar 1998 A
5733074 Stock et al. Mar 1998 A
5735848 Yates et al. Apr 1998 A
5741226 Strukel et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5752973 Kieturakis May 1998 A
5755717 Yates et al. May 1998 A
5759183 VanDusseldorp Jun 1998 A
5762255 Chrisman et al. Jun 1998 A
5766164 Mueller et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5776130 Buysse et al. Jul 1998 A
5776155 Beaupre et al. Jul 1998 A
5779130 Alesi et al. Jul 1998 A
5779701 McBrayer et al. Jul 1998 A
5782834 Lucey et al. Jul 1998 A
5792135 Madhani et al. Aug 1998 A
5792138 Shipp Aug 1998 A
5792165 Klieman et al. Aug 1998 A
5796188 Bays Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5797958 Yoon Aug 1998 A
5797959 Castro et al. Aug 1998 A
5800432 Swanson Sep 1998 A
5800448 Banko Sep 1998 A
5800449 Wales Sep 1998 A
5805140 Rosenberg et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5808396 Boukhny Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810828 Lightman et al. Sep 1998 A
5810859 DiMatteo et al. Sep 1998 A
5817033 DeSantis et al. Oct 1998 A
5817084 Jensen Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5823197 Edwards Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827323 Klieman et al. Oct 1998 A
5828160 Sugishita Oct 1998 A
5833696 Whitfield et al. Nov 1998 A
5836897 Sakurai et al. Nov 1998 A
5836909 Cosmescu Nov 1998 A
5836943 Miller, III Nov 1998 A
5836957 Schulz et al. Nov 1998 A
5836990 Li Nov 1998 A
5843109 Mehta et al. Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5853412 Mayenberger Dec 1998 A
5854590 Dalstein Dec 1998 A
5858018 Shipp et al. Jan 1999 A
5865361 Milliman et al. Feb 1999 A
5873873 Smith et al. Feb 1999 A
5873882 Straub et al. Feb 1999 A
5876401 Schulze et al. Mar 1999 A
5878193 Wang et al. Mar 1999 A
5879364 Bromfield et al. Mar 1999 A
5880668 Hall Mar 1999 A
5883615 Fago et al. Mar 1999 A
5891142 Eggers et al. Apr 1999 A
5893835 Witt et al. Apr 1999 A
5897523 Wright et al. Apr 1999 A
5897569 Kellogg et al. Apr 1999 A
5903607 Tailliet May 1999 A
5904681 West, Jr. May 1999 A
5906625 Bito et al. May 1999 A
5906627 Spaulding May 1999 A
5906628 Miyawaki et al. May 1999 A
5910129 Koblish et al. Jun 1999 A
5911699 Anis et al. Jun 1999 A
5913823 Hedberg et al. Jun 1999 A
5916229 Evans Jun 1999 A
5921956 Grinberg et al. Jul 1999 A
5929846 Rosenberg et al. Jul 1999 A
5935143 Hood Aug 1999 A
5935144 Estabrook Aug 1999 A
5938633 Beaupre Aug 1999 A
5944718 Austin et al. Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5947984 Whipple Sep 1999 A
5954717 Behl et al. Sep 1999 A
5954736 Bishop et al. Sep 1999 A
5954746 Holthaus et al. Sep 1999 A
5957882 Nita et al. Sep 1999 A
5957943 Vaitekunas Sep 1999 A
5968007 Simon et al. Oct 1999 A
5968060 Kellogg Oct 1999 A
5974342 Petrofsky Oct 1999 A
D416089 Barton et al. Nov 1999 S
5980510 Tsonton et al. Nov 1999 A
5980546 Hood Nov 1999 A
5984938 Yoon Nov 1999 A
5987344 West Nov 1999 A
5989274 Davison et al. Nov 1999 A
5989275 Estabrook et al. Nov 1999 A
5993465 Shipp et al. Nov 1999 A
5993972 Reich et al. Nov 1999 A
5994855 Lundell et al. Nov 1999 A
6003517 Sheffield et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6013052 Durman et al. Jan 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024744 Kese et al. Feb 2000 A
6024750 Mastri et al. Feb 2000 A
6027515 Cimino Feb 2000 A
6031526 Shipp Feb 2000 A
6033375 Brumbach Mar 2000 A
6033399 Gines Mar 2000 A
6036667 Manna et al. Mar 2000 A
6036707 Spaulding Mar 2000 A
6039734 Goble Mar 2000 A
6048224 Kay Apr 2000 A
6050943 Slayton et al. Apr 2000 A
6050996 Schmaltz et al. Apr 2000 A
6051010 DiMatteo et al. Apr 2000 A
6056735 Okada et al. May 2000 A
6063098 Houser et al. May 2000 A
6066132 Chen et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6068647 Witt et al. May 2000 A
6074389 Levine et al. Jun 2000 A
6077285 Boukhny Jun 2000 A
6080149 Huang et al. Jun 2000 A
6083191 Rose Jul 2000 A
6086584 Miller Jul 2000 A
6090120 Wright et al. Jul 2000 A
6091995 Ingle et al. Jul 2000 A
6096033 Tu et al. Aug 2000 A
6099483 Palmer et al. Aug 2000 A
6099542 Cohn et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6102909 Chen et al. Aug 2000 A
6109500 Alli et al. Aug 2000 A
6110127 Suzuki Aug 2000 A
6113594 Savage Sep 2000 A
6113598 Baker Sep 2000 A
6117152 Huitema Sep 2000 A
H1904 Yates et al. Oct 2000 H
6126629 Perkins Oct 2000 A
6126658 Baker Oct 2000 A
6129735 Okada et al. Oct 2000 A
6129740 Michelson Oct 2000 A
6132368 Cooper Oct 2000 A
6132427 Jones et al. Oct 2000 A
6132429 Baker Oct 2000 A
6132448 Perez et al. Oct 2000 A
6139320 Hahn Oct 2000 A
6139561 Shibata et al. Oct 2000 A
6142615 Qiu et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6144402 Norsworthy et al. Nov 2000 A
6147560 Erhage et al. Nov 2000 A
6152902 Christian et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6154198 Rosenberg Nov 2000 A
6156029 Mueller Dec 2000 A
6159160 Hsei et al. Dec 2000 A
6159175 Strukel et al. Dec 2000 A
6162194 Shipp Dec 2000 A
6162208 Hipps Dec 2000 A
6165150 Banko Dec 2000 A
6174309 Wrublewski et al. Jan 2001 B1
6174310 Kirwan, Jr. Jan 2001 B1
6176857 Ashley Jan 2001 B1
6179853 Sachse et al. Jan 2001 B1
6183426 Akisada et al. Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6193709 Miyawaki et al. Feb 2001 B1
6204592 Hur Mar 2001 B1
6205383 Hermann Mar 2001 B1
6205855 Pfeiffer Mar 2001 B1
6206844 Reichel et al. Mar 2001 B1
6206876 Levine et al. Mar 2001 B1
6210337 Dunham et al. Apr 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210403 Klicek Apr 2001 B1
6214023 Whipple et al. Apr 2001 B1
6228080 Gines May 2001 B1
6231565 Tovey et al. May 2001 B1
6232899 Craven May 2001 B1
6233476 Strommer et al. May 2001 B1
6238366 Savage et al. May 2001 B1
6238384 Peer May 2001 B1
6241724 Fleischman et al. Jun 2001 B1
6245065 Panescu et al. Jun 2001 B1
6251110 Wampler Jun 2001 B1
6252110 Uemura et al. Jun 2001 B1
D444365 Bass et al. Jul 2001 S
D445092 Lee Jul 2001 S
D445764 Lee Jul 2001 S
6254623 Haibel, Jr. et al. Jul 2001 B1
6257241 Wampler Jul 2001 B1
6258034 Hanafy Jul 2001 B1
6259230 Chou Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6267761 Ryan Jul 2001 B1
6270831 Kumar et al. Aug 2001 B2
6273852 Lehe et al. Aug 2001 B1
6274963 Estabrook et al. Aug 2001 B1
6277115 Saadat Aug 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6278218 Madan et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6283981 Beaupre Sep 2001 B1
6287344 Wampler et al. Sep 2001 B1
6290575 Shipp Sep 2001 B1
6292700 Morrison et al. Sep 2001 B1
6299591 Banko Oct 2001 B1
6306131 Hareyama et al. Oct 2001 B1
6306157 Shchervinsky Oct 2001 B1
6309400 Beaupre Oct 2001 B2
6311783 Harpell Nov 2001 B1
6319221 Savage et al. Nov 2001 B1
6325795 Lindemann et al. Dec 2001 B1
6325799 Goble Dec 2001 B1
6325811 Messerly Dec 2001 B1
6328751 Beaupre Dec 2001 B1
6332891 Himes Dec 2001 B1
6338657 Harper et al. Jan 2002 B1
6340352 Okada et al. Jan 2002 B1
6340878 Oglesbee Jan 2002 B1
6350269 Shipp et al. Feb 2002 B1
6352532 Kramer et al. Mar 2002 B1
6356224 Wohlfarth Mar 2002 B1
6358246 Behl et al. Mar 2002 B1
6358264 Banko Mar 2002 B2
6364888 Niemeyer et al. Apr 2002 B1
6379320 Lafon et al. Apr 2002 B1
D457958 Dycus et al. May 2002 S
6383194 Pothula May 2002 B1
6384690 Wilhelmsson et al. May 2002 B1
6387094 Eitenmuller May 2002 B1
6387109 Davison et al. May 2002 B1
6388657 Natoli May 2002 B1
6390973 Ouchi May 2002 B1
6391026 Hung et al. May 2002 B1
6391042 Cimino May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6402743 Orszulak et al. Jun 2002 B1
6402748 Schoenman et al. Jun 2002 B1
6405184 Bohme et al. Jun 2002 B1
6405733 Fogarty et al. Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6416469 Phung et al. Jul 2002 B1
6416486 Wampler Jul 2002 B1
6417969 DeLuca et al. Jul 2002 B1
6419675 Gallo, Sr. Jul 2002 B1
6423073 Bowman Jul 2002 B2
6423082 Houser et al. Jul 2002 B1
6425906 Young et al. Jul 2002 B1
6428538 Blewett et al. Aug 2002 B1
6428539 Baxter et al. Aug 2002 B1
6430446 Knowlton Aug 2002 B1
6432118 Messerly Aug 2002 B1
6436114 Novak et al. Aug 2002 B1
6436115 Beaupre Aug 2002 B1
6436129 Sharkey et al. Aug 2002 B1
6440062 Ouchi Aug 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6443969 Novak et al. Sep 2002 B1
6449006 Shipp Sep 2002 B1
6454781 Witt et al. Sep 2002 B1
6454782 Schwemberger Sep 2002 B1
6458128 Schulze Oct 2002 B1
6458130 Frazier et al. Oct 2002 B1
6458142 Faller et al. Oct 2002 B1
6459363 Walker et al. Oct 2002 B1
6461363 Gadberry et al. Oct 2002 B1
6464689 Qin et al. Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6468270 Hovda et al. Oct 2002 B1
6475211 Chess et al. Nov 2002 B2
6475215 Tanrisever Nov 2002 B1
6480796 Wiener Nov 2002 B2
6485490 Wampler et al. Nov 2002 B2
6491690 Goble et al. Dec 2002 B1
6491701 Tierney et al. Dec 2002 B2
6491708 Madan et al. Dec 2002 B2
6497715 Satou Dec 2002 B2
6500112 Khouri Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6500188 Harper et al. Dec 2002 B2
6500312 Wedekamp Dec 2002 B2
6503248 Levine Jan 2003 B1
6506208 Hunt et al. Jan 2003 B2
6511478 Burnside et al. Jan 2003 B1
6511480 Tetzlaff et al. Jan 2003 B1
6511493 Moutafis et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6514267 Jewett Feb 2003 B2
6517565 Whitman et al. Feb 2003 B1
6524251 Rabiner et al. Feb 2003 B2
6524316 Nicholson et al. Feb 2003 B1
6527736 Attinger et al. Mar 2003 B1
6531846 Smith Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6537291 Friedman et al. Mar 2003 B2
6543452 Lavigne Apr 2003 B1
6543456 Freeman Apr 2003 B1
6544260 Markel et al. Apr 2003 B1
6551309 LePivert Apr 2003 B1
6554829 Schulze et al. Apr 2003 B2
6558376 Bishop May 2003 B2
6558380 Lingenfelder et al. May 2003 B2
6561983 Cronin et al. May 2003 B2
6562035 Levin May 2003 B1
6562037 Paton et al. May 2003 B2
6565558 Lindenmeier et al. May 2003 B1
6572563 Ouchi Jun 2003 B2
6572632 Zisterer et al. Jun 2003 B2
6572639 Ingle et al. Jun 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6582427 Goble et al. Jun 2003 B1
6582451 Marucci et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
D477408 Bromley Jul 2003 S
6585735 Frazier et al. Jul 2003 B1
6588277 Giordano et al. Jul 2003 B2
6589200 Schwemberger et al. Jul 2003 B1
6589239 Khandkar et al. Jul 2003 B2
6590733 Wilson et al. Jul 2003 B1
6599288 Maguire et al. Jul 2003 B2
6602252 Mollenauer Aug 2003 B2
6602262 Griego et al. Aug 2003 B2
6607540 Shipp Aug 2003 B1
6610059 West, Jr. Aug 2003 B1
6610060 Mulier et al. Aug 2003 B2
6611793 Burnside et al. Aug 2003 B1
6616450 Mossle et al. Sep 2003 B2
6619529 Green et al. Sep 2003 B2
6620161 Schulze et al. Sep 2003 B2
6622731 Daniel et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6623500 Cook et al. Sep 2003 B1
6623501 Heller et al. Sep 2003 B2
6626848 Neuenfeldt Sep 2003 B2
6626926 Friedman et al. Sep 2003 B2
6629974 Penny et al. Oct 2003 B2
6632221 Edwards et al. Oct 2003 B1
6633234 Wiener et al. Oct 2003 B2
6635057 Harano et al. Oct 2003 B2
6644532 Green et al. Nov 2003 B2
6651669 Burnside Nov 2003 B1
6652513 Panescu et al. Nov 2003 B2
6652539 Shipp et al. Nov 2003 B2
6652545 Shipp et al. Nov 2003 B2
6656132 Ouchi Dec 2003 B1
6656177 Truckai et al. Dec 2003 B2
6656198 Tsonton et al. Dec 2003 B2
6660017 Beaupre Dec 2003 B2
6662127 Wiener et al. Dec 2003 B2
6663941 Brown et al. Dec 2003 B2
6666860 Takahashi Dec 2003 B1
6666875 Sakurai et al. Dec 2003 B1
6669690 Okada et al. Dec 2003 B1
6669710 Moutafis et al. Dec 2003 B2
6673248 Chowdhury Jan 2004 B2
6676660 Wampler et al. Jan 2004 B2
6678621 Wiener et al. Jan 2004 B2
6679875 Honda et al. Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6679899 Wiener et al. Jan 2004 B2
6682501 Nelson et al. Jan 2004 B1
6682544 Mastri et al. Jan 2004 B2
6685700 Behl et al. Feb 2004 B2
6685701 Orszulak et al. Feb 2004 B2
6685703 Pearson et al. Feb 2004 B2
6689145 Lee et al. Feb 2004 B2
6689146 Himes Feb 2004 B1
6690960 Chen et al. Feb 2004 B2
6695840 Schulze Feb 2004 B2
6702821 Bonutti Mar 2004 B2
6716215 David et al. Apr 2004 B1
6719692 Kleffner et al. Apr 2004 B2
6719765 Bonutti Apr 2004 B2
6719776 Baxter et al. Apr 2004 B2
6722552 Fenton, Jr. Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
D490059 Conway et al. May 2004 S
6730080 Harano et al. May 2004 B2
6731047 Kauf et al. May 2004 B2
6733498 Paton et al. May 2004 B2
6733506 McDevitt et al. May 2004 B1
6736813 Yamauchi et al. May 2004 B2
6739872 Turri May 2004 B1
6740079 Eggers et al. May 2004 B1
D491666 Kimmell et al. Jun 2004 S
6743245 Lobdell Jun 2004 B2
6746284 Spink, Jr. Jun 2004 B1
6746443 Morley et al. Jun 2004 B1
6752815 Beaupre Jun 2004 B2
6755825 Shoenman et al. Jun 2004 B2
6761698 Shibata et al. Jul 2004 B2
6762535 Take et al. Jul 2004 B2
6766202 Underwood et al. Jul 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773434 Ciarrocca Aug 2004 B2
6773435 Schulze et al. Aug 2004 B2
6773443 Truwit et al. Aug 2004 B2
6773444 Messerly Aug 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6778023 Christensen Aug 2004 B2
6783524 Anderson et al. Aug 2004 B2
6786382 Hoffman Sep 2004 B1
6786383 Stegelmann Sep 2004 B2
6789939 Schrodinger et al. Sep 2004 B2
6790173 Saadat et al. Sep 2004 B2
6790216 Ishikawa Sep 2004 B1
6794027 Araki et al. Sep 2004 B1
6796981 Wham et al. Sep 2004 B2
D496997 Dycus et al. Oct 2004 S
6800085 Selmon et al. Oct 2004 B2
6802843 Truckai et al. Oct 2004 B2
6808525 Latterell et al. Oct 2004 B2
6809508 Donofrio Oct 2004 B2
6810281 Brock et al. Oct 2004 B2
6811842 Ehrnsperger et al. Nov 2004 B1
6814731 Swanson Nov 2004 B2
6819027 Saraf Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6827712 Tovey et al. Dec 2004 B2
6828712 Battaglin et al. Dec 2004 B2
6835082 Gonnering Dec 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6840938 Morley et al. Jan 2005 B1
6843789 Goble Jan 2005 B2
6849073 Hoey et al. Feb 2005 B2
6860878 Brock Mar 2005 B2
6860880 Treat et al. Mar 2005 B2
6863676 Lee et al. Mar 2005 B2
6866671 Tierney et al. Mar 2005 B2
6869439 White et al. Mar 2005 B2
6875220 Du et al. Apr 2005 B2
6877647 Green et al. Apr 2005 B2
6882439 Ishijima Apr 2005 B2
6887209 Kadziauskas et al. May 2005 B2
6887252 Okada et al. May 2005 B1
6893435 Goble May 2005 B2
6898536 Wiener et al. May 2005 B2
6899685 Kermode et al. May 2005 B2
6905497 Truckai et al. Jun 2005 B2
6908463 Treat et al. Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6915623 Dey et al. Jul 2005 B2
6923804 Eggers et al. Aug 2005 B2
6923806 Hooven et al. Aug 2005 B2
6926712 Phan Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6926717 Garito et al. Aug 2005 B1
6929602 Hirakui et al. Aug 2005 B2
6929622 Chian Aug 2005 B2
6929632 Nita et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6933656 Matsushita et al. Aug 2005 B2
D509589 Wells Sep 2005 S
6942660 Pantera et al. Sep 2005 B2
6942677 Nita et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6946779 Birgel Sep 2005 B2
6948503 Refior et al. Sep 2005 B2
6953461 McClurken et al. Oct 2005 B2
6958070 Witt et al. Oct 2005 B2
D511145 Donofrio et al. Nov 2005 S
6974450 Weber et al. Dec 2005 B2
6976844 Hickok et al. Dec 2005 B2
6976969 Messerly Dec 2005 B2
6977495 Donofrio Dec 2005 B2
6979332 Adams Dec 2005 B2
6981628 Wales Jan 2006 B2
6984220 Wuchinich Jan 2006 B2
6984231 Goble et al. Jan 2006 B2
6988295 Tillim Jan 2006 B2
6988649 Shelton, IV et al. Jan 2006 B2
6994708 Manzo Feb 2006 B2
6994709 Iida Feb 2006 B2
7000818 Shelton, IV et al. Feb 2006 B2
7001335 Adachi et al. Feb 2006 B2
7001379 Behl et al. Feb 2006 B2
7001382 Gallo, Sr. Feb 2006 B2
7004951 Gibbens, III Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7014638 Michelson Mar 2006 B2
7018389 Camerlengo Mar 2006 B2
7025732 Thompson et al. Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7033357 Baxter et al. Apr 2006 B2
7037306 Podany et al. May 2006 B2
7041083 Chu et al. May 2006 B2
7041088 Nawrocki et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7044949 Orszulak et al. May 2006 B2
7052494 Goble et al. May 2006 B2
7052496 Yamauchi May 2006 B2
7055731 Shelton, IV et al. Jun 2006 B2
7063699 Hess et al. Jun 2006 B2
7066893 Hibner et al. Jun 2006 B2
7066895 Podany Jun 2006 B2
7066936 Ryan Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7074218 Washington et al. Jul 2006 B2
7074219 Levine et al. Jul 2006 B2
7077039 Gass et al. Jul 2006 B2
7077845 Hacker et al. Jul 2006 B2
7077853 Kramer et al. Jul 2006 B2
7083075 Swayze et al. Aug 2006 B2
7083613 Treat Aug 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7090637 Danitz et al. Aug 2006 B2
7090672 Underwood et al. Aug 2006 B2
7094235 Francischelli Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7101378 Salameh et al. Sep 2006 B2
7104834 Robinson et al. Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
7113831 Hooven Sep 2006 B2
D531311 Guerra et al. Oct 2006 S
7117034 Kronberg Oct 2006 B2
7118564 Ritchie et al. Oct 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7118587 Dycus et al. Oct 2006 B2
7119516 Denning Oct 2006 B2
7124932 Isaacson et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7128720 Podany Oct 2006 B2
7131860 Sartor et al. Nov 2006 B2
7131970 Moses et al. Nov 2006 B2
7135018 Ryan et al. Nov 2006 B2
7135030 Schwemberger et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7143925 Shelton, IV et al. Dec 2006 B2
7144403 Booth Dec 2006 B2
7147138 Shelton, IV Dec 2006 B2
7153315 Miller Dec 2006 B2
D536093 Nakajima et al. Jan 2007 S
7156189 Bar-Cohen et al. Jan 2007 B1
7156846 Dycus et al. Jan 2007 B2
7156853 Muratsu Jan 2007 B2
7157058 Marhasin et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160259 Tardy et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7160298 Lawes et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7163548 Stulen et al. Jan 2007 B2
7166103 Carmel et al. Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7169156 Hart Jan 2007 B2
7179254 Pendekanti et al. Feb 2007 B2
7179271 Friedman et al. Feb 2007 B2
7186253 Truckai et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
7195631 Dumbauld Mar 2007 B2
D541418 Schechter et al. Apr 2007 S
7198635 Danek et al. Apr 2007 B2
7204820 Akahoshi Apr 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7207997 Shipp et al. Apr 2007 B2
7208005 Frecker et al. Apr 2007 B2
7210881 Greenberg May 2007 B2
7211079 Treat May 2007 B2
7217128 Atkin et al. May 2007 B2
7217269 El-Galley et al. May 2007 B2
7220951 Truckai et al. May 2007 B2
7223229 Inman et al. May 2007 B2
7225964 Mastri et al. Jun 2007 B2
7226447 Uchida et al. Jun 2007 B2
7226448 Bertolero et al. Jun 2007 B2
7229455 Sakurai et al. Jun 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7235071 Gonnering Jun 2007 B2
7235073 Levine et al. Jun 2007 B2
7241294 Reschke Jul 2007 B2
7244262 Wiener et al. Jul 2007 B2
7251531 Mosher et al. Jul 2007 B2
7252641 Thompson et al. Aug 2007 B2
7252667 Moses et al. Aug 2007 B2
7258688 Shah et al. Aug 2007 B1
7264618 Murakami et al. Sep 2007 B2
7267677 Johnson et al. Sep 2007 B2
7267685 Butaric et al. Sep 2007 B2
7269873 Brewer et al. Sep 2007 B2
7273483 Wiener et al. Sep 2007 B2
D552241 Bromley et al. Oct 2007 S
7282048 Goble et al. Oct 2007 B2
7285895 Beaupre Oct 2007 B2
7287682 Ezzat et al. Oct 2007 B1
7297149 Vitali et al. Nov 2007 B2
7300431 Dubrovsky Nov 2007 B2
7300435 Wham et al. Nov 2007 B2
7300446 Beaupre Nov 2007 B2
7300450 Vleugels et al. Nov 2007 B2
7303531 Lee et al. Dec 2007 B2
7303557 Wham et al. Dec 2007 B2
7306597 Manzo Dec 2007 B2
7307313 Ohyanagi et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311706 Schoenman et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7317955 McGreevy Jan 2008 B2
7318831 Alvarez et al. Jan 2008 B2
7318832 Young et al. Jan 2008 B2
7326236 Andreas et al. Feb 2008 B2
7329257 Kanehira et al. Feb 2008 B2
7331410 Yong et al. Feb 2008 B2
7335165 Truwit et al. Feb 2008 B2
7335997 Wiener Feb 2008 B2
7337010 Howard et al. Feb 2008 B2
7353068 Tanaka et al. Apr 2008 B2
7354440 Truckal et al. Apr 2008 B2
7357287 Shelton, IV et al. Apr 2008 B2
7357802 Palanker et al. Apr 2008 B2
7361172 Cimino Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
7367976 Lawes et al. May 2008 B2
7371227 Zeiner May 2008 B2
RE40388 Gines Jun 2008 E
7380695 Doll et al. Jun 2008 B2
7380696 Shelton, IV et al. Jun 2008 B2
7381209 Truckai et al. Jun 2008 B2
7384420 Dycus et al. Jun 2008 B2
7390317 Taylor et al. Jun 2008 B2
7396356 Mollenauer Jul 2008 B2
7403224 Fuller et al. Jul 2008 B2
7404508 Smith et al. Jul 2008 B2
7407077 Ortiz et al. Aug 2008 B2
7408288 Hara Aug 2008 B2
7412008 Lliev Aug 2008 B2
7416101 Shelton, IV et al. Aug 2008 B2
7416437 Sartor et al. Aug 2008 B2
D576725 Shumer et al. Sep 2008 S
7419490 Falkenstein et al. Sep 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7422463 Kuo Sep 2008 B2
7422582 Malackowski et al. Sep 2008 B2
D578643 Shumer et al. Oct 2008 S
D578644 Shumer et al. Oct 2008 S
D578645 Shumer et al. Oct 2008 S
7431694 Stefanchik et al. Oct 2008 B2
7431704 Babaev Oct 2008 B2
7431720 Pendekanti et al. Oct 2008 B2
7435582 Zimmermann et al. Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7442193 Shields et al. Oct 2008 B2
7445621 Dumbauld et al. Nov 2008 B2
7449004 Yamada et al. Nov 2008 B2
7451904 Shelton, IV Nov 2008 B2
7455208 Wales et al. Nov 2008 B2
7455641 Yamada et al. Nov 2008 B2
7462181 Kraft et al. Dec 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7464849 Shelton, IV et al. Dec 2008 B2
7472815 Shelton, IV et al. Jan 2009 B2
7473145 Ehr et al. Jan 2009 B2
7473253 Dycus et al. Jan 2009 B2
7473263 Johnston et al. Jan 2009 B2
7479148 Beaupre Jan 2009 B2
7479160 Branch et al. Jan 2009 B2
7481775 Weikel, Jr. et al. Jan 2009 B2
7488285 Honda et al. Feb 2009 B2
7488319 Yates Feb 2009 B2
7491201 Shields et al. Feb 2009 B2
7491202 Odom et al. Feb 2009 B2
7494468 Rabiner et al. Feb 2009 B2
7494501 Ahlberg et al. Feb 2009 B2
7498080 Tung et al. Mar 2009 B2
7502234 Goliszek et al. Mar 2009 B2
7503893 Kucklick Mar 2009 B2
7503895 Rabiner et al. Mar 2009 B2
7506790 Shelton, IV Mar 2009 B2
7506791 Omaits et al. Mar 2009 B2
7507239 Shadduck Mar 2009 B2
7510107 Timm et al. Mar 2009 B2
7510556 Nguyen et al. Mar 2009 B2
7513025 Fischer Apr 2009 B2
7517349 Truckai et al. Apr 2009 B2
7520865 Radley Young et al. Apr 2009 B2
7524320 Tierney et al. Apr 2009 B2
7525309 Sherman et al. Apr 2009 B2
7530986 Beaupre et al. May 2009 B2
7534243 Chin et al. May 2009 B1
7535233 Kojovic et al. May 2009 B2
D594983 Price et al. Jun 2009 S
7540871 Gonnering Jun 2009 B2
7540872 Schechter et al. Jun 2009 B2
7543730 Marczyk Jun 2009 B1
7544200 Houser Jun 2009 B2
7549564 Boudreaux Jun 2009 B2
7550216 Ofer et al. Jun 2009 B2
7553309 Buysse et al. Jun 2009 B2
7554343 Bromfield Jun 2009 B2
7559450 Wales et al. Jul 2009 B2
7559452 Wales et al. Jul 2009 B2
7563259 Takahashi Jul 2009 B2
7566318 Haefner Jul 2009 B2
7567012 Namikawa Jul 2009 B2
7568603 Shelton, IV et al. Aug 2009 B2
7569057 Liu et al. Aug 2009 B2
7572266 Young et al. Aug 2009 B2
7572268 Babaev Aug 2009 B2
7578820 Moore et al. Aug 2009 B2
7582084 Swanson et al. Sep 2009 B2
7582086 Privitera et al. Sep 2009 B2
7582087 Tetzlaff et al. Sep 2009 B2
7582095 Shipp et al. Sep 2009 B2
7585181 Olsen Sep 2009 B2
7586289 Andruk et al. Sep 2009 B2
7587536 McLeod Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7588177 Racenet Sep 2009 B2
7594925 Danek et al. Sep 2009 B2
7597693 Garrison Oct 2009 B2
7601119 Shahinian Oct 2009 B2
7601136 Akahoshi Oct 2009 B2
7604150 Boudreaux Oct 2009 B2
7607557 Shelton, IV et al. Oct 2009 B2
7617961 Viola Nov 2009 B2
7621930 Houser Nov 2009 B2
7625370 Hart et al. Dec 2009 B2
7628791 Garrison et al. Dec 2009 B2
7628792 Guerra Dec 2009 B2
7632267 Dahla Dec 2009 B2
7632269 Truckai et al. Dec 2009 B2
7637410 Marczyk Dec 2009 B2
7641653 Dalla Betta et al. Jan 2010 B2
7641671 Crainich Jan 2010 B2
7644848 Swayze et al. Jan 2010 B2
7645240 Thompson et al. Jan 2010 B2
7645277 McClurken et al. Jan 2010 B2
7645278 Ichihashi et al. Jan 2010 B2
7648499 Orszulak et al. Jan 2010 B2
7649410 Andersen et al. Jan 2010 B2
7654431 Hueil et al. Feb 2010 B2
7655003 Lorang et al. Feb 2010 B2
7658311 Boudreaux Feb 2010 B2
7659833 Warner et al. Feb 2010 B2
7662151 Crompton, Jr. et al. Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7666206 Taniguchi et al. Feb 2010 B2
7667592 Ohyama et al. Feb 2010 B2
7670334 Hueil et al. Mar 2010 B2
7670338 Albrecht et al. Mar 2010 B2
7674263 Ryan Mar 2010 B2
7678069 Baker et al. Mar 2010 B1
7678105 McGreevy et al. Mar 2010 B2
7678125 Shipp Mar 2010 B2
7682366 Sakurai et al. Mar 2010 B2
7686770 Cohen Mar 2010 B2
7686826 Lee et al. Mar 2010 B2
7688028 Phillips et al. Mar 2010 B2
7691095 Bednarek et al. Apr 2010 B2
7691098 Wallace et al. Apr 2010 B2
7696441 Kataoka Apr 2010 B2
7699846 Ryan Apr 2010 B2
7703459 Saadat et al. Apr 2010 B2
7703653 Shah et al. Apr 2010 B2
7708735 Chapman et al. May 2010 B2
7708751 Hughes et al. May 2010 B2
7708758 Lee et al. May 2010 B2
7708768 Danek et al. May 2010 B2
7713202 Boukhny et al. May 2010 B2
7713267 Pozzato May 2010 B2
7714481 Sakai May 2010 B2
7717312 Beetel May 2010 B2
7717914 Kimura May 2010 B2
7717915 Miyazawa May 2010 B2
7721935 Racenet et al. May 2010 B2
7722527 Bouchier et al. May 2010 B2
7722607 Dumbauld et al. May 2010 B2
D618797 Price et al. Jun 2010 S
7726537 Olson et al. Jun 2010 B2
7727177 Bayat Jun 2010 B2
7731717 Odom et al. Jun 2010 B2
7738969 Bleich Jun 2010 B2
7740594 Hibner Jun 2010 B2
7744615 Couture Jun 2010 B2
7749240 Takahashi et al. Jul 2010 B2
7751115 Song Jul 2010 B2
7753245 Boudreaux et al. Jul 2010 B2
7753904 Shelton, IV et al. Jul 2010 B2
7753908 Swanson Jul 2010 B2
7762445 Heinrich et al. Jul 2010 B2
D621503 Otten et al. Aug 2010 S
7766210 Shelton, IV et al. Aug 2010 B2
7766693 Sartor et al. Aug 2010 B2
7766910 Hixson et al. Aug 2010 B2
7768510 Tsai et al. Aug 2010 B2
7770774 Mastri et al. Aug 2010 B2
7770775 Shelton, IV et al. Aug 2010 B2
7771425 Dycus et al. Aug 2010 B2
7771444 Patel et al. Aug 2010 B2
7775972 Brock et al. Aug 2010 B2
7776036 Schechter et al. Aug 2010 B2
7776037 Odom Aug 2010 B2
7778733 Nowlin et al. Aug 2010 B2
7780054 Wales Aug 2010 B2
7780593 Ueno et al. Aug 2010 B2
7780651 Madhani et al. Aug 2010 B2
7780659 Okada et al. Aug 2010 B2
7780663 Yates et al. Aug 2010 B2
7784662 Wales et al. Aug 2010 B2
7784663 Shelton, IV Aug 2010 B2
7789883 Takashino et al. Sep 2010 B2
7793814 Racenet et al. Sep 2010 B2
7794475 Hess et al. Sep 2010 B2
7796969 Kelly et al. Sep 2010 B2
7798386 Schall et al. Sep 2010 B2
7799020 Shores et al. Sep 2010 B2
7799027 Hafner Sep 2010 B2
7799045 Masuda Sep 2010 B2
7803151 Whitman Sep 2010 B2
7803152 Honda et al. Sep 2010 B2
7803156 Eder et al. Sep 2010 B2
7803168 Gifford et al. Sep 2010 B2
7806891 Nowlin et al. Oct 2010 B2
7810693 Broehl et al. Oct 2010 B2
7811283 Moses et al. Oct 2010 B2
7815238 Cao Oct 2010 B2
7815641 Dodde et al. Oct 2010 B2
7819298 Hall et al. Oct 2010 B2
7819299 Shelton, IV et al. Oct 2010 B2
7819819 Quick et al. Oct 2010 B2
7819872 Johnson et al. Oct 2010 B2
7821143 Wiener Oct 2010 B2
D627066 Romero Nov 2010 S
7824401 Manzo et al. Nov 2010 B2
7832408 Shelton, IV et al. Nov 2010 B2
7832611 Boyden et al. Nov 2010 B2
7832612 Baxter, III et al. Nov 2010 B2
7834484 Sartor Nov 2010 B2
7837699 Yamada et al. Nov 2010 B2
7845537 Shelton, IV et al. Dec 2010 B2
7846155 Houser et al. Dec 2010 B2
7846159 Morrison et al. Dec 2010 B2
7846160 Payne et al. Dec 2010 B2
7846161 Dumbauld et al. Dec 2010 B2
7854735 Houser et al. Dec 2010 B2
D631155 Peine et al. Jan 2011 S
7861906 Doll et al. Jan 2011 B2
7862560 Marion Jan 2011 B2
7862561 Swanson et al. Jan 2011 B2
7867228 Nobis et al. Jan 2011 B2
7871392 Sartor Jan 2011 B2
7871423 Livneh Jan 2011 B2
7876030 Taki et al. Jan 2011 B2
D631965 Price et al. Feb 2011 S
7877852 Unger et al. Feb 2011 B2
7878991 Babaev Feb 2011 B2
7879029 Jimenez Feb 2011 B2
7879033 Sartor et al. Feb 2011 B2
7879035 Garrison et al. Feb 2011 B2
7879070 Ortiz et al. Feb 2011 B2
7883475 Dupont et al. Feb 2011 B2
7892606 Thies et al. Feb 2011 B2
7896875 Heim et al. Mar 2011 B2
7897792 Iikura et al. Mar 2011 B2
7901400 Wham et al. Mar 2011 B2
7901423 Stulen et al. Mar 2011 B2
7905881 Masuda et al. Mar 2011 B2
7909220 Viola Mar 2011 B2
7909820 Lipson et al. Mar 2011 B2
7909824 Masuda et al. Mar 2011 B2
7918848 Lau et al. Apr 2011 B2
7919184 Mohapatra et al. Apr 2011 B2
7922061 Shelton, IV et al. Apr 2011 B2
7922651 Yamada et al. Apr 2011 B2
7931611 Novak et al. Apr 2011 B2
7931649 Couture et al. Apr 2011 B2
D637288 Houghton May 2011 S
D638540 Ijiri et al. May 2011 S
7935114 Takashino et al. May 2011 B2
7936203 Zimlich May 2011 B2
7951095 Makin et al. May 2011 B2
7951165 Golden et al. May 2011 B2
7954682 Giordano et al. Jun 2011 B2
7955331 Truckai et al. Jun 2011 B2
7956620 Gilbert Jun 2011 B2
7959050 Smith et al. Jun 2011 B2
7959626 Hong et al. Jun 2011 B2
7963963 Francischelli et al. Jun 2011 B2
7967602 Lindquist Jun 2011 B2
7972328 Wham et al. Jul 2011 B2
7972329 Refior et al. Jul 2011 B2
7975895 Milliman Jul 2011 B2
7976544 McClurken et al. Jul 2011 B2
7980443 Scheib et al. Jul 2011 B2
7981050 Ritchart et al. Jul 2011 B2
7981113 Truckai et al. Jul 2011 B2
7997278 Utley et al. Aug 2011 B2
7998157 Culp et al. Aug 2011 B2
8002732 Visconti Aug 2011 B2
8002770 Swanson et al. Aug 2011 B2
8020743 Shelton, IV Sep 2011 B2
8025672 Novak et al. Sep 2011 B2
8028885 Smith et al. Oct 2011 B2
8033173 Ehlert et al. Oct 2011 B2
8034049 Odom et al. Oct 2011 B2
8038693 Allen Oct 2011 B2
8048070 O'Brien et al. Nov 2011 B2
8048074 Masuda Nov 2011 B2
8052672 Laufer et al. Nov 2011 B2
8055208 Lilla et al. Nov 2011 B2
8056720 Hawkes Nov 2011 B2
8056787 Boudreaux et al. Nov 2011 B2
8057468 Konesky Nov 2011 B2
8057498 Robertson Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8061014 Smith et al. Nov 2011 B2
8066167 Measamer et al. Nov 2011 B2
8070036 Knodel Dec 2011 B1
8070711 Bassinger et al. Dec 2011 B2
8070762 Escudero et al. Dec 2011 B2
8075555 Truckai et al. Dec 2011 B2
8075558 Truckai et al. Dec 2011 B2
8089197 Rinner et al. Jan 2012 B2
8092475 Cotter et al. Jan 2012 B2
8096459 Ortiz et al. Jan 2012 B2
8097012 Kagarise Jan 2012 B2
8100894 Mucko et al. Jan 2012 B2
8105230 Honda et al. Jan 2012 B2
8105323 Buysse et al. Jan 2012 B2
8105324 Palanker et al. Jan 2012 B2
8114104 Young et al. Feb 2012 B2
8118276 Sanders et al. Feb 2012 B2
8128624 Couture et al. Mar 2012 B2
8133218 Daw et al. Mar 2012 B2
8136712 Zingman Mar 2012 B2
8141762 Bedi et al. Mar 2012 B2
8142421 Cooper et al. Mar 2012 B2
8142461 Houser et al. Mar 2012 B2
8147485 Wham et al. Apr 2012 B2
8147488 Masuda Apr 2012 B2
8147508 Madan et al. Apr 2012 B2
8152801 Goldberg et al. Apr 2012 B2
8152825 Madan et al. Apr 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8161977 Shelton, IV et al. Apr 2012 B2
8162966 Connor et al. Apr 2012 B2
8170717 Sutherland et al. May 2012 B2
8172846 Brunnett et al. May 2012 B2
8172870 Shipp May 2012 B2
8177800 Spitz et al. May 2012 B2
8182502 Stulen et al. May 2012 B2
8186560 Hess et al. May 2012 B2
8186877 Klimovitch et al. May 2012 B2
8187267 Pappone et al. May 2012 B2
D661801 Price et al. Jun 2012 S
D661802 Price et al. Jun 2012 S
D661803 Price et al. Jun 2012 S
D661804 Price et al. Jun 2012 S
8197472 Lau et al. Jun 2012 B2
8197479 Olson et al. Jun 2012 B2
8197502 Smith et al. Jun 2012 B2
8207651 Gilbert Jun 2012 B2
8210411 Yates et al. Jul 2012 B2
8211100 Podhajsky et al. Jul 2012 B2
8216223 Wham et al. Jul 2012 B2
8220688 Laurent et al. Jul 2012 B2
8221306 Okada et al. Jul 2012 B2
8221415 Francischelli Jul 2012 B2
8221418 Prakash et al. Jul 2012 B2
8226580 Govari et al. Jul 2012 B2
8226665 Cohen Jul 2012 B2
8226675 Houser et al. Jul 2012 B2
8231607 Takuma Jul 2012 B2
8235917 Joseph et al. Aug 2012 B2
8236018 Yoshimine et al. Aug 2012 B2
8236019 Houser Aug 2012 B2
8236020 Smith et al. Aug 2012 B2
8241235 Kahler et al. Aug 2012 B2
8241271 Millman et al. Aug 2012 B2
8241282 Unger et al. Aug 2012 B2
8241283 Guerra et al. Aug 2012 B2
8241284 Dycus et al. Aug 2012 B2
8241312 Messerly Aug 2012 B2
8246575 Viola Aug 2012 B2
8246615 Behnke Aug 2012 B2
8246616 Amoah et al. Aug 2012 B2
8246618 Bucciaglia et al. Aug 2012 B2
8246642 Houser et al. Aug 2012 B2
8251994 McKenna et al. Aug 2012 B2
8252012 Stulen Aug 2012 B2
8253303 Giordano et al. Aug 2012 B2
8257377 Wiener et al. Sep 2012 B2
8257387 Cunningham Sep 2012 B2
8262563 Bakos et al. Sep 2012 B2
8267300 Boudreaux Sep 2012 B2
8267935 Couture et al. Sep 2012 B2
8273087 Kimura et al. Sep 2012 B2
D669992 Schafer et al. Oct 2012 S
D669993 Merchant et al. Oct 2012 S
8277446 Heard Oct 2012 B2
8277447 Garrison et al. Oct 2012 B2
8277471 Wiener et al. Oct 2012 B2
8282581 Zhao et al. Oct 2012 B2
8282669 Gerber et al. Oct 2012 B2
8286846 Smith et al. Oct 2012 B2
8287485 Kimura et al. Oct 2012 B2
8287528 Wham et al. Oct 2012 B2
8287532 Carroll et al. Oct 2012 B2
8292886 Kerr et al. Oct 2012 B2
8292888 Whitman Oct 2012 B2
8292905 Taylor et al. Oct 2012 B2
8295902 Salahieh et al. Oct 2012 B2
8298223 Wham et al. Oct 2012 B2
8298225 Gilbert Oct 2012 B2
8298232 Unger Oct 2012 B2
8298233 Mueller Oct 2012 B2
8303576 Brock Nov 2012 B2
8303579 Shibata Nov 2012 B2
8303580 Wham et al. Nov 2012 B2
8303583 Hosier et al. Nov 2012 B2
8303613 Crandall et al. Nov 2012 B2
8306629 Mioduski et al. Nov 2012 B2
8308040 Huang et al. Nov 2012 B2
8308721 Shibata et al. Nov 2012 B2
8319400 Houser et al. Nov 2012 B2
8323302 Robertson et al. Dec 2012 B2
8323310 Kingsley Dec 2012 B2
8328061 Kasvikis Dec 2012 B2
8328761 Widenhouse et al. Dec 2012 B2
8328802 Deville et al. Dec 2012 B2
8328833 Cuny Dec 2012 B2
8328834 Isaacs et al. Dec 2012 B2
8333764 Francischelli et al. Dec 2012 B2
8333778 Smith et al. Dec 2012 B2
8333779 Smith et al. Dec 2012 B2
8334468 Palmer et al. Dec 2012 B2
8334635 Voegele et al. Dec 2012 B2
8337407 Quistgaard et al. Dec 2012 B2
8338726 Palmer et al. Dec 2012 B2
8343146 Godara et al. Jan 2013 B2
8344596 Nield et al. Jan 2013 B2
8348880 Messerly et al. Jan 2013 B2
8348947 Takashino et al. Jan 2013 B2
8348967 Stulen Jan 2013 B2
8353297 Dacquay et al. Jan 2013 B2
8357103 Mark et al. Jan 2013 B2
8357144 Whitman et al. Jan 2013 B2
8357149 Govari et al. Jan 2013 B2
8357158 McKenna et al. Jan 2013 B2
8360299 Zemlok et al. Jan 2013 B2
8361066 Long et al. Jan 2013 B2
8361072 Dumbauld et al. Jan 2013 B2
8361569 Saito et al. Jan 2013 B2
8366727 Witt et al. Feb 2013 B2
8372064 Douglass et al. Feb 2013 B2
8372099 Deville et al. Feb 2013 B2
8372101 Smith et al. Feb 2013 B2
8372102 Stulen et al. Feb 2013 B2
8374670 Selkee Feb 2013 B2
8377044 Coe et al. Feb 2013 B2
8377059 Deville et al. Feb 2013 B2
8377085 Smith et al. Feb 2013 B2
8382748 Geisel Feb 2013 B2
8382775 Bender et al. Feb 2013 B1
8382782 Robertson et al. Feb 2013 B2
8382792 Chojin Feb 2013 B2
8388646 Chojin Mar 2013 B2
8388647 Nau, Jr. et al. Mar 2013 B2
8393514 Shelton, IV et al. Mar 2013 B2
8394115 Houser et al. Mar 2013 B2
8397971 Yates et al. Mar 2013 B2
8398394 Sauter et al. Mar 2013 B2
8398674 Prestel Mar 2013 B2
8403926 Nobis et al. Mar 2013 B2
8403945 Whitfield et al. Mar 2013 B2
8403948 Deville et al. Mar 2013 B2
8403949 Palmer et al. Mar 2013 B2
8403950 Palmer et al. Mar 2013 B2
8409234 Stahler et al. Apr 2013 B2
8414577 Boudreaux et al. Apr 2013 B2
8418073 Mohr et al. Apr 2013 B2
8418349 Smith et al. Apr 2013 B2
8419757 Smith et al. Apr 2013 B2
8419758 Smith et al. Apr 2013 B2
8419759 Dietz Apr 2013 B2
8423182 Robinson et al. Apr 2013 B2
8425410 Murray et al. Apr 2013 B2
8425545 Smith et al. Apr 2013 B2
8430811 Hess et al. Apr 2013 B2
8430874 Newton et al. Apr 2013 B2
8430876 Kappus et al. Apr 2013 B2
8430897 Novak et al. Apr 2013 B2
8430898 Wiener et al. Apr 2013 B2
8435257 Smith et al. May 2013 B2
8437832 Govari et al. May 2013 B2
8439912 Cunningham et al. May 2013 B2
8439939 Deville et al. May 2013 B2
8444036 Shelton, IV May 2013 B2
8444637 Podmore et al. May 2013 B2
8444662 Palmer et al. May 2013 B2
8444663 Houser et al. May 2013 B2
8444664 Balanev et al. May 2013 B2
8453906 Huang et al. Jun 2013 B2
8454599 Inagaki et al. Jun 2013 B2
8454639 Du et al. Jun 2013 B2
8459525 Yates et al. Jun 2013 B2
8460284 Aronow et al. Jun 2013 B2
8460288 Tamai et al. Jun 2013 B2
8460292 Truckai et al. Jun 2013 B2
8461744 Wiener et al. Jun 2013 B2
8469981 Robertson et al. Jun 2013 B2
8471685 Shingai Jun 2013 B2
8479969 Shelton, IV Jul 2013 B2
8480703 Nicholas et al. Jul 2013 B2
8484833 Cunningham et al. Jul 2013 B2
8485413 Scheib et al. Jul 2013 B2
8485970 Widenhouse et al. Jul 2013 B2
8486057 Behnke, II Jul 2013 B2
8486096 Robertson et al. Jul 2013 B2
8491578 Manwaring et al. Jul 2013 B2
8491625 Horner Jul 2013 B2
8496682 Guerra et al. Jul 2013 B2
D687549 Johnson et al. Aug 2013 S
8506555 Ruiz Morales Aug 2013 B2
8509318 Tailliet Aug 2013 B2
8512336 Couture Aug 2013 B2
8512337 Francischelli et al. Aug 2013 B2
8512359 Whitman et al. Aug 2013 B2
8512364 Kowalski et al. Aug 2013 B2
8512365 Wiener et al. Aug 2013 B2
8517239 Scheib et al. Aug 2013 B2
8518067 Masuda et al. Aug 2013 B2
8521331 Itkowitz Aug 2013 B2
8523043 Ullrich et al. Sep 2013 B2
8523882 Huitema et al. Sep 2013 B2
8523889 Stulen et al. Sep 2013 B2
8528563 Gruber Sep 2013 B2
8529437 Taylor et al. Sep 2013 B2
8529565 Masuda et al. Sep 2013 B2
8531064 Robertson et al. Sep 2013 B2
8535308 Govari et al. Sep 2013 B2
8535311 Schall Sep 2013 B2
8535340 Allen Sep 2013 B2
8535341 Allen Sep 2013 B2
8540128 Shelton, IV et al. Sep 2013 B2
8546996 Messerly et al. Oct 2013 B2
8546999 Houser et al. Oct 2013 B2
8551077 Main et al. Oct 2013 B2
8551086 Kimura et al. Oct 2013 B2
8556929 Harper et al. Oct 2013 B2
8561870 Baxter, III et al. Oct 2013 B2
8562592 Conlon et al. Oct 2013 B2
8562598 Falkenstein et al. Oct 2013 B2
8562600 Kirkpatrick et al. Oct 2013 B2
8562604 Nishimura Oct 2013 B2
8568390 Mueller Oct 2013 B2
8568397 Horner et al. Oct 2013 B2
8568400 Gilbert Oct 2013 B2
8568412 Brandt et al. Oct 2013 B2
8569997 Lee Oct 2013 B2
8573461 Shelton, IV et al. Nov 2013 B2
8573465 Shelton, IV Nov 2013 B2
8574231 Boudreaux et al. Nov 2013 B2
8574253 Gruber et al. Nov 2013 B2
8579176 Smith et al. Nov 2013 B2
8579897 Vakharia et al. Nov 2013 B2
8579928 Robertson et al. Nov 2013 B2
8579937 Gresham Nov 2013 B2
8585727 Polo Nov 2013 B2
8588371 Ogawa et al. Nov 2013 B2
8591459 Clymer et al. Nov 2013 B2
8591506 Wham et al. Nov 2013 B2
8591536 Robertson Nov 2013 B2
D695407 Price et al. Dec 2013 S
D696631 Price et al. Dec 2013 S
8596513 Olson et al. Dec 2013 B2
8597193 Grunwald et al. Dec 2013 B2
8597287 Benamou et al. Dec 2013 B2
8602031 Reis et al. Dec 2013 B2
8602288 Shelton, IV et al. Dec 2013 B2
8603085 Jimenez Dec 2013 B2
8603089 Viola Dec 2013 B2
8608044 Hueil et al. Dec 2013 B2
8608045 Smith et al. Dec 2013 B2
8608745 Guzman et al. Dec 2013 B2
8613383 Beckman et al. Dec 2013 B2
8616431 Timm et al. Dec 2013 B2
8617152 Werneth et al. Dec 2013 B2
8617194 Beaupre Dec 2013 B2
8622274 Yates et al. Jan 2014 B2
8623011 Spivey Jan 2014 B2
8623016 Fischer Jan 2014 B2
8623027 Price et al. Jan 2014 B2
8623040 Artsyukhovich et al. Jan 2014 B2
8623044 Timm et al. Jan 2014 B2
8628529 Aldridge et al. Jan 2014 B2
8628534 Jones et al. Jan 2014 B2
8632461 Glossop Jan 2014 B2
8636736 Yates et al. Jan 2014 B2
8638428 Brown Jan 2014 B2
8640788 Dachs, II et al. Feb 2014 B2
8641663 Kirschenman et al. Feb 2014 B2
8647350 Mohan et al. Feb 2014 B2
8650728 Wan et al. Feb 2014 B2
8652120 Giordano et al. Feb 2014 B2
8652132 Tsuchiya et al. Feb 2014 B2
8652155 Houser et al. Feb 2014 B2
8657489 Ladurner et al. Feb 2014 B2
8659208 Rose et al. Feb 2014 B1
8663214 Weinberg et al. Mar 2014 B2
8663220 Wiener et al. Mar 2014 B2
8663222 Anderson et al. Mar 2014 B2
8663223 Masuda et al. Mar 2014 B2
8663262 Smith et al. Mar 2014 B2
8668691 Heard Mar 2014 B2
8668710 Slipszenko et al. Mar 2014 B2
8684253 Giordano et al. Apr 2014 B2
8685016 Wham et al. Apr 2014 B2
8685020 Weizman et al. Apr 2014 B2
8690582 Rohrbach et al. Apr 2014 B2
8695866 Leimbach et al. Apr 2014 B2
8696366 Chen et al. Apr 2014 B2
8696665 Hunt et al. Apr 2014 B2
8696666 Sanai et al. Apr 2014 B2
8696917 Petisce et al. Apr 2014 B2
8702609 Hadjicostis Apr 2014 B2
8702702 Edwards et al. Apr 2014 B1
8702704 Shelton, IV et al. Apr 2014 B2
8704425 Giordano et al. Apr 2014 B2
8708213 Shelton, IV et al. Apr 2014 B2
8709008 Willis et al. Apr 2014 B2
8709031 Stulen Apr 2014 B2
8709035 Johnson et al. Apr 2014 B2
8715270 Weitzner et al. May 2014 B2
8715277 Weizman May 2014 B2
8721640 Taylor et al. May 2014 B2
8721657 Kondoh et al. May 2014 B2
8733613 Huitema et al. May 2014 B2
8733614 Ross et al. May 2014 B2
8734443 Hixson et al. May 2014 B2
8738110 Tabada et al. May 2014 B2
8747238 Shelton, IV et al. Jun 2014 B2
8747351 Schultz Jun 2014 B2
8747404 Boudreaux et al. Jun 2014 B2
8749116 Messerly et al. Jun 2014 B2
8752264 Ackley et al. Jun 2014 B2
8752749 Moore et al. Jun 2014 B2
8753338 Widenhouse et al. Jun 2014 B2
8754570 Voegele et al. Jun 2014 B2
8758342 Bales et al. Jun 2014 B2
8758352 Cooper et al. Jun 2014 B2
8758391 Swayze et al. Jun 2014 B2
8764735 Coe et al. Jul 2014 B2
8764747 Cummings et al. Jul 2014 B2
8767970 Eppolito Jul 2014 B2
8770459 Racenet et al. Jul 2014 B2
8771269 Sherman et al. Jul 2014 B2
8771270 Burbank Jul 2014 B2
8771293 Surti et al. Jul 2014 B2
8773001 Wiener et al. Jul 2014 B2
8777944 Frankhouser et al. Jul 2014 B2
8777945 Floume et al. Jul 2014 B2
8779648 Giordano et al. Jul 2014 B2
8783541 Shelton, IV et al. Jul 2014 B2
8784415 Malackowski et al. Jul 2014 B2
8784418 Romero Jul 2014 B2
8790342 Stulen et al. Jul 2014 B2
8795274 Hanna Aug 2014 B2
8795275 Hafner Aug 2014 B2
8795276 Dietz et al. Aug 2014 B2
8795327 Dietz et al. Aug 2014 B2
8800838 Shelton, IV Aug 2014 B2
8801710 Ullrich et al. Aug 2014 B2
8801752 Fortier et al. Aug 2014 B2
8807414 Ross et al. Aug 2014 B2
8808204 Irisawa et al. Aug 2014 B2
8808319 Houser et al. Aug 2014 B2
8814856 Elmouelhi et al. Aug 2014 B2
8814870 Paraschiv et al. Aug 2014 B2
8820605 Shelton, IV Sep 2014 B2
8821388 Naito et al. Sep 2014 B2
8827992 Koss et al. Sep 2014 B2
8827995 Schaller et al. Sep 2014 B2
8834466 Cummings et al. Sep 2014 B2
8834518 Faller et al. Sep 2014 B2
8844789 Shelton, IV et al. Sep 2014 B2
8845537 Tanaka et al. Sep 2014 B2
8845630 Mehta et al. Sep 2014 B2
8848808 Dress Sep 2014 B2
8851354 Swensgard et al. Oct 2014 B2
8852184 Kucklick Oct 2014 B2
8858547 Brogna Oct 2014 B2
8862955 Cesari Oct 2014 B2
8864749 Okada Oct 2014 B2
8864757 Klimovitch et al. Oct 2014 B2
8864761 Johnson et al. Oct 2014 B2
8870865 Frankhouser et al. Oct 2014 B2
8874220 Draghici et al. Oct 2014 B2
8876726 Amit et al. Nov 2014 B2
8876858 Braun Nov 2014 B2
8882766 Couture et al. Nov 2014 B2
8882791 Stulen Nov 2014 B2
8888776 Dietz et al. Nov 2014 B2
8888783 Young Nov 2014 B2
8888809 Davison et al. Nov 2014 B2
8899462 Kostrzewski et al. Dec 2014 B2
8900259 Houser et al. Dec 2014 B2
8906016 Boudreaux et al. Dec 2014 B2
8906017 Rioux et al. Dec 2014 B2
8911438 Swoyer et al. Dec 2014 B2
8911460 Neurohr et al. Dec 2014 B2
8920412 Fritz et al. Dec 2014 B2
8920414 Stone et al. Dec 2014 B2
8920421 Rupp Dec 2014 B2
8926607 Norvell et al. Jan 2015 B2
8926608 Bacher et al. Jan 2015 B2
8926620 Chasmawala et al. Jan 2015 B2
8931682 Timm et al. Jan 2015 B2
8932282 Gilbert Jan 2015 B2
8932299 Bono et al. Jan 2015 B2
8936614 Allen, IV Jan 2015 B2
8939974 Boudreaux et al. Jan 2015 B2
8945126 Garrison et al. Feb 2015 B2
8951248 Messerly et al. Feb 2015 B2
8951272 Robertson et al. Feb 2015 B2
8956349 Aldridge et al. Feb 2015 B2
8960520 McCuen Feb 2015 B2
8961515 Twomey et al. Feb 2015 B2
8961547 Dietz et al. Feb 2015 B2
8967443 McCuen Mar 2015 B2
8968283 Kharin Mar 2015 B2
8968294 Maass et al. Mar 2015 B2
8968296 McPherson Mar 2015 B2
8968355 Malkowski et al. Mar 2015 B2
8974447 Kimball et al. Mar 2015 B2
8974477 Yamada Mar 2015 B2
8974479 Ross et al. Mar 2015 B2
8974932 McGahan et al. Mar 2015 B2
8979843 Timm et al. Mar 2015 B2
8979844 White et al. Mar 2015 B2
8979890 Boudreaux Mar 2015 B2
8986287 Park et al. Mar 2015 B2
8986297 Daniel et al. Mar 2015 B2
8986302 Aldridge et al. Mar 2015 B2
8989855 Murphy et al. Mar 2015 B2
8989903 Weir et al. Mar 2015 B2
8991678 Wellman et al. Mar 2015 B2
8992422 Spivey et al. Mar 2015 B2
8992526 Brodbeck et al. Mar 2015 B2
8998891 Garito et al. Apr 2015 B2
9005199 Beckman et al. Apr 2015 B2
9011437 Woodruff et al. Apr 2015 B2
9011471 Timm et al. Apr 2015 B2
9017326 DiNardo et al. Apr 2015 B2
9017355 Smith et al. Apr 2015 B2
9017370 Reschke et al. Apr 2015 B2
9017372 Artale et al. Apr 2015 B2
9023035 Allen, IV et al. May 2015 B2
9023070 Levine et al. May 2015 B2
9023071 Miller et al. May 2015 B2
9028397 Naito May 2015 B2
9028476 Bonn May 2015 B2
9028478 Mueller May 2015 B2
9028481 Behnke, II May 2015 B2
9028494 Shelton, IV et al. May 2015 B2
9028519 Yates et al. May 2015 B2
9031667 Williams May 2015 B2
9033973 Krapohl et al. May 2015 B2
9035741 Hamel et al. May 2015 B2
9037259 Mathur May 2015 B2
9039690 Kersten et al. May 2015 B2
9039691 Moua et al. May 2015 B2
9039692 Behnke, II et al. May 2015 B2
9039695 Giordano et al. May 2015 B2
9039696 Assmus et al. May 2015 B2
9039705 Takashino May 2015 B2
9039731 Joseph May 2015 B2
9043018 Mohr May 2015 B2
9044227 Shelton, IV et al. Jun 2015 B2
9044230 Morgan et al. Jun 2015 B2
9044238 Orszulak Jun 2015 B2
9044243 Johnson et al. Jun 2015 B2
9044245 Condie et al. Jun 2015 B2
9044256 Cadeddu et al. Jun 2015 B2
9044261 Houser Jun 2015 B2
9050083 Yates et al. Jun 2015 B2
9050093 Aldridge et al. Jun 2015 B2
9050098 Deville et al. Jun 2015 B2
9050123 Krause et al. Jun 2015 B2
9050124 Houser Jun 2015 B2
9055961 Manzo et al. Jun 2015 B2
9059547 McLawhorn Jun 2015 B2
9060770 Shelton, IV et al. Jun 2015 B2
9060775 Wiener et al. Jun 2015 B2
9060776 Yates et al. Jun 2015 B2
9060778 Condie et al. Jun 2015 B2
9066720 Ballakur et al. Jun 2015 B2
9066723 Beller et al. Jun 2015 B2
9066747 Robertson Jun 2015 B2
9072523 Houser et al. Jul 2015 B2
9072535 Shelton, IV et al. Jul 2015 B2
9072536 Shelton, IV et al. Jul 2015 B2
9072538 Suzuki et al. Jul 2015 B2
9072539 Messerly et al. Jul 2015 B2
9084624 Larkin et al. Jul 2015 B2
9089327 Worrell et al. Jul 2015 B2
9089360 Messerly et al. Jul 2015 B2
9095333 Konesky et al. Aug 2015 B2
9095362 Dachs, II et al. Aug 2015 B2
9095367 Olson et al. Aug 2015 B2
9099863 Smith et al. Aug 2015 B2
9101358 Kerr et al. Aug 2015 B2
9101385 Shelton, IV et al. Aug 2015 B2
9107684 Ma Aug 2015 B2
9107689 Robertson et al. Aug 2015 B2
9107690 Bales, Jr. et al. Aug 2015 B2
9113900 Buysse et al. Aug 2015 B2
9113907 Allen, IV et al. Aug 2015 B2
9113940 Twomey Aug 2015 B2
9119657 Shelton, IV et al. Sep 2015 B2
9119957 Gantz et al. Sep 2015 B2
9125662 Shelton, IV Sep 2015 B2
9125667 Stone et al. Sep 2015 B2
9144453 Rencher et al. Sep 2015 B2
9147965 Lee Sep 2015 B2
9149324 Huang et al. Oct 2015 B2
9149325 Worrell et al. Oct 2015 B2
9161803 Yates et al. Oct 2015 B2
9165114 Jain et al. Oct 2015 B2
9168054 Turner et al. Oct 2015 B2
9168085 Juzkiw et al. Oct 2015 B2
9168089 Buysse et al. Oct 2015 B2
9173656 Schurr et al. Nov 2015 B2
9179912 Yates et al. Nov 2015 B2
9186199 Strauss et al. Nov 2015 B2
9186204 Nishimura et al. Nov 2015 B2
9186796 Ogawa Nov 2015 B2
9192380 (Tarinelli) Racenet et al. Nov 2015 B2
9192421 Garrison Nov 2015 B2
9192428 Houser et al. Nov 2015 B2
9192431 Woodruff et al. Nov 2015 B2
9198714 Worrell et al. Dec 2015 B2
9198715 Livneh Dec 2015 B2
9198718 Marczyk et al. Dec 2015 B2
9198776 Young Dec 2015 B2
9204879 Shelton, IV Dec 2015 B2
9204891 Weitzman Dec 2015 B2
9204918 Germain et al. Dec 2015 B2
9204923 Manzo et al. Dec 2015 B2
9216050 Condie et al. Dec 2015 B2
9216051 Fischer et al. Dec 2015 B2
9216062 Duque et al. Dec 2015 B2
9220483 Frankhouser et al. Dec 2015 B2
9220527 Houser et al. Dec 2015 B2
9220559 Worrell et al. Dec 2015 B2
9226750 Weir et al. Jan 2016 B2
9226751 Shelton, IV et al. Jan 2016 B2
9226766 Aldridge et al. Jan 2016 B2
9226767 Stulen et al. Jan 2016 B2
9232979 Parihar et al. Jan 2016 B2
9237891 Shelton, IV Jan 2016 B2
9237921 Messerly et al. Jan 2016 B2
9241060 Fujisaki Jan 2016 B1
9241692 Gunday et al. Jan 2016 B2
9241728 Price et al. Jan 2016 B2
9241730 Babaev Jan 2016 B2
9241731 Boudreaux et al. Jan 2016 B2
9241768 Sandhu et al. Jan 2016 B2
9247953 Palmer et al. Feb 2016 B2
9254165 Aronow et al. Feb 2016 B2
9259234 Robertson et al. Feb 2016 B2
9259265 Harris et al. Feb 2016 B2
9265567 Orban, III et al. Feb 2016 B2
9265926 Strobl et al. Feb 2016 B2
9265973 Akagane Feb 2016 B2
9266310 Krogdahl et al. Feb 2016 B2
9277962 Koss et al. Mar 2016 B2
9282974 Shelton, IV Mar 2016 B2
9283027 Monson et al. Mar 2016 B2
9283045 Rhee et al. Mar 2016 B2
9283054 Morgan et al. Mar 2016 B2
9289256 Shelton, IV et al. Mar 2016 B2
9295514 Shelton, IV et al. Mar 2016 B2
9301759 Spivey et al. Apr 2016 B2
9305497 Seo et al. Apr 2016 B2
9307388 Liang et al. Apr 2016 B2
9307986 Hall et al. Apr 2016 B2
9308009 Madan et al. Apr 2016 B2
9308014 Fischer Apr 2016 B2
9314261 Bales, Jr. et al. Apr 2016 B2
9314292 Trees et al. Apr 2016 B2
9314301 Ben-Haim et al. Apr 2016 B2
9326754 Polster May 2016 B2
9326767 Koch et al. May 2016 B2
9326787 Sanai et al. May 2016 B2
9326788 Batross et al. May 2016 B2
9332987 Leimbach et al. May 2016 B2
9333025 Monson et al. May 2016 B2
9333034 Hancock May 2016 B2
9339289 Robertson May 2016 B2
9339323 Eder et al. May 2016 B2
9339326 McCullagh et al. May 2016 B2
9345481 Hall et al. May 2016 B2
9345534 Artale et al. May 2016 B2
9345900 Wu et al. May 2016 B2
9351642 Nadkarni et al. May 2016 B2
9351726 Leimbach et al. May 2016 B2
9351727 Leimbach et al. May 2016 B2
9351754 Vakharia et al. May 2016 B2
9352173 Yamada et al. May 2016 B2
9358003 Hall et al. Jun 2016 B2
9358065 Ladtkow et al. Jun 2016 B2
9364171 Harris et al. Jun 2016 B2
9364230 Shelton, IV et al. Jun 2016 B2
9364279 Houser et al. Jun 2016 B2
9370364 Smith et al. Jun 2016 B2
9370400 Parihar Jun 2016 B2
9370611 Ross et al. Jun 2016 B2
9375206 Vidal et al. Jun 2016 B2
9375230 Ross et al. Jun 2016 B2
9375232 Hunt et al. Jun 2016 B2
9375256 Cunningham et al. Jun 2016 B2
9375264 Horner et al. Jun 2016 B2
9375267 Kerr et al. Jun 2016 B2
9385831 Marr et al. Jul 2016 B2
9386983 Swensgard et al. Jul 2016 B2
9393037 Olson et al. Jul 2016 B2
9393070 Gelfand et al. Jul 2016 B2
9398911 Auld Jul 2016 B2
9402680 Ginnebaugh et al. Aug 2016 B2
9402682 Worrell et al. Aug 2016 B2
9408606 Shelton, IV Aug 2016 B2
9408622 Stulen et al. Aug 2016 B2
9408660 Strobl et al. Aug 2016 B2
9414853 Stulen et al. Aug 2016 B2
9414880 Monson et al. Aug 2016 B2
9421014 Ingmanson et al. Aug 2016 B2
9421060 Monson et al. Aug 2016 B2
9427249 Robertson et al. Aug 2016 B2
9427279 Muniz-Medina et al. Aug 2016 B2
9439668 Timm et al. Sep 2016 B2
9439669 Wiener et al. Sep 2016 B2
9439671 Akagane Sep 2016 B2
9442288 Tanimura Sep 2016 B2
9445784 O'Keeffe Sep 2016 B2
9445832 Wiener et al. Sep 2016 B2
9451967 Jordan et al. Sep 2016 B2
9456863 Moua Oct 2016 B2
9456864 Witt et al. Oct 2016 B2
9468438 Baber et al. Oct 2016 B2
9468498 Sigmon, Jr. Oct 2016 B2
9474542 Slipszenko et al. Oct 2016 B2
9474568 Akagane Oct 2016 B2
9486236 Price et al. Nov 2016 B2
9492146 Kostrzewski et al. Nov 2016 B2
9492224 Boudreaux et al. Nov 2016 B2
9498245 Voegele et al. Nov 2016 B2
9498275 Wham et al. Nov 2016 B2
9504483 Houser et al. Nov 2016 B2
9504520 Worrell et al. Nov 2016 B2
9504524 Behnke, II Nov 2016 B2
9504855 Messerly et al. Nov 2016 B2
9510850 Robertson et al. Dec 2016 B2
9510906 Boudreaux et al. Dec 2016 B2
9522029 Yates et al. Dec 2016 B2
9522032 Behnke Dec 2016 B2
9526564 Rusin Dec 2016 B2
9526565 Strobl Dec 2016 B2
9545253 Worrell et al. Jan 2017 B2
9545497 Wenderow et al. Jan 2017 B2
9554465 Liu et al. Jan 2017 B1
9554794 Baber et al. Jan 2017 B2
9554846 Boudreaux Jan 2017 B2
9554854 Yates et al. Jan 2017 B2
9560995 Addison et al. Feb 2017 B2
9561038 Shelton, IV et al. Feb 2017 B2
9572592 Price et al. Feb 2017 B2
9574644 Parihar Feb 2017 B2
9585714 Livneh Mar 2017 B2
9592056 Mozdzierz et al. Mar 2017 B2
9592072 Akagane Mar 2017 B2
9597143 Madan et al. Mar 2017 B2
9603669 Govari et al. Mar 2017 B2
9610091 Johnson et al. Apr 2017 B2
9610114 Baxter, III et al. Apr 2017 B2
9615877 Tyrrell et al. Apr 2017 B2
9623237 Turner et al. Apr 2017 B2
9629623 Lytle, IV et al. Apr 2017 B2
9629629 Leimbach et al. Apr 2017 B2
9632573 Ogawa et al. Apr 2017 B2
9636135 Stulen May 2017 B2
9636165 Larson et al. May 2017 B2
9636167 Gregg May 2017 B2
9638770 Dietz et al. May 2017 B2
9642644 Houser et al. May 2017 B2
9642669 Takashino et al. May 2017 B2
9643052 Tchao et al. May 2017 B2
9649110 Parihar et al. May 2017 B2
9649111 Shelton, IV et al. May 2017 B2
9649126 Robertson et al. May 2017 B2
9649173 Choi et al. May 2017 B2
9655670 Larson et al. May 2017 B2
9662131 Omori et al. May 2017 B2
9668806 Unger et al. Jun 2017 B2
9671860 Ogawa et al. Jun 2017 B2
9674949 Liu et al. Jun 2017 B1
9675374 Stulen et al. Jun 2017 B2
9675375 Houser et al. Jun 2017 B2
9681884 Clem et al. Jun 2017 B2
9687230 Leimbach et al. Jun 2017 B2
9687290 Keller Jun 2017 B2
9690362 Leimbach et al. Jun 2017 B2
9693817 Mehta et al. Jul 2017 B2
9700309 Jaworek et al. Jul 2017 B2
9700339 Nield Jul 2017 B2
9700343 Messerly et al. Jul 2017 B2
9705456 Gilbert Jul 2017 B2
9707004 Houser et al. Jul 2017 B2
9707027 Ruddenklau et al. Jul 2017 B2
9707030 Davison et al. Jul 2017 B2
9713507 Stulen et al. Jul 2017 B2
9717548 Couture Aug 2017 B2
9717552 Cosman et al. Aug 2017 B2
9724094 Baber et al. Aug 2017 B2
9724118 Schulte et al. Aug 2017 B2
9724120 Faller et al. Aug 2017 B2
9724152 Horlle et al. Aug 2017 B2
9730695 Leimbach et al. Aug 2017 B2
9733663 Leimbach et al. Aug 2017 B2
9737301 Baber et al. Aug 2017 B2
9737326 Worrell et al. Aug 2017 B2
9737355 Yates et al. Aug 2017 B2
9737358 Beckman et al. Aug 2017 B2
9743929 Leimbach et al. Aug 2017 B2
9743946 Faller et al. Aug 2017 B2
9743947 Price et al. Aug 2017 B2
9750499 Leimbach et al. Sep 2017 B2
9757142 Shimizu Sep 2017 B2
9757150 Alexander et al. Sep 2017 B2
9757186 Boudreaux et al. Sep 2017 B2
9764164 Wiener et al. Sep 2017 B2
9770285 Zoran et al. Sep 2017 B2
9782169 Kimsey et al. Oct 2017 B2
9782214 Houser et al. Oct 2017 B2
9788836 Overmyer et al. Oct 2017 B2
9788851 Dannaher et al. Oct 2017 B2
9795405 Price et al. Oct 2017 B2
9795436 Yates et al. Oct 2017 B2
9795808 Messerly et al. Oct 2017 B2
9801626 Parihar et al. Oct 2017 B2
9801648 Houser et al. Oct 2017 B2
9802033 Hibner et al. Oct 2017 B2
9804618 Leimbach et al. Oct 2017 B2
9808244 Leimbach et al. Nov 2017 B2
9808246 Shelton, IV et al. Nov 2017 B2
9808308 Faller et al. Nov 2017 B2
9814460 Kimsey et al. Nov 2017 B2
9814514 Shelton, IV et al. Nov 2017 B2
9815211 Cao et al. Nov 2017 B2
9820738 Lytle, IV et al. Nov 2017 B2
9820768 Gee et al. Nov 2017 B2
9820771 Norton et al. Nov 2017 B2
9820806 Lee et al. Nov 2017 B2
9826976 Parihar et al. Nov 2017 B2
9839443 Brockman et al. Dec 2017 B2
9844368 Boudreaux et al. Dec 2017 B2
9844374 Lytle, IV et al. Dec 2017 B2
9844375 Overmyer et al. Dec 2017 B2
9848901 Robertson et al. Dec 2017 B2
9848902 Price et al. Dec 2017 B2
9848937 Trees et al. Dec 2017 B2
9861381 Johnson Jan 2018 B2
9861428 Trees et al. Jan 2018 B2
9867612 Parihar et al. Jan 2018 B2
9867651 Wham Jan 2018 B2
9867670 Brannan et al. Jan 2018 B2
9872722 Lech Jan 2018 B2
9872725 Worrell et al. Jan 2018 B2
9872726 Morisaki Jan 2018 B2
9877720 Worrell et al. Jan 2018 B2
9877776 Boudreaux Jan 2018 B2
9877782 Voegele et al. Jan 2018 B2
9878184 Beaupre Jan 2018 B2
9883860 Leimbach Feb 2018 B2
9883884 Neurohr et al. Feb 2018 B2
9888919 Leimbach et al. Feb 2018 B2
9888958 Evans et al. Feb 2018 B2
9895148 Shelton, IV et al. Feb 2018 B2
9895160 Fan et al. Feb 2018 B2
9901321 Harks et al. Feb 2018 B2
9901342 Shelton, IV et al. Feb 2018 B2
9901383 Hassler, Jr. Feb 2018 B2
9901754 Yamada Feb 2018 B2
9907563 Germain et al. Mar 2018 B2
9913642 Leimbach et al. Mar 2018 B2
9913656 Stulen Mar 2018 B2
9913680 Voegele et al. Mar 2018 B2
9918730 Trees et al. Mar 2018 B2
9924961 Shelton, IV et al. Mar 2018 B2
9925003 Parihar et al. Mar 2018 B2
9931118 Shelton, IV et al. Apr 2018 B2
9937001 Nakamura Apr 2018 B2
9943309 Shelton, IV et al. Apr 2018 B2
9949785 Price et al. Apr 2018 B2
9949788 Boudreaux Apr 2018 B2
9962182 Dietz et al. May 2018 B2
9968355 Shelton, IV et al. May 2018 B2
9974539 Yates et al. May 2018 B2
9987000 Shelton, IV et al. Jun 2018 B2
9987033 Neurohr et al. Jun 2018 B2
9993248 Shelton, IV et al. Jun 2018 B2
9993258 Shelton, IV et al. Jun 2018 B2
9993289 Sobajima et al. Jun 2018 B2
10004497 Overmyer et al. Jun 2018 B2
10004501 Shelton, IV et al. Jun 2018 B2
10004526 Dycus et al. Jun 2018 B2
10004527 Gee et al. Jun 2018 B2
D822206 Shelton, IV et al. Jul 2018 S
10010339 Witt et al. Jul 2018 B2
10010341 Houser et al. Jul 2018 B2
10013049 Leimbach et al. Jul 2018 B2
10016199 Baber et al. Jul 2018 B2
10016207 Suzuki et al. Jul 2018 B2
10022142 Aranyi et al. Jul 2018 B2
10022567 Messerly et al. Jul 2018 B2
10022568 Messerly et al. Jul 2018 B2
10028761 Leimbach et al. Jul 2018 B2
10028786 Mucilli et al. Jul 2018 B2
10034684 Weisenburgh, II et al. Jul 2018 B2
10034704 Asher et al. Jul 2018 B2
D826405 Shelton, IV et al. Aug 2018 S
10039588 Harper et al. Aug 2018 B2
10041822 Zemlok Aug 2018 B2
10045776 Shelton, IV et al. Aug 2018 B2
10045779 Savage et al. Aug 2018 B2
10045794 Witt et al. Aug 2018 B2
10045810 Schall et al. Aug 2018 B2
10045819 Jensen et al. Aug 2018 B2
10052044 Shelton, IV et al. Aug 2018 B2
10052102 Baxter, III et al. Aug 2018 B2
10070916 Artale Sep 2018 B2
10080609 Hancock et al. Sep 2018 B2
10085748 Morgan et al. Oct 2018 B2
10085762 Timm et al. Oct 2018 B2
10085792 Johnson et al. Oct 2018 B2
10092310 Boudreaux et al. Oct 2018 B2
10092344 Mohr et al. Oct 2018 B2
10092347 Weisshaupt et al. Oct 2018 B2
10092348 Boudreaux Oct 2018 B2
10092350 Rothweiler et al. Oct 2018 B2
10105140 Malinouskas et al. Oct 2018 B2
10111679 Baber et al. Oct 2018 B2
10111699 Boudreaux Oct 2018 B2
10111703 Cosman, Jr. et al. Oct 2018 B2
10117649 Baxter et al. Nov 2018 B2
10117667 Robertson et al. Nov 2018 B2
10117702 Danziger et al. Nov 2018 B2
10123835 Keller et al. Nov 2018 B2
10130367 Cappola et al. Nov 2018 B2
10130410 Strobl et al. Nov 2018 B2
10130412 Wham Nov 2018 B2
10135242 Baber et al. Nov 2018 B2
10136887 Shelton, IV et al. Nov 2018 B2
10149680 Parihar et al. Dec 2018 B2
10154848 Chernov et al. Dec 2018 B2
10154852 Conlon et al. Dec 2018 B2
10159483 Beckman et al. Dec 2018 B2
10159524 Yates et al. Dec 2018 B2
10166060 Johnson et al. Jan 2019 B2
10172665 Heckel et al. Jan 2019 B2
10172669 Felder et al. Jan 2019 B2
10178992 Wise et al. Jan 2019 B2
10179022 Yates et al. Jan 2019 B2
10180463 Beckman et al. Jan 2019 B2
10182816 Shelton, IV et al. Jan 2019 B2
10182818 Hensel et al. Jan 2019 B2
10188385 Kerr et al. Jan 2019 B2
10188455 Hancock et al. Jan 2019 B2
10194907 Marczyk et al. Feb 2019 B2
10194972 Yates et al. Feb 2019 B2
10194973 Wiener et al. Feb 2019 B2
10194976 Boudreaux Feb 2019 B2
10194977 Yang Feb 2019 B2
10194999 Bacher et al. Feb 2019 B2
10201364 Leimbach et al. Feb 2019 B2
10201365 Boudreaux et al. Feb 2019 B2
10201382 Wiener et al. Feb 2019 B2
10206676 Shelton, IV Feb 2019 B2
10226250 Beckman et al. Mar 2019 B2
10226273 Messerly et al. Mar 2019 B2
10231747 Stulen et al. Mar 2019 B2
10238385 Yates et al. Mar 2019 B2
10238391 Leimbach et al. Mar 2019 B2
10245027 Shelton, IV et al. Apr 2019 B2
10245028 Shelton, IV et al. Apr 2019 B2
10245029 Hunter et al. Apr 2019 B2
10245030 Hunter et al. Apr 2019 B2
10245033 Overmyer et al. Apr 2019 B2
10245095 Boudreaux Apr 2019 B2
10245097 Honda et al. Apr 2019 B2
10245104 McKenna et al. Apr 2019 B2
10251664 Shelton, IV et al. Apr 2019 B2
10258331 Shelton, IV et al. Apr 2019 B2
10258505 Ovchinnikov Apr 2019 B2
10263171 Wiener et al. Apr 2019 B2
10265068 Harris et al. Apr 2019 B2
10265117 Wiener et al. Apr 2019 B2
10265118 Gerhardt Apr 2019 B2
10271840 Sapre Apr 2019 B2
10271851 Shelton, IV et al. Apr 2019 B2
D847989 Shelton, IV et al. May 2019 S
10278721 Dietz et al. May 2019 B2
10285705 Shelton, IV et al. May 2019 B2
10285724 Faller et al. May 2019 B2
10285750 Coulson et al. May 2019 B2
10292704 Harris et al. May 2019 B2
10299810 Robertson et al. May 2019 B2
10299821 Shelton, IV et al. May 2019 B2
D850617 Shelton, IV et al. Jun 2019 S
D851762 Shelton, IV et al. Jun 2019 S
10307159 Harris et al. Jun 2019 B2
10314579 Chowaniec et al. Jun 2019 B2
10314582 Shelton, IV et al. Jun 2019 B2
10314638 Gee et al. Jun 2019 B2
10321907 Shelton, IV et al. Jun 2019 B2
10321950 Yates et al. Jun 2019 B2
D854151 Shelton, IV et al. Jul 2019 S
10335149 Baxter, III et al. Jul 2019 B2
10335182 Stulen et al. Jul 2019 B2
10335183 Worrell et al. Jul 2019 B2
10335614 Messerly et al. Jul 2019 B2
10342543 Shelton, IV et al. Jul 2019 B2
10342602 Strobl et al. Jul 2019 B2
10342606 Cosman et al. Jul 2019 B2
10342623 Huelman et al. Jul 2019 B2
10348941 Elliot, Jr. et al. Jul 2019 B2
10349999 Yates et al. Jul 2019 B2
10350016 Burbank et al. Jul 2019 B2
10350025 Loyd et al. Jul 2019 B1
10357246 Shelton, IV et al. Jul 2019 B2
10357247 Shelton, IV et al. Jul 2019 B2
10357303 Conlon et al. Jul 2019 B2
10363084 Friedrichs Jul 2019 B2
10368861 Baxter, III et al. Aug 2019 B2
10368865 Harris et al. Aug 2019 B2
10376263 Morgan et al. Aug 2019 B2
10376305 Yates et al. Aug 2019 B2
10390841 Shelton, IV et al. Aug 2019 B2
10398439 Cabrera et al. Sep 2019 B2
10398466 Stulen et al. Sep 2019 B2
10398497 Batross et al. Sep 2019 B2
10405857 Shelton, IV et al. Sep 2019 B2
10405863 Wise et al. Sep 2019 B2
10413291 Worthington et al. Sep 2019 B2
10413293 Shelton, IV et al. Sep 2019 B2
10413297 Harris et al. Sep 2019 B2
10413352 Thomas et al. Sep 2019 B2
10413353 Kerr et al. Sep 2019 B2
10420552 Shelton, IV et al. Sep 2019 B2
10420579 Wiener et al. Sep 2019 B2
10420607 Woloszko et al. Sep 2019 B2
D865175 Widenhouse et al. Oct 2019 S
10426471 Shelton, IV et al. Oct 2019 B2
10426507 Wiener et al. Oct 2019 B2
10426546 Graham et al. Oct 2019 B2
10426978 Akagane Oct 2019 B2
10433837 Worthington et al. Oct 2019 B2
10433849 Shelton, IV et al. Oct 2019 B2
10433865 Witt et al. Oct 2019 B2
10433866 Witt et al. Oct 2019 B2
10433900 Harris et al. Oct 2019 B2
10441279 Shelton, IV et al. Oct 2019 B2
10441308 Robertson Oct 2019 B2
10441310 Olson et al. Oct 2019 B2
10441345 Aldridge et al. Oct 2019 B2
10448948 Shelton, IV et al. Oct 2019 B2
10448950 Shelton, IV et al. Oct 2019 B2
10448986 Zikorus et al. Oct 2019 B2
10456140 Shelton, IV et al. Oct 2019 B2
10456193 Yates et al. Oct 2019 B2
10463421 Boudreaux et al. Nov 2019 B2
10463887 Witt et al. Nov 2019 B2
10470762 Leimbach et al. Nov 2019 B2
10470764 Baxter, III et al. Nov 2019 B2
10478182 Taylor Nov 2019 B2
10478190 Miller et al. Nov 2019 B2
10485542 Shelton, IV et al. Nov 2019 B2
10485543 Shelton, IV et al. Nov 2019 B2
10485607 Strobl et al. Nov 2019 B2
D869655 Shelton, IV et al. Dec 2019 S
10492785 Overmyer et al. Dec 2019 B2
10492849 Juergens et al. Dec 2019 B2
10499914 Huang et al. Dec 2019 B2
10507033 Dickerson et al. Dec 2019 B2
10512795 Voegele et al. Dec 2019 B2
10517595 Hunter et al. Dec 2019 B2
10517596 Hunter et al. Dec 2019 B2
10517627 Timm et al. Dec 2019 B2
10524787 Shelton, IV et al. Jan 2020 B2
10524789 Swayze et al. Jan 2020 B2
10524854 Woodruff et al. Jan 2020 B2
10524872 Stewart et al. Jan 2020 B2
10531874 Morgan et al. Jan 2020 B2
10537324 Shelton, IV et al. Jan 2020 B2
10537325 Bakos et al. Jan 2020 B2
10537351 Shelton, IV et al. Jan 2020 B2
10542979 Shelton, IV et al. Jan 2020 B2
10542982 Beckman et al. Jan 2020 B2
10542991 Shelton, IV et al. Jan 2020 B2
10543008 Vakharia et al. Jan 2020 B2
10548504 Shelton, IV et al. Feb 2020 B2
10548655 Scheib et al. Feb 2020 B2
10555769 Worrell et al. Feb 2020 B2
10561560 Boutoussov et al. Feb 2020 B2
10568624 Shelton, IV et al. Feb 2020 B2
10568625 Harris et al. Feb 2020 B2
10568626 Shelton, IV et al. Feb 2020 B2
10568632 Miller et al. Feb 2020 B2
10575892 Danziger et al. Mar 2020 B2
10582928 Hunter et al. Mar 2020 B2
10588625 Weaner et al. Mar 2020 B2
10588630 Shelton, IV et al. Mar 2020 B2
10588631 Shelton, IV et al. Mar 2020 B2
10588632 Shelton, IV et al. Mar 2020 B2
10588633 Shelton, IV et al. Mar 2020 B2
10595929 Boudreaux et al. Mar 2020 B2
10595930 Scheib et al. Mar 2020 B2
10603036 Hunter et al. Mar 2020 B2
10610224 Shelton, IV et al. Apr 2020 B2
10610286 Wiener et al. Apr 2020 B2
10610313 Bailey et al. Apr 2020 B2
10617412 Shelton, IV et al. Apr 2020 B2
10617420 Shelton, IV et al. Apr 2020 B2
10617464 Duppuis Apr 2020 B2
10624635 Harris et al. Apr 2020 B2
10624691 Wiener et al. Apr 2020 B2
10631858 Burbank Apr 2020 B2
10631859 Shelton, IV et al. Apr 2020 B2
10631928 Basu et al. Apr 2020 B2
10632630 Cao et al. Apr 2020 B2
RE47996 Turner et al. May 2020 E
10639034 Harris et al. May 2020 B2
10639035 Shelton, IV et al. May 2020 B2
10639037 Shelton, IV et al. May 2020 B2
10639092 Corbett et al. May 2020 B2
10639098 Cosman et al. May 2020 B2
10646269 Worrell et al. May 2020 B2
10646292 Solomon et al. May 2020 B2
10653413 Worthington et al. May 2020 B2
10660692 Lesko et al. May 2020 B2
10667809 Bakos et al. Jun 2020 B2
10667810 Shelton, IV et al. Jun 2020 B2
10667811 Harris et al. Jun 2020 B2
10675021 Harris et al. Jun 2020 B2
10675024 Shelton, IV et al. Jun 2020 B2
10675025 Swayze et al. Jun 2020 B2
10675026 Harris et al. Jun 2020 B2
10677764 Ross et al. Jun 2020 B2
10682136 Harris et al. Jun 2020 B2
10682138 Shelton, IV et al. Jun 2020 B2
10687806 Shelton, IV et al. Jun 2020 B2
10687809 Shelton, IV et al. Jun 2020 B2
10687810 Shelton, IV et al. Jun 2020 B2
10687884 Wiener et al. Jun 2020 B2
10688321 Wiener et al. Jun 2020 B2
10695055 Shelton, IV et al. Jun 2020 B2
10695057 Shelton, IV et al. Jun 2020 B2
10695058 Lytle, IV et al. Jun 2020 B2
10695119 Smith Jun 2020 B2
10702270 Shelton, IV et al. Jul 2020 B2
10702329 Strobl et al. Jul 2020 B2
10709446 Harris et al. Jul 2020 B2
10709469 Shelton, IV et al. Jul 2020 B2
10709906 Nield Jul 2020 B2
10716615 Shelton, IV et al. Jul 2020 B2
10722233 Wellman Jul 2020 B2
D893717 Messerly et al. Aug 2020 S
10729458 Stoddard et al. Aug 2020 B2
10729494 Parihar et al. Aug 2020 B2
10736629 Shelton, IV et al. Aug 2020 B2
10736685 Wiener et al. Aug 2020 B2
10751108 Yates et al. Aug 2020 B2
10751138 Giordano et al. Aug 2020 B2
10758229 Shelton, IV et al. Sep 2020 B2
10758230 Shelton, IV et al. Sep 2020 B2
10758232 Shelton, IV et al. Sep 2020 B2
10758294 Jones Sep 2020 B2
10765427 Shelton, IV et al. Sep 2020 B2
10765470 Yates et al. Sep 2020 B2
10772629 Shelton, IV et al. Sep 2020 B2
10772630 Wixey Sep 2020 B2
10779821 Harris et al. Sep 2020 B2
10779823 Shelton, IV et al. Sep 2020 B2
10779824 Shelton, IV et al. Sep 2020 B2
10779825 Shelton, IV et al. Sep 2020 B2
10779845 Timm et al. Sep 2020 B2
10779849 Shelton, IV et al. Sep 2020 B2
10779879 Yates et al. Sep 2020 B2
10786253 Shelton, IV et al. Sep 2020 B2
10786276 Hirai et al. Sep 2020 B2
10806454 Kopp Oct 2020 B2
10813638 Shelton, IV et al. Oct 2020 B2
10820938 Fischer et al. Nov 2020 B2
10828058 Shelton, IV et al. Nov 2020 B2
10835245 Swayze et al. Nov 2020 B2
10835246 Shelton, IV et al. Nov 2020 B2
10835247 Shelton, IV et al. Nov 2020 B2
10835307 Shelton, IV et al. Nov 2020 B2
10842492 Shelton, IV et al. Nov 2020 B2
10842523 Shelton, IV et al. Nov 2020 B2
10842563 Gilbert et al. Nov 2020 B2
D906355 Messerly et al. Dec 2020 S
10856867 Shelton, IV et al. Dec 2020 B2
10856868 Shelton, IV et al. Dec 2020 B2
10856869 Shelton, IV et al. Dec 2020 B2
10856870 Harris et al. Dec 2020 B2
10856896 Eichmann et al. Dec 2020 B2
10856929 Yates et al. Dec 2020 B2
10856934 Trees et al. Dec 2020 B2
10874465 Weir et al. Dec 2020 B2
D908216 Messerly et al. Jan 2021 S
10881399 Shelton, IV et al. Jan 2021 B2
10881401 Baber et al. Jan 2021 B2
10881409 Cabrera Jan 2021 B2
10881449 Boudreaux et al. Jan 2021 B2
10888322 Morgan et al. Jan 2021 B2
10888347 Witt et al. Jan 2021 B2
10893863 Shelton, IV et al. Jan 2021 B2
10893864 Harris et al. Jan 2021 B2
10893883 Dannaher Jan 2021 B2
10898186 Bakos et al. Jan 2021 B2
10898256 Yates et al. Jan 2021 B2
10912559 Harris et al. Feb 2021 B2
10912580 Green et al. Feb 2021 B2
10912603 Boudreaux et al. Feb 2021 B2
10918385 Overmyer et al. Feb 2021 B2
10925659 Shelton, IV et al. Feb 2021 B2
D914878 Shelton, IV et al. Mar 2021 S
10932766 Tesar et al. Mar 2021 B2
10932847 Yates et al. Mar 2021 B2
10945727 Shelton, IV et al. Mar 2021 B2
10952788 Asher et al. Mar 2021 B2
10959727 Hunter et al. Mar 2021 B2
10966741 Illizaliturri-Sanchez et al. Apr 2021 B2
10966747 Worrell et al. Apr 2021 B2
10973516 Shelton, IV et al. Apr 2021 B2
10973517 Wixey Apr 2021 B2
10973520 Shelton, IV et al. Apr 2021 B2
10980536 Weaner et al. Apr 2021 B2
10987105 Cappola et al. Apr 2021 B2
10987123 Weir et al. Apr 2021 B2
10987156 Trees et al. Apr 2021 B2
10993715 Shelton, IV et al. May 2021 B2
10993716 Shelton, IV et al. May 2021 B2
10993763 Batross et al. May 2021 B2
11000278 Shelton, IV et al. May 2021 B2
11000279 Shelton, IV et al. May 2021 B2
11020114 Shelton, IV et al. Jun 2021 B2
11020140 Gee et al. Jun 2021 B2
11033322 Wiener et al. Jun 2021 B2
11039834 Harris et al. Jun 2021 B2
11045191 Shelton, IV et al. Jun 2021 B2
11045192 Harris et al. Jun 2021 B2
11045275 Boudreaux et al. Jun 2021 B2
11051840 Shelton, IV et al. Jul 2021 B2
11051873 Wiener et al. Jul 2021 B2
11058424 Shelton, IV et al. Jul 2021 B2
11058447 Houser Jul 2021 B2
11058448 Shelton, IV et al. Jul 2021 B2
11058475 Wiener et al. Jul 2021 B2
11064997 Shelton, IV et al. Jul 2021 B2
11065048 Messerly et al. Jul 2021 B2
11083455 Shelton, IV et al. Aug 2021 B2
11083458 Harris et al. Aug 2021 B2
11090048 Fanelli et al. Aug 2021 B2
11090049 Bakos et al. Aug 2021 B2
11090104 Wiener et al. Aug 2021 B2
11096688 Shelton, IV et al. Aug 2021 B2
11096752 Stulen et al. Aug 2021 B2
11109866 Shelton, IV et al. Sep 2021 B2
11129611 Shelton, IV et al. Sep 2021 B2
11129666 Messerly et al. Sep 2021 B2
11129669 Stulen et al. Sep 2021 B2
11129670 Shelton, IV et al. Sep 2021 B2
11134942 Harris et al. Oct 2021 B2
11134978 Shelton, IV et al. Oct 2021 B2
11141154 Shelton, IV et al. Oct 2021 B2
11141213 Yates et al. Oct 2021 B2
11147551 Shelton, IV Oct 2021 B2
11147553 Shelton, IV Oct 2021 B2
11160551 Shelton, IV et al. Nov 2021 B2
11166716 Shelton, IV et al. Nov 2021 B2
11172929 Shelton, IV Nov 2021 B2
11179155 Shelton, IV et al. Nov 2021 B2
11191539 Overmyer et al. Dec 2021 B2
11191540 Aronhalt et al. Dec 2021 B2
11197668 Shelton, IV et al. Dec 2021 B2
11202670 Worrell et al. Dec 2021 B2
11207065 Harris et al. Dec 2021 B2
11207067 Shelton, IV et al. Dec 2021 B2
11213293 Worthington et al. Jan 2022 B2
11213294 Shelton, IV et al. Jan 2022 B2
11219453 Shelton, IV et al. Jan 2022 B2
11224426 Shelton, IV et al. Jan 2022 B2
11224497 Shelton, IV et al. Jan 2022 B2
11229437 Shelton, IV et al. Jan 2022 B2
11229450 Shelton, IV et al. Jan 2022 B2
11229471 Shelton, IV et al. Jan 2022 B2
11229472 Shelton, IV et al. Jan 2022 B2
11234698 Shelton, IV et al. Feb 2022 B2
11241235 Shelton, IV et al. Feb 2022 B2
11246592 Shelton, IV et al. Feb 2022 B2
11246625 Kane et al. Feb 2022 B2
11246678 Shelton, IV et al. Feb 2022 B2
11253256 Harris et al. Feb 2022 B2
11259803 Shelton, IV et al. Mar 2022 B2
11259805 Shelton, IV et al. Mar 2022 B2
11259806 Shelton, IV et al. Mar 2022 B2
11259807 Shelton, IV et al. Mar 2022 B2
11266405 Shelton, IV et al. Mar 2022 B2
11266430 Clauda et al. Mar 2022 B2
11272931 Boudreaux et al. Mar 2022 B2
11278280 Shelton, IV et al. Mar 2022 B2
11284890 Nalagatla et al. Mar 2022 B2
11291440 Harris et al. Apr 2022 B2
11291444 Boudreaux et al. Apr 2022 B2
11291445 Shelton, IV et al. Apr 2022 B2
11291447 Shelton, IV et al. Apr 2022 B2
11291451 Shelton, IV Apr 2022 B2
11298127 Shelton, IV Apr 2022 B2
11298129 Bakos et al. Apr 2022 B2
11298130 Bakos et al. Apr 2022 B2
11304695 Shelton, IV et al. Apr 2022 B2
11304696 Shelton, IV et al. Apr 2022 B2
11311306 Shelton, IV et al. Apr 2022 B2
11311342 Parihar et al. Apr 2022 B2
D950728 Bakos et al. May 2022 S
D952144 Boudreaux May 2022 S
11317915 Boudreaux et al. May 2022 B2
11324503 Shelton, IV et al. May 2022 B2
11324557 Shelton, IV et al. May 2022 B2
11331100 Boudreaux et al. May 2022 B2
11331101 Harris et al. May 2022 B2
11350938 Shelton, IV et al. Jun 2022 B2
11357503 Bakos et al. Jun 2022 B2
11361176 Shelton, IV et al. Jun 2022 B2
11369377 Boudreaux et al. Jun 2022 B2
11376098 Shelton, IV et al. Jul 2022 B2
D964564 Boudreaux Sep 2022 S
11653920 Shelton, IV et al. May 2023 B2
20010025173 Ritchie et al. Sep 2001 A1
20010025183 Shahidi Sep 2001 A1
20010025184 Messerly Sep 2001 A1
20010031950 Ryan Oct 2001 A1
20010039419 Francischelli et al. Nov 2001 A1
20020002377 Cimino Jan 2002 A1
20020002380 Bishop Jan 2002 A1
20020019649 Sikora et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020029036 Goble et al. Mar 2002 A1
20020029055 Bonutti Mar 2002 A1
20020032452 Tierney et al. Mar 2002 A1
20020049551 Friedman et al. Apr 2002 A1
20020052617 Anis et al. May 2002 A1
20020077550 Rabiner et al. Jun 2002 A1
20020107517 Witt et al. Aug 2002 A1
20020123749 Jain Sep 2002 A1
20020133152 Strul Sep 2002 A1
20020151884 Hoey et al. Oct 2002 A1
20020156466 Sakurai et al. Oct 2002 A1
20020156493 Houser et al. Oct 2002 A1
20020165577 Witt et al. Nov 2002 A1
20020177373 Shibata et al. Nov 2002 A1
20020177862 Aranyi et al. Nov 2002 A1
20030009164 Woloszko et al. Jan 2003 A1
20030014053 Nguyen et al. Jan 2003 A1
20030014087 Fang et al. Jan 2003 A1
20030036705 Hare et al. Feb 2003 A1
20030040758 Wang et al. Feb 2003 A1
20030050572 Brautigam et al. Mar 2003 A1
20030055443 Spotnitz Mar 2003 A1
20030073981 Whitman et al. Apr 2003 A1
20030109778 Rashidi Jun 2003 A1
20030109875 Tetzlaff et al. Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030130693 Levin et al. Jul 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030144680 Kellogg et al. Jul 2003 A1
20030158548 Phan et al. Aug 2003 A1
20030171747 Kanehira et al. Sep 2003 A1
20030176778 Messing et al. Sep 2003 A1
20030181898 Bowers Sep 2003 A1
20030199794 Sakurai et al. Oct 2003 A1
20030204199 Novak et al. Oct 2003 A1
20030208186 Moreyra Nov 2003 A1
20030212332 Fenton et al. Nov 2003 A1
20030212363 Shipp Nov 2003 A1
20030212392 Fenton et al. Nov 2003 A1
20030212422 Fenton et al. Nov 2003 A1
20030225332 Okada et al. Dec 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20040030254 Babaev Feb 2004 A1
20040030330 Brassell et al. Feb 2004 A1
20040047485 Sherrit et al. Mar 2004 A1
20040054364 Aranyi et al. Mar 2004 A1
20040064151 Mollenauer Apr 2004 A1
20040087943 Dycus et al. May 2004 A1
20040092921 Kadziauskas et al. May 2004 A1
20040092992 Adams et al. May 2004 A1
20040094597 Whitman et al. May 2004 A1
20040097911 Murakami et al. May 2004 A1
20040097912 Gonnering May 2004 A1
20040097919 Wellman et al. May 2004 A1
20040097996 Rabiner et al. May 2004 A1
20040116952 Sakurai et al. Jun 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040132383 Langford et al. Jul 2004 A1
20040138621 Jahns et al. Jul 2004 A1
20040142667 Lochhead et al. Jul 2004 A1
20040143263 Schechter et al. Jul 2004 A1
20040147934 Kiester Jul 2004 A1
20040147945 Fritzsch Jul 2004 A1
20040158237 Abboud et al. Aug 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040176686 Hare et al. Sep 2004 A1
20040176751 Weitzner et al. Sep 2004 A1
20040181242 Stack et al. Sep 2004 A1
20040193150 Sharkey et al. Sep 2004 A1
20040193153 Sartor et al. Sep 2004 A1
20040193212 Taniguchi et al. Sep 2004 A1
20040199193 Hayashi et al. Oct 2004 A1
20040215132 Yoon Oct 2004 A1
20040243147 Lipow Dec 2004 A1
20040249374 Tetzlaff et al. Dec 2004 A1
20040260273 Wan Dec 2004 A1
20040260300 Gorensek et al. Dec 2004 A1
20040267311 Viola et al. Dec 2004 A1
20050015125 Mioduski et al. Jan 2005 A1
20050020967 Ono Jan 2005 A1
20050021018 Anderson et al. Jan 2005 A1
20050021065 Yamada et al. Jan 2005 A1
20050021078 Vleugels et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050033337 Muir et al. Feb 2005 A1
20050070800 Takahashi Mar 2005 A1
20050080427 Govari et al. Apr 2005 A1
20050088285 Jei Apr 2005 A1
20050090817 Phan Apr 2005 A1
20050096683 Ellins et al. May 2005 A1
20050099824 Dowling et al. May 2005 A1
20050107777 West et al. May 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050143769 White et al. Jun 2005 A1
20050149108 Cox Jul 2005 A1
20050165429 Douglas et al. Jul 2005 A1
20050171522 Christopherson Aug 2005 A1
20050171533 Latterell et al. Aug 2005 A1
20050177184 Easley Aug 2005 A1
20050182339 Lee et al. Aug 2005 A1
20050187576 Whitman et al. Aug 2005 A1
20050188743 Land Sep 2005 A1
20050192610 Houser et al. Sep 2005 A1
20050192611 Houser Sep 2005 A1
20050206583 Lemelson et al. Sep 2005 A1
20050222598 Ho et al. Oct 2005 A1
20050234484 Houser et al. Oct 2005 A1
20050249667 Tuszynski et al. Nov 2005 A1
20050256405 Makin et al. Nov 2005 A1
20050261588 Makin et al. Nov 2005 A1
20050262175 Iino et al. Nov 2005 A1
20050267464 Truckai et al. Dec 2005 A1
20050271807 Iljima et al. Dec 2005 A1
20050273090 Nieman et al. Dec 2005 A1
20050288659 Kimura et al. Dec 2005 A1
20060025757 Heim Feb 2006 A1
20060030797 Zhou et al. Feb 2006 A1
20060030848 Craig et al. Feb 2006 A1
20060058825 Ogura et al. Mar 2006 A1
20060063130 Hayman et al. Mar 2006 A1
20060064086 Odom Mar 2006 A1
20060066181 Bromfield et al. Mar 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060079874 Faller et al. Apr 2006 A1
20060079879 Faller et al. Apr 2006 A1
20060095046 Trieu et al. May 2006 A1
20060109061 Dobson et al. May 2006 A1
20060142656 Malackowski et al. Jun 2006 A1
20060159731 Shoshan Jul 2006 A1
20060190034 Nishizawa et al. Aug 2006 A1
20060206100 Eskridge et al. Sep 2006 A1
20060206115 Schomer et al. Sep 2006 A1
20060211943 Beaupre Sep 2006 A1
20060217700 Garito et al. Sep 2006 A1
20060217729 Eskridge et al. Sep 2006 A1
20060224160 Trieu et al. Oct 2006 A1
20060247558 Yamada Nov 2006 A1
20060253050 Yoshimine et al. Nov 2006 A1
20060259026 Godara et al. Nov 2006 A1
20060259102 Slatkine Nov 2006 A1
20060264809 Hansmann et al. Nov 2006 A1
20060264995 Fanton et al. Nov 2006 A1
20060265035 Yachi et al. Nov 2006 A1
20060270916 Skwarek et al. Nov 2006 A1
20060271030 Francis et al. Nov 2006 A1
20060293656 Shadduck et al. Dec 2006 A1
20070016235 Tanaka et al. Jan 2007 A1
20070016236 Beaupre Jan 2007 A1
20070021738 Hasser et al. Jan 2007 A1
20070027468 Wales et al. Feb 2007 A1
20070032704 Gandini et al. Feb 2007 A1
20070055228 Berg et al. Mar 2007 A1
20070056596 Fanney et al. Mar 2007 A1
20070060935 Schwardt et al. Mar 2007 A1
20070063618 Bromfield Mar 2007 A1
20070066971 Podhajsky Mar 2007 A1
20070067123 Jungerman Mar 2007 A1
20070073185 Nakao Mar 2007 A1
20070073341 Smith et al. Mar 2007 A1
20070074584 Talarico et al. Apr 2007 A1
20070106317 Shelton et al. May 2007 A1
20070118115 Artale et al. May 2007 A1
20070129726 Eder et al. Jun 2007 A1
20070130771 Ehlert et al. Jun 2007 A1
20070135803 Belson Jun 2007 A1
20070149881 Rabin Jun 2007 A1
20070156163 Davison et al. Jul 2007 A1
20070166663 Telles et al. Jul 2007 A1
20070173803 Wham et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070173872 Neuenfeldt Jul 2007 A1
20070175955 Shelton et al. Aug 2007 A1
20070185474 Nahen Aug 2007 A1
20070191712 Messerly et al. Aug 2007 A1
20070191713 Eichmann et al. Aug 2007 A1
20070203483 Kim et al. Aug 2007 A1
20070208336 Kim et al. Sep 2007 A1
20070208340 Ganz et al. Sep 2007 A1
20070219481 Babaev Sep 2007 A1
20070232926 Stulen et al. Oct 2007 A1
20070232928 Wiener et al. Oct 2007 A1
20070236213 Paden et al. Oct 2007 A1
20070239101 Kellogg Oct 2007 A1
20070249941 Salehi et al. Oct 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070265560 Soltani et al. Nov 2007 A1
20070265613 Edelstein et al. Nov 2007 A1
20070265616 Couture et al. Nov 2007 A1
20070265620 Kraas et al. Nov 2007 A1
20070275348 Lemon Nov 2007 A1
20070287933 Phan et al. Dec 2007 A1
20070288055 Lee Dec 2007 A1
20070299895 Johnson et al. Dec 2007 A1
20080005213 Holtzman Jan 2008 A1
20080013809 Zhu et al. Jan 2008 A1
20080015473 Shimizu Jan 2008 A1
20080015575 Odom et al. Jan 2008 A1
20080033465 Schmitz et al. Feb 2008 A1
20080039746 Hissong et al. Feb 2008 A1
20080046122 Manzo et al. Feb 2008 A1
20080051812 Schmitz et al. Feb 2008 A1
20080058775 Darian et al. Mar 2008 A1
20080058845 Shimizu et al. Mar 2008 A1
20080071269 Hilario et al. Mar 2008 A1
20080077145 Boyden et al. Mar 2008 A1
20080082039 Babaev Apr 2008 A1
20080082098 Tanaka et al. Apr 2008 A1
20080097501 Blier Apr 2008 A1
20080114355 Whayne et al. May 2008 A1
20080114364 Goldin et al. May 2008 A1
20080122496 Wagner May 2008 A1
20080125768 Tahara et al. May 2008 A1
20080147058 Horrell et al. Jun 2008 A1
20080147062 Truckai et al. Jun 2008 A1
20080147092 Rogge et al. Jun 2008 A1
20080161809 Schmitz et al. Jul 2008 A1
20080167670 Shelton et al. Jul 2008 A1
20080171938 Masuda et al. Jul 2008 A1
20080177268 Daum et al. Jul 2008 A1
20080188755 Hart Aug 2008 A1
20080200940 Eichmann et al. Aug 2008 A1
20080208108 Kimura Aug 2008 A1
20080208231 Ota et al. Aug 2008 A1
20080214967 Aranyi et al. Sep 2008 A1
20080234709 Houser Sep 2008 A1
20080243162 Shibata et al. Oct 2008 A1
20080255413 Zemlok et al. Oct 2008 A1
20080275440 Kratoska et al. Nov 2008 A1
20080281200 Voic et al. Nov 2008 A1
20080281315 Gines Nov 2008 A1
20080287944 Pearson et al. Nov 2008 A1
20080287948 Newton et al. Nov 2008 A1
20080296346 Shelton, IV et al. Dec 2008 A1
20080300588 Groth et al. Dec 2008 A1
20090012516 Curtis et al. Jan 2009 A1
20090023985 Ewers Jan 2009 A1
20090036913 Wiener et al. Feb 2009 A1
20090043293 Pankratov et al. Feb 2009 A1
20090048537 Lydon et al. Feb 2009 A1
20090048589 Takashino et al. Feb 2009 A1
20090054886 Yachi et al. Feb 2009 A1
20090054889 Newton et al. Feb 2009 A1
20090054894 Yachi Feb 2009 A1
20090065565 Cao Mar 2009 A1
20090076506 Baker Mar 2009 A1
20090082716 Akahoshi Mar 2009 A1
20090082766 Unger et al. Mar 2009 A1
20090088745 Hushka et al. Apr 2009 A1
20090088785 Masuda Apr 2009 A1
20090090763 Zemlok et al. Apr 2009 A1
20090101692 Whitman et al. Apr 2009 A1
20090105750 Price et al. Apr 2009 A1
20090112206 Dumbauld et al. Apr 2009 A1
20090118751 Wiener et al. May 2009 A1
20090131885 Akahoshi May 2009 A1
20090131934 Odom May 2009 A1
20090138025 Stahler et al. May 2009 A1
20090143678 Keast et al. Jun 2009 A1
20090143799 Smith et al. Jun 2009 A1
20090143800 Deville et al. Jun 2009 A1
20090157064 Hodel Jun 2009 A1
20090163807 Sliwa Jun 2009 A1
20090177119 Heidner et al. Jul 2009 A1
20090179923 Amundson et al. Jul 2009 A1
20090182322 D'Amelio et al. Jul 2009 A1
20090182331 D'Amelio et al. Jul 2009 A1
20090182332 Long et al. Jul 2009 A1
20090182333 Eder Jul 2009 A1
20090192441 Gelbart et al. Jul 2009 A1
20090198272 Kerver et al. Aug 2009 A1
20090204114 Odom Aug 2009 A1
20090216157 Yamada Aug 2009 A1
20090223033 Houser Sep 2009 A1
20090240244 Malis et al. Sep 2009 A1
20090248021 McKenna Oct 2009 A1
20090248022 Falkenstein et al. Oct 2009 A1
20090254077 Craig Oct 2009 A1
20090254080 Honda Oct 2009 A1
20090259149 Tahara et al. Oct 2009 A1
20090264909 Beaupre Oct 2009 A1
20090270771 Takahashi Oct 2009 A1
20090270812 Litscher et al. Oct 2009 A1
20090270853 Yachi et al. Oct 2009 A1
20090270891 Beaupre Oct 2009 A1
20090270899 Carusillo et al. Oct 2009 A1
20090287205 Ingle Nov 2009 A1
20090292283 Odom Nov 2009 A1
20090299141 Downey et al. Dec 2009 A1
20090306639 Nevo et al. Dec 2009 A1
20090327715 Smith et al. Dec 2009 A1
20100004508 Naito et al. Jan 2010 A1
20100022825 Yoshie Jan 2010 A1
20100030233 Whitman et al. Feb 2010 A1
20100034605 Huckins et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100036373 Ward Feb 2010 A1
20100042093 Wham et al. Feb 2010 A9
20100049180 Wells et al. Feb 2010 A1
20100057081 Hanna Mar 2010 A1
20100057118 Dietz et al. Mar 2010 A1
20100063437 Nelson et al. Mar 2010 A1
20100063525 Beaupre et al. Mar 2010 A1
20100063528 Beaupre Mar 2010 A1
20100081863 Hess et al. Apr 2010 A1
20100081864 Hess et al. Apr 2010 A1
20100081883 Murray et al. Apr 2010 A1
20100094323 Isaacs et al. Apr 2010 A1
20100106173 Yoshimine Apr 2010 A1
20100109480 Forslund et al. May 2010 A1
20100145335 Johnson et al. Jun 2010 A1
20100158307 Kubota et al. Jun 2010 A1
20100168741 Sanai et al. Jul 2010 A1
20100181966 Sakakibara Jul 2010 A1
20100187283 Crainich et al. Jul 2010 A1
20100193566 Scheib et al. Aug 2010 A1
20100204721 Young et al. Aug 2010 A1
20100222714 Muir et al. Sep 2010 A1
20100222752 Collins, Jr. et al. Sep 2010 A1
20100225209 Goldberg et al. Sep 2010 A1
20100228249 Mohr et al. Sep 2010 A1
20100228250 Brogna Sep 2010 A1
20100234906 Koh Sep 2010 A1
20100256635 McKenna et al. Oct 2010 A1
20100274160 Yachi et al. Oct 2010 A1
20100274278 Fleenor et al. Oct 2010 A1
20100280368 Can et al. Nov 2010 A1
20100298743 Nield et al. Nov 2010 A1
20100305564 Livneh Dec 2010 A1
20100331742 Masuda Dec 2010 A1
20100331871 Nield et al. Dec 2010 A1
20110004233 Muir et al. Jan 2011 A1
20110015632 Artale Jan 2011 A1
20110015650 Choi et al. Jan 2011 A1
20110022032 Zemlok et al. Jan 2011 A1
20110028964 Edwards Feb 2011 A1
20110071523 Dickhans Mar 2011 A1
20110082494 Kerr et al. Apr 2011 A1
20110106141 Nakamura May 2011 A1
20110112400 Emery et al. May 2011 A1
20110125149 El-Galley et al. May 2011 A1
20110125151 Strauss et al. May 2011 A1
20110144640 Heinrich et al. Jun 2011 A1
20110160725 Kabaya et al. Jun 2011 A1
20110238010 Kirschenman et al. Sep 2011 A1
20110238079 Hannaford et al. Sep 2011 A1
20110273465 Konishi et al. Nov 2011 A1
20110278343 Knodel et al. Nov 2011 A1
20110279268 Konishi et al. Nov 2011 A1
20110282339 Weizman Nov 2011 A1
20110284014 Cadeddu et al. Nov 2011 A1
20110290856 Shelton, IV et al. Dec 2011 A1
20110295295 Shelton, IV et al. Dec 2011 A1
20110306967 Payne et al. Dec 2011 A1
20110313415 Fernandez et al. Dec 2011 A1
20120004655 Kim et al. Jan 2012 A1
20120016413 Timm et al. Jan 2012 A1
20120022519 Huang et al. Jan 2012 A1
20120022526 Aldridge et al. Jan 2012 A1
20120022528 White et al. Jan 2012 A1
20120022583 Sugalski et al. Jan 2012 A1
20120041358 Mann et al. Feb 2012 A1
20120053597 Anvari et al. Mar 2012 A1
20120059286 Hastings et al. Mar 2012 A1
20120059289 Nield et al. Mar 2012 A1
20120071863 Lee et al. Mar 2012 A1
20120078244 Worrell et al. Mar 2012 A1
20120080344 Shelton, IV Apr 2012 A1
20120101493 Masuda et al. Apr 2012 A1
20120101495 Young et al. Apr 2012 A1
20120109186 Parrott et al. May 2012 A1
20120116222 Sawada et al. May 2012 A1
20120116265 Houser et al. May 2012 A1
20120116266 Houser et al. May 2012 A1
20120116381 Houser et al. May 2012 A1
20120136279 Tanaka et al. May 2012 A1
20120136347 Brustad et al. May 2012 A1
20120136386 Kishida et al. May 2012 A1
20120143182 Ullrich et al. Jun 2012 A1
20120143211 Kishi Jun 2012 A1
20120150049 Zielinski et al. Jun 2012 A1
20120150169 Zielinksi et al. Jun 2012 A1
20120172904 Muir et al. Jul 2012 A1
20120191091 Allen Jul 2012 A1
20120193396 Zemlok et al. Aug 2012 A1
20120211542 Racenet Aug 2012 A1
20120226266 Ghosal et al. Sep 2012 A1
20120234893 Schuckmann et al. Sep 2012 A1
20120253328 Cunningham et al. Oct 2012 A1
20120253329 Zemlok et al. Oct 2012 A1
20120265241 Hart et al. Oct 2012 A1
20120296239 Chernov et al. Nov 2012 A1
20120296325 Takashino Nov 2012 A1
20120296371 Kappus et al. Nov 2012 A1
20130023925 Mueller Jan 2013 A1
20130071282 Fry Mar 2013 A1
20130085510 Stefanchik et al. Apr 2013 A1
20130103031 Garrison Apr 2013 A1
20130123776 Monson et al. May 2013 A1
20130158659 Bergs et al. Jun 2013 A1
20130158660 Bergs et al. Jun 2013 A1
20130165929 Muir et al. Jun 2013 A1
20130190760 Allen, IV et al. Jul 2013 A1
20130214025 Zemlok et al. Aug 2013 A1
20130253256 Griffith et al. Sep 2013 A1
20130253480 Kimball et al. Sep 2013 A1
20130264369 Whitman Oct 2013 A1
20130267874 Marcotte et al. Oct 2013 A1
20130277410 Fernandez et al. Oct 2013 A1
20130296843 Boudreaux et al. Nov 2013 A1
20130321425 Greene et al. Dec 2013 A1
20130334989 Kataoka Dec 2013 A1
20130345701 Allen, IV et al. Dec 2013 A1
20140001231 Shelton, IV et al. Jan 2014 A1
20140001234 Shelton, IV et al. Jan 2014 A1
20140005640 Shelton, IV et al. Jan 2014 A1
20140005663 Heard et al. Jan 2014 A1
20140005678 Shelton, IV et al. Jan 2014 A1
20140005702 Timm et al. Jan 2014 A1
20140005705 Weir et al. Jan 2014 A1
20140005718 Shelton, IV et al. Jan 2014 A1
20140014544 Bugnard et al. Jan 2014 A1
20140077426 Park Mar 2014 A1
20140107538 Wiener et al. Apr 2014 A1
20140121569 Schafer et al. May 2014 A1
20140135804 Weisenburgh, II et al. May 2014 A1
20140163541 Shelton, IV et al. Jun 2014 A1
20140163549 Yates et al. Jun 2014 A1
20140180274 Kabaya et al. Jun 2014 A1
20140194868 Sanai et al. Jul 2014 A1
20140194874 Dietz et al. Jul 2014 A1
20140194875 Reschke et al. Jul 2014 A1
20140207124 Aldridge et al. Jul 2014 A1
20140207135 Winter Jul 2014 A1
20140214025 Worrell Jul 2014 A1
20140221994 Reschke Aug 2014 A1
20140236152 Walberg et al. Aug 2014 A1
20140246475 Hall et al. Sep 2014 A1
20140249557 Koch et al. Sep 2014 A1
20140263541 Leimbach et al. Sep 2014 A1
20140263552 Hall et al. Sep 2014 A1
20140276794 Batchelor et al. Sep 2014 A1
20140276797 Batchelor et al. Sep 2014 A1
20140276798 Batchelor et al. Sep 2014 A1
20140303605 Boyden et al. Oct 2014 A1
20140303612 Williams Oct 2014 A1
20140357984 Wallace et al. Dec 2014 A1
20140373003 Grez et al. Dec 2014 A1
20150014392 Williams et al. Jan 2015 A1
20150025528 Arts Jan 2015 A1
20150032150 Ishida et al. Jan 2015 A1
20150048140 Penna et al. Feb 2015 A1
20150066027 Garrison et al. Mar 2015 A1
20150080876 Worrell et al. Mar 2015 A1
20150080887 Sobajima et al. Mar 2015 A1
20150080889 Cunningham et al. Mar 2015 A1
20150088122 Jensen Mar 2015 A1
20150100056 Nakamura Apr 2015 A1
20150112335 Boudreaux et al. Apr 2015 A1
20150119901 Steege Apr 2015 A1
20150157356 Gee Jun 2015 A1
20150164533 Felder et al. Jun 2015 A1
20150164534 Felder et al. Jun 2015 A1
20150164535 Felder et al. Jun 2015 A1
20150164536 Czarnecki et al. Jun 2015 A1
20150164537 Cagle et al. Jun 2015 A1
20150164538 Aldridge et al. Jun 2015 A1
20150230796 Calderoni Aug 2015 A1
20150238260 Nau, Jr. Aug 2015 A1
20150272557 Overmyer et al. Oct 2015 A1
20150272571 Leimbach et al. Oct 2015 A1
20150272580 Leimbach et al. Oct 2015 A1
20150272581 Leimbach et al. Oct 2015 A1
20150272582 Leimbach et al. Oct 2015 A1
20150272657 Yates et al. Oct 2015 A1
20150272659 Boudreaux et al. Oct 2015 A1
20150282879 Ruelas Oct 2015 A1
20150289364 Ilkko et al. Oct 2015 A1
20150313667 Allen, IV Nov 2015 A1
20150317899 Dumbauld et al. Nov 2015 A1
20150351765 Valentine et al. Dec 2015 A1
20150351857 Vander Poorten et al. Dec 2015 A1
20150374430 Weiler et al. Dec 2015 A1
20150374457 Colby Dec 2015 A1
20160000437 Giordano et al. Jan 2016 A1
20160038228 Daniel et al. Feb 2016 A1
20160044841 Chamberlain Feb 2016 A1
20160045248 Unger et al. Feb 2016 A1
20160051314 Batchelor et al. Feb 2016 A1
20160051316 Boudreaux Feb 2016 A1
20160066909 Swayze et al. Mar 2016 A1
20160066913 Swayze et al. Mar 2016 A1
20160120601 Boudreaux et al. May 2016 A1
20160175025 Strobl Jun 2016 A1
20160175029 Witt et al. Jun 2016 A1
20160206342 Robertson et al. Jul 2016 A1
20160228171 Boudreaux Aug 2016 A1
20160249910 Shelton, IV et al. Sep 2016 A1
20160262786 Madan et al. Sep 2016 A1
20160270842 Strobl et al. Sep 2016 A1
20160296251 Olson et al. Oct 2016 A1
20160296252 Olson et al. Oct 2016 A1
20160296270 Strobl et al. Oct 2016 A1
20160317216 Hermes et al. Nov 2016 A1
20160331455 Hancock et al. Nov 2016 A1
20160358849 Jur et al. Dec 2016 A1
20170020614 Jackson et al. Jan 2017 A1
20170065331 Mayer et al. Mar 2017 A1
20170086909 Yates et al. Mar 2017 A1
20170119426 Akagane May 2017 A1
20170135751 Rothweiler et al. May 2017 A1
20170164972 Johnson et al. Jun 2017 A1
20170164997 Johnson et al. Jun 2017 A1
20170189095 Danziger et al. Jul 2017 A1
20170202591 Shelton, IV Jul 2017 A1
20170202595 Shelton, IV Jul 2017 A1
20170209145 Swayze et al. Jul 2017 A1
20170224332 Hunter et al. Aug 2017 A1
20170224405 Takashino et al. Aug 2017 A1
20170231628 Shelton, IV et al. Aug 2017 A1
20170281186 Shelton, IV et al. Oct 2017 A1
20170296169 Yates et al. Oct 2017 A1
20170296177 Harris et al. Oct 2017 A1
20170296180 Harris et al. Oct 2017 A1
20170303954 Ishii Oct 2017 A1
20170312018 Trees et al. Nov 2017 A1
20170325874 Noack et al. Nov 2017 A1
20170333073 Faller et al. Nov 2017 A1
20170348043 Wang et al. Dec 2017 A1
20170348044 Wang et al. Dec 2017 A1
20170367772 Gunn et al. Dec 2017 A1
20180014872 Dickerson Jan 2018 A1
20180085157 Batchelor et al. Mar 2018 A1
20180098785 Price et al. Apr 2018 A1
20180132850 Leimbach et al. May 2018 A1
20180168575 Simms et al. Jun 2018 A1
20180168577 Aronhalt et al. Jun 2018 A1
20180168579 Aronhalt et al. Jun 2018 A1
20180168592 Overmyer et al. Jun 2018 A1
20180168598 Shelton, IV et al. Jun 2018 A1
20180168608 Shelton, IV et al. Jun 2018 A1
20180168609 Fanelli et al. Jun 2018 A1
20180168610 Shelton, IV et al. Jun 2018 A1
20180168615 Shelton, IV et al. Jun 2018 A1
20180168618 Scott et al. Jun 2018 A1
20180168619 Scott et al. Jun 2018 A1
20180168623 Simms et al. Jun 2018 A1
20180168625 Posada et al. Jun 2018 A1
20180168633 Shelton, IV et al. Jun 2018 A1
20180168647 Shelton, IV et al. Jun 2018 A1
20180168648 Shelton, IV et al. Jun 2018 A1
20180168650 Shelton, IV et al. Jun 2018 A1
20180188125 Park et al. Jul 2018 A1
20180206904 Felder et al. Jul 2018 A1
20180221045 Zimmerman et al. Aug 2018 A1
20180235691 Voegele et al. Aug 2018 A1
20180250066 Ding et al. Sep 2018 A1
20180271578 Coulombe Sep 2018 A1
20180289432 Kostrzewski et al. Oct 2018 A1
20180303493 Chapolini Oct 2018 A1
20180325517 Wingardner et al. Nov 2018 A1
20180333179 Weisenburgh, II et al. Nov 2018 A1
20180353245 Mccloud et al. Dec 2018 A1
20180368844 Bakos et al. Dec 2018 A1
20190000459 Shelton, IV et al. Jan 2019 A1
20190000461 Shelton, IV et al. Jan 2019 A1
20190000462 Shelton, IV et al. Jan 2019 A1
20190000474 Shelton, IV et al. Jan 2019 A1
20190000475 Shelton, IV et al. Jan 2019 A1
20190000476 Shelton, IV et al. Jan 2019 A1
20190000477 Shelton, IV et al. Jan 2019 A1
20190029746 Dudhedia et al. Jan 2019 A1
20190038282 Shelton, IV et al. Feb 2019 A1
20190038283 Shelton, IV et al. Feb 2019 A1
20190053818 Nelson et al. Feb 2019 A1
20190104919 Shelton, IV et al. Apr 2019 A1
20190105067 Boudreaux et al. Apr 2019 A1
20190117293 Kano et al. Apr 2019 A1
20190125361 Shelton, IV et al. May 2019 A1
20190125384 Scheib et al. May 2019 A1
20190125390 Shelton, IV et al. May 2019 A1
20190175258 Tsuruta Jun 2019 A1
20190183504 Shelton, IV et al. Jun 2019 A1
20190200844 Shelton, IV et al. Jul 2019 A1
20190200977 Shelton, IV et al. Jul 2019 A1
20190200981 Harris et al. Jul 2019 A1
20190200987 Shelton, IV et al. Jul 2019 A1
20190201029 Shelton, IV et al. Jul 2019 A1
20190201030 Shelton, IV et al. Jul 2019 A1
20190201045 Yates et al. Jul 2019 A1
20190201046 Shelton, IV et al. Jul 2019 A1
20190201047 Yates et al. Jul 2019 A1
20190201048 Stulen et al. Jul 2019 A1
20190201104 Shelton, IV et al. Jul 2019 A1
20190201136 Shelton, IV et al. Jul 2019 A1
20190201137 Shelton, IV et al. Jul 2019 A1
20190201594 Shelton, IV et al. Jul 2019 A1
20190206562 Shelton, IV et al. Jul 2019 A1
20190206563 Shelton, IV et al. Jul 2019 A1
20190206564 Shelton, IV et al. Jul 2019 A1
20190206565 Shelton, IV Jul 2019 A1
20190206569 Shelton, IV et al. Jul 2019 A1
20190208641 Yates et al. Jul 2019 A1
20190209201 Boudreaux et al. Jul 2019 A1
20190223941 Kitamura et al. Jul 2019 A1
20190262030 Faller et al. Aug 2019 A1
20190269455 Mensch et al. Sep 2019 A1
20190274700 Robertson et al. Sep 2019 A1
20190282288 Boudreaux Sep 2019 A1
20190290265 Shelton, IV et al. Sep 2019 A1
20190298340 Shelton, IV et al. Oct 2019 A1
20190298350 Shelton, IV et al. Oct 2019 A1
20190298352 Shelton, IV et al. Oct 2019 A1
20190298353 Shelton, IV et al. Oct 2019 A1
20190366562 Zhang et al. Dec 2019 A1
20190388091 Eschbach et al. Dec 2019 A1
20200030021 Yates et al. Jan 2020 A1
20200054321 Harris et al. Feb 2020 A1
20200054382 Yates et al. Feb 2020 A1
20200078076 Henderson et al. Mar 2020 A1
20200078085 Yates et al. Mar 2020 A1
20200078106 Henderson et al. Mar 2020 A1
20200078609 Messerly et al. Mar 2020 A1
20200085465 Timm et al. Mar 2020 A1
20200100825 Henderson et al. Apr 2020 A1
20200100830 Henderson et al. Apr 2020 A1
20200113622 Honegger Apr 2020 A1
20200129261 Eschbach Apr 2020 A1
20200138473 Shelton, IV et al. May 2020 A1
20200188047 Itkowitz et al. Jun 2020 A1
20200222111 Yates et al. Jul 2020 A1
20200222112 Hancock et al. Jul 2020 A1
20200229833 Vakharia et al. Jul 2020 A1
20200229834 Olson et al. Jul 2020 A1
20200237434 Scheib et al. Jul 2020 A1
20200261078 Bakos et al. Aug 2020 A1
20200261086 Zeiner et al. Aug 2020 A1
20200261087 Timm et al. Aug 2020 A1
20200261141 Wiener et al. Aug 2020 A1
20200268430 Takei et al. Aug 2020 A1
20200268433 Wiener et al. Aug 2020 A1
20200305870 Shelton, IV Oct 2020 A1
20200315623 Eisinger et al. Oct 2020 A1
20200315712 Jasperson et al. Oct 2020 A1
20200338370 Wiener et al. Oct 2020 A1
20200405296 Shelton, IV et al. Dec 2020 A1
20200405302 Shelton, IV et al. Dec 2020 A1
20200405312 Shelton, IV et al. Dec 2020 A1
20200405314 Shelton, IV et al. Dec 2020 A1
20200405316 Shelton, IV et al. Dec 2020 A1
20200405409 Shelton, IV et al. Dec 2020 A1
20200405410 Shelton, IV Dec 2020 A1
20200405437 Shelton, IV et al. Dec 2020 A1
20200405439 Shelton, IV et al. Dec 2020 A1
20200410177 Shelton, IV Dec 2020 A1
20210052313 Shelton, IV et al. Feb 2021 A1
20210100578 Weir et al. Apr 2021 A1
20210100579 Shelton, IV et al. Apr 2021 A1
20210153927 Ross et al. May 2021 A1
20210177481 Shelton, IV et al. Jun 2021 A1
20210177494 Houser et al. Jun 2021 A1
20210177496 Shelton, IV et al. Jun 2021 A1
20210186492 Shelton, IV et al. Jun 2021 A1
20210186493 Shelton, IV et al. Jun 2021 A1
20210186494 Shelton, IV et al. Jun 2021 A1
20210186495 Shelton, IV et al. Jun 2021 A1
20210186497 Shelton, IV et al. Jun 2021 A1
20210186498 Boudreaux et al. Jun 2021 A1
20210186499 Shelton, IV et al. Jun 2021 A1
20210186500 Shelton, IV et al. Jun 2021 A1
20210186501 Shelton, IV et al. Jun 2021 A1
20210186502 Shelton, IV et al. Jun 2021 A1
20210186504 Shelton, IV et al. Jun 2021 A1
20210186505 Shelton, IV et al. Jun 2021 A1
20210186507 Shelton, IV et al. Jun 2021 A1
20210186553 Green et al. Jun 2021 A1
20210186554 Green et al. Jun 2021 A1
20210196263 Shelton, IV et al. Jul 2021 A1
20210196265 Shelton, IV et al. Jul 2021 A1
20210196266 Shelton, IV et al. Jul 2021 A1
20210196267 Shelton, IV et al. Jul 2021 A1
20210196268 Shelton, IV et al. Jul 2021 A1
20210196269 Shelton, IV et al. Jul 2021 A1
20210196270 Shelton, IV et al. Jul 2021 A1
20210196271 Shelton, IV et al. Jul 2021 A1
20210196301 Shelton, IV et al. Jul 2021 A1
20210196302 Shelton, IV et al. Jul 2021 A1
20210196305 Strobl Jul 2021 A1
20210196306 Estera et al. Jul 2021 A1
20210196307 Shelton, IV Jul 2021 A1
20210196334 Sarley et al. Jul 2021 A1
20210196335 Messerly et al. Jul 2021 A1
20210196336 Faller et al. Jul 2021 A1
20210196343 Shelton, IV et al. Jul 2021 A1
20210196344 Shelton, IV et al. Jul 2021 A1
20210196345 Messerly et al. Jul 2021 A1
20210196349 Fiebig et al. Jul 2021 A1
20210196350 Fiebig et al. Jul 2021 A1
20210196351 Sarley et al. Jul 2021 A1
20210196352 Messerly et al. Jul 2021 A1
20210196353 Gee et al. Jul 2021 A1
20210196354 Shelton, IV et al. Jul 2021 A1
20210196355 Shelton, IV et al. Jul 2021 A1
20210196356 Shelton, IV et al. Jul 2021 A1
20210196357 Shelton, IV et al. Jul 2021 A1
20210196358 Shelton, IV et al. Jul 2021 A1
20210196359 Shelton, IV et al. Jul 2021 A1
20210196360 Shelton, IV et al. Jul 2021 A1
20210196361 Shelton, IV et al. Jul 2021 A1
20210196362 Shelton, IV et al. Jul 2021 A1
20210196363 Shelton, IV et al. Jul 2021 A1
20210196364 Shelton, IV et al. Jul 2021 A1
20210196365 Shelton, IV et al. Jul 2021 A1
20210196366 Shelton, IV et al. Jul 2021 A1
20210196367 Salguero et al. Jul 2021 A1
20210212744 Shelton, IV et al. Jul 2021 A1
20210212754 Olson Jul 2021 A1
20210220036 Shelton, IV et al. Jul 2021 A1
20210236195 Asher et al. Aug 2021 A1
20210282804 Worrell et al. Sep 2021 A1
20210393288 Shelton, IV et al. Dec 2021 A1
20210393314 Wiener et al. Dec 2021 A1
20210393319 Shelton, IV et al. Dec 2021 A1
20220039891 Stulen et al. Feb 2022 A1
20220071655 Price et al. Mar 2022 A1
20220167982 Shelton, IV et al. Jun 2022 A1
20220168005 Aldridge et al. Jun 2022 A1
20220168039 Worrell et al. Jun 2022 A1
20220226014 Clauda, IV et al. Jul 2022 A1
20220304736 Boudreaux Sep 2022 A1
20220313297 Aldridge et al. Oct 2022 A1
20220346863 Yates et al. Nov 2022 A1
20220387067 Faller et al. Dec 2022 A1
20220406452 Shelton, IV Dec 2022 A1
20230038162 Timm et al. Feb 2023 A1
20230048996 Vakharia et al. Feb 2023 A1
20230270486 Wiener et al. Aug 2023 A1
20230277205 Olson et al. Sep 2023 A1
Foreign Referenced Citations (177)
Number Date Country
2535467 Apr 1993 CA
2460047 Nov 2001 CN
1634601 Jul 2005 CN
1775323 May 2006 CN
1922563 Feb 2007 CN
2868227 Feb 2007 CN
201029899 Mar 2008 CN
101474081 Jul 2009 CN
101516285 Aug 2009 CN
101522112 Sep 2009 CN
102100582 Jun 2011 CN
102149312 Aug 2011 CN
202027624 Nov 2011 CN
102792181 Nov 2012 CN
103281982 Sep 2013 CN
103379853 Oct 2013 CN
203468630 Mar 2014 CN
104001276 Aug 2014 CN
104013444 Sep 2014 CN
104434298 Mar 2015 CN
107374752 Nov 2017 CN
3904558 Aug 1990 DE
9210327 Nov 1992 DE
4300307 Jul 1994 DE
29623113 Oct 1997 DE
20004812 Sep 2000 DE
20021619 Mar 2001 DE
10042606 Aug 2001 DE
10201569 Jul 2003 DE
102012109037 Apr 2014 DE
0171967 Feb 1986 EP
0336742 Oct 1989 EP
0136855 Nov 1989 EP
0705571 Apr 1996 EP
1698289 Sep 2006 EP
1862133 Dec 2007 EP
1972264 Sep 2008 EP
2060238 May 2009 EP
1747761 Oct 2009 EP
2131760 Dec 2009 EP
1214913 Jul 2010 EP
1946708 Jun 2011 EP
1767164 Jan 2013 EP
2578172 Apr 2013 EP
2668922 Dec 2013 EP
2076195 Dec 2015 EP
2510891 Jun 2016 EP
3476302 May 2019 EP
3476331 May 2019 EP
3694298 Aug 2020 EP
2032221 Apr 1980 GB
2317566 Apr 1998 GB
S50100891 Aug 1975 JP
S5968513 May 1984 JP
S59141938 Aug 1984 JP
S62221343 Sep 1987 JP
S62227343 Oct 1987 JP
S62292153 Dec 1987 JP
S62292154 Dec 1987 JP
S63109386 May 1988 JP
S63315049 Dec 1988 JP
H01151452 Jun 1989 JP
H01198540 Aug 1989 JP
H0271510 May 1990 JP
H02286149 Nov 1990 JP
H02292193 Dec 1990 JP
H0337061 Feb 1991 JP
H0425707 Feb 1992 JP
H0464351 Feb 1992 JP
H0430508 Mar 1992 JP
H04152942 May 1992 JP
H 0541716 Feb 1993 JP
H0576482 Mar 1993 JP
H0595955 Apr 1993 JP
H05115490 May 1993 JP
H0670938 Mar 1994 JP
H06104503 Apr 1994 JP
H0824266 Jan 1996 JP
H08229050 Sep 1996 JP
H08275951 Oct 1996 JP
H08299351 Nov 1996 JP
H08336545 Dec 1996 JP
H09130655 May 1997 JP
H09135553 May 1997 JP
H09140722 Jun 1997 JP
H105237 Jan 1998 JP
10127654 May 1998 JP
H10295700 Nov 1998 JP
H11128238 May 1999 JP
H11169381 Jun 1999 JP
2000210299 Aug 2000 JP
2000271142 Oct 2000 JP
2000271145 Oct 2000 JP
2000287987 Oct 2000 JP
2001029353 Feb 2001 JP
2002059380 Feb 2002 JP
2002186901 Jul 2002 JP
2002263579 Sep 2002 JP
2002330977 Nov 2002 JP
2003000612 Jan 2003 JP
2003010201 Jan 2003 JP
2003116870 Apr 2003 JP
2003126104 May 2003 JP
2003126110 May 2003 JP
2003153919 May 2003 JP
2003339730 Dec 2003 JP
2004129871 Apr 2004 JP
2004147701 May 2004 JP
2005003496 Jan 2005 JP
2005027026 Jan 2005 JP
2005074088 Mar 2005 JP
2005337119 Dec 2005 JP
2006068396 Mar 2006 JP
2006081664 Mar 2006 JP
2006114072 Apr 2006 JP
2006217716 Aug 2006 JP
2006288431 Oct 2006 JP
2007037568 Feb 2007 JP
200801876 Jan 2008 JP
2008017876 Jan 2008 JP
200833644 Feb 2008 JP
2008188160 Aug 2008 JP
D1339835 Aug 2008 JP
2010009686 Jan 2010 JP
2010121865 Jun 2010 JP
2012071186 Apr 2012 JP
2012223582 Nov 2012 JP
2012235658 Nov 2012 JP
2013126430 Jun 2013 JP
100789356 Dec 2007 KR
101298237 Aug 2013 KR
2154437 Aug 2000 RU
22035 Mar 2002 RU
2201169 Mar 2003 RU
2405603 Dec 2010 RU
2013119977 Nov 2014 RU
850068 Jul 1981 SU
WO-8103272 Nov 1981 WO
WO-9308757 May 1993 WO
WO-9314708 Aug 1993 WO
WO-9421183 Sep 1994 WO
WO-9424949 Nov 1994 WO
WO-9639086 Dec 1996 WO
WO-9712557 Apr 1997 WO
WO-9800069 Jan 1998 WO
WO-9840015 Sep 1998 WO
WO-9920213 Apr 1999 WO
WO-9923960 May 1999 WO
WO-0024330 May 2000 WO
WO-0064358 Nov 2000 WO
WO-0128444 Apr 2001 WO
WO-0167970 Sep 2001 WO
WO-0172251 Oct 2001 WO
WO-0195810 Dec 2001 WO
WO-02080793 Oct 2002 WO
WO-03095028 Nov 2003 WO
WO-2004037095 May 2004 WO
WO-2004078051 Sep 2004 WO
WO-2004098426 Nov 2004 WO
WO-2006091494 Aug 2006 WO
WO-2007008710 Jan 2007 WO
WO-2008118709 Oct 2008 WO
WO-2008130793 Oct 2008 WO
WO-2010027109 Mar 2010 WO
WO-2010104755 Sep 2010 WO
WO-2011008672 Jan 2011 WO
WO-2011044343 Apr 2011 WO
WO-2011052939 May 2011 WO
WO-2011060031 May 2011 WO
WO-2011092464 Aug 2011 WO
WO-2012044606 Apr 2012 WO
WO-2012061722 May 2012 WO
WO-2012088535 Jun 2012 WO
WO-2012150567 Nov 2012 WO
WO-2016130844 Aug 2016 WO
WO-2019130090 Jul 2019 WO
WO-2019130113 Jul 2019 WO
Non-Patent Literature Citations (63)
Entry
IEEE Std 802.3-2012 (Revision of IEEE Std 802.3-2008, published Dec. 28, 2012.
“ATM-MPLS Network Interworking Version 2.0, af-aic-0178.001” ATM Standard, The ATM Forum Technical Committee, published Aug. 2003.
Missinne, et al. “Stretchable Optical Waveguides,” vol. 22, No. 4, Feb. 18, 2014, pp. 4168-4179 (12 pages).
Covidien Brochure, [Value Analysis Brief], LigaSure Advance™ Pistol Grip, dated Rev. Apr. 2010 (7 pages).
Wright, et al., “Time-Temperature Equivalence of Heat-Induced Changes in Cells and Proteins,” Feb. 1998. ASME Journal of Biomechanical Engineering, vol. 120, pp. 22-26.
Covidien Brochure, LigaSure Impact™ Instrument LF4318, dated Feb. 2013 (3 pages).
Covidien Brochure, LigaSure Atlas™ Hand Switching Instruments, dated Dec. 2008 (2 pages).
Covidien Brochure, The LigaSure™ 5 mm Blunt Tip Sealer/Divider Family, dated Apr. 2013 (2 pages).
Jang, J. et al. “Neuro-fuzzy and Soft Computing.” Prentice Hall, 1997, pp. 13-89, 199-293, 335-393, 453-496, 535-549.
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291.
Weir, C.E., “Rate of shrinkage of tendon collagen—heat, entropy and free energy of activation of the shrinkage of untreated tendon. Effect of acid salt, pickle, and tannage on the activation of tendon collagen.” Journal of the American Leather Chemists Association, 44, pp. 108-140 (1949).
Wall et al., “Thermal modification of collagen,” J Shoulder Elbow Surg, No. 8, pp. 339-344 (Jul./Aug. 1999).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal Free Shrinkage,” Transactions of the ASME, vol. 119, pp. 372-378 (Nov. 1997).
Chen et al., “Phenomenological Evolution Equations for Heat-Induced Shrinkage of a Collagenous Tissue,” IEEE Transactions on Biomedical Engineering, vol. 45, No. 10, pp. 1234-1240 (Oct. 1998).
Harris et al., “Kinetics of Thermal Damage to a Collagenous Membrane Under Biaxial Isotonic Loading,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 2, pp. 371-379 (Feb. 2004).
Harris et al., “Altered Mechanical Behavior of Epicardium Due to Isothermal Heating Under Biaxial Isotonic Loads,” Journal of Biomechanical Engineering, vol. 125, pp. 381-388 (Jun. 2003).
Lee et al., “A multi-sample denaturation temperature tester for collagenous biomaterials,” Med. Eng. Phy., vol. 17, No. 2, pp. 115-121 (Mar. 1995).
Moran et al., “Thermally Induced Shrinkage of Joint Capsule,” Clinical Orthopaedics and Related Research, No. 281, pp. 248-255 (Dec. 2000).
Wells et al., “Altered Mechanical Behavior of Epicardium Under Isothermal Biaxial Loading,” Transactions of the ASME, Journal of Biomedical Engineering, vol. 126, pp. 492-497 (Aug. 2004).
Gibson, “Magnetic Refrigerator Successfully Tested,” U.S. Department of Energy Research News, accessed online on Aug. 6, 2010 at http://www.eurekalert.org/features/doe/2001-11/dl-mrs062802.php (Nov. 1, 2001).
Humphrey, J.D., “Continuum Thermomechanics and the Clinical Treatment of Disease and Injury,” Appl. Mech. Rev., vol. 56, No. 2 pp. 231-260 (Mar. 2003).
National Semiconductors Temperature Sensor Handbook—http://www.national.com/appinfo/tempsensors/files/temphb.pdf; accessed online: Apr. 1, 2011.
Hayashi et al., “The Effect of Thermal Heating on the Length and Histologic Properties of the Glenohumeral Joint Capsule,” American Journal of Sports Medicine, vol. 25, Issue 1, 11 pages (Jan. 1997), URL: http://www.mdconsult.com/das/article/body/156183648-2/jorg=journal&source=MI&sp=1 . . . , accessed Aug. 25, 2009.
Douglas, S.C. “Introduction to Adaptive Filter”. Digital Signal Processing Handbook. Ed. Vijay K. Madisetti and Douglas B. Williams. Boca Raton: CRC Press LLC, 1999.
Chen et al., “Heat-induced changes in the mechanics of a collagenous tissue: pseudoelastic behavior at 37° C.,” Journal of Biomechanics, 31, pp. 211-216 (1998).
Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages).
Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002.
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006).
Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003).
Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973).
Incropera et al., Fundamentals of Heat and Mass Transfer, Wiley, New York (1990). (Book—not attached).
F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990).
http://www.apicalinstr.com/generators.htm.
http://www.dotmed.com/listing/electrosurical-unit/ethicon/ultracision-g110-/1466724.
http:/www.ethicon.com/gb-en/healthcare-professionals/products/energy-devices/capital//ge . . . .
http://www.medicalexpo.com/medical-manufacturer/electrosurgical-generator-6951.html.
http://www.megadyne.com/es_generator.php.
http://www.valleylab.com/product/es/generators/index.html.
Graff, K.F., “Elastic Wave Propagation in a Curved Sonic Transmission Line,” IEEE Transactions on Sonics and Ultrasonics, SU-17(1), 1-6 (1970).
Makarov, S. N., Ochmann, M., Desinger, K., “The longitudinal vibration response of a curved fiber used for laser ultrasound surgical therapy,” Journal of the Acoustical Society of America 102, 1191-1199 (1997).
Walsh, S. J., White, R. G., “Vibrational Power Transmission in Curved Beams,” Journal of Sound and Vibration, 233(3), 455-488 (2000).
Covidien 501(k) Summary Sonicision, dated Feb. 24, 2011 (7 pages).
Morley, L. S. D., “Elastic Waves in a Naturally Curved Rod,” Quarterly Journal of Mechanics and Applied Mathematics, 14: 155-172 (1961).
Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages).
Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288.
Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995).
Fowler, K.R., “A Programmable, Arbitrary Waveform Electrosurgical Device,” IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, pp. 1324, 1325 (1988).
LaCourse, J.R.; Vogt, M.C.; Miller, W.T., III; Selikowitz, S.M., “Spectral Analysis Interpretation of Electrosurgical Generator Nerve and Muscle Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, pp. 505-509, Jul. 1988.
Campbell et al, “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008).
Gerhard, Glen C., “Surgical Electrotechnology: Quo Vadis?,” IEEE Transactions on Biomedical Engineering, vol. BME-31, No. 12, pp. 787-792, Dec. 1984.
http://www.4-traders.com/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-Ethicon-E . . . .
Henriques. F.C., “Studies in thermal injury V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury.” Archives of Pathology, 434, pp. 489-502 (1947).
Arnoczky et al., “Thermal Modification of Conective Tissues: Basic Science Considerations and Clinical Implications,” J. Am Acad Orthop Surg, vol. 8, No. 5, pp. 305-313 (Sep./Oct. 2000).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal, Isotonic Shrinkage,” Transactions of the ASME, vol. 120, pp. 382-388 (Jun. 1998).
Kurt Gieck & Reiner Gieck, Engineering Formulas § Z.7 (7th ed. 1997).
https://www.kjmagnetics.com/fieldcalculator.asp, retrieved Jul. 11, 2016, backdated to Nov. 11, 2011 via https://web.archive.org/web/20111116164447/http://www.kjmagnetics.com/fieldcalculator.asp.
Leonard I. Malis, M.D., “The Value of Irrigation During Bipolar Coagulation,” 1989.
Covidien Brochure, The LigaSure Precise™ Instrument, dated Mar. 2011 (2 pages).
Glaser and Subak-Sharpe, Integrated Circuit Engineering, Addison-Wesley Publishing, Reading, MA (1979). (book—not attached).
Erbe Electrosurgery VIO® 200 S, (2012), p. 7, 12 pages, accessed Mar. 31, 2014 at http://www.erbe-med. com/erbe/media/Marketing materialien/85140170 ERBE EN VIO 200 S D027541.
Hörmann et al., “Reversible and irreversible denaturation of collagen fibers.” Biochemistry, 10, pp. 932-937 (1971).
Dean, D.A., “Electrical Impedance Spectroscopy Study of Biological Tissues,” J. Electrostat, 66(3-4), Mar. 2008, pp. 165-177. Accessed Apr. 10, 2018: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597841/.
Moraleda et al., A Temperature Sensor Based on a Polymer Optical Fiber Macro-Bend, Sensors 2013, 13, 13076-13089, doi: 10.3390/s131013076, ISSN 1424-8220.
Related Publications (1)
Number Date Country
20210196346 A1 Jul 2021 US
Provisional Applications (1)
Number Date Country
62955292 Dec 2019 US